Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 99
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021)

  • Govarts, Eva
  • Montazeri, Parisa, 1988-
  • Schoeters, Greet
As one of the core elements of the European Human Biomonitoring Initiative (HBM4EU) a human biomonitoring (HBM) survey was conducted in 23 countries to generate EU-wide comparable HBM data. This survey has built on existing HBM capacity in Europe by aligning national or regional HBM studies, referred to as the HBM4EU Aligned Studies. The HBM4EU Aligned Studies included a total of 10,795 participants of three age groups: (i) 3,576 children aged 6-12 years, (ii) 3,117 teenagers aged 12-18 years and (iii) 4,102 young adults aged 20-39 years. The participants were recruited between 2014 and 2021 in 11-12 countries per age group, geographically distributed across Europe. Depending on the age group, internal exposure to phthalates and the substitute DINCH, halogenated and organophosphorus flame retardants, per- and polyfluoroalkyl substances (PFASs), cadmium, bisphenols, polycyclic aromatic hydrocarbons (PAHs), arsenic species, acrylamide, mycotoxins (deoxynivalenol (total DON)), benzophenones and selected pesticides was assessed by measuring substance specific biomarkers subjected to stringent quality control programs for chemical analysis. For substance groups analyzed in different age groups higher average exposure levels were observed in the youngest age group, i.e., phthalates/DINCH in children versus teenagers, acrylamide and pesticides in children versus adults, benzophenones in teenagers versus adults. Many biomarkers in teenagers and adults varied significantly according to educational attainment, with higher exposure levels of bisphenols, phthalates, benzophenones, PAHs and acrylamide in participants (from households) with lower educational attainment, while teenagers from households with higher educational attainment have higher exposure levels for PFASs and arsenic. In children, a social gradient was only observed for the non-specific pyrethroid metabolite 3-PBA and di-isodecyl phthalate (DiDP), with higher levels in children from households with higher educational attainment. Geographical variations were seen for all exposure biomarkers. For 15 biomarkers, the available health-based HBM guidance values were exceeded with highest exceedance rates for toxicologically relevant arsenic in teenagers (40%), 3-PBA in children (36%), and between 11 and 14% for total DON, Σ (PFOA + PFNA + PFHxS + PFOS), bisphenol S and cadmium. The infrastructure and harmonized approach succeeded in obtaining comparable European wide internal exposure data for a prioritized set of 11 chemical groups. These data serve as a reference for comparison at the global level, provide a baseline to compare the efficacy of the European Commission's chemical strategy for sustainability and will give leverage to national policy makers for the implementation of targeted measures., We would like to acknowledge Sun Kyoung Jung from the National Institute of Environmental Research of South-Korea for providing the KoNEHS Cycle III results (crt adjusted). HBM4EU is co-financed under Horizon 2020 (grant agreement No 733032). The authors thank all principal investigators of the contributing studies for their participation and contribution to the HBM4EU Aligned Studies and the national program owners for their financial support. Further details on funding for all the participating studies can be found in the Supplemental Material, Table S12.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: a panel study

  • Fabbri, Lorenzo
  • Garlantézec, Ronan
  • Audouze, Karine
  • Bustamante Pineda, Mariona
  • Carracedo, Ángel
  • Chatzi, Leda
  • González, Juan Ramón
  • Gražulevičienė, Regina
  • Keun, Hector C.
  • Lau, Chung-Ho E.
  • Sabidó Aguadé, Eduard, 1981-
  • Siskos, Alexandros P.
  • Slama, Rémy
  • Thomsen, Cathrine
  • Wright, John
  • Yuan, Wen Lun
  • Casas, Maribel
  • Vrijheid, Martine
  • Maitre, Léa
Individuals are exposed to environmental pollutants with endocrine disrupting activity (endocrine disruptors, EDCs) and the early stages of life are particularly susceptible to these exposures. Previous studies have focused on identifying molecular signatures associated with EDCs, but none have used repeated sampling strategy and integrated multiple omics. We aimed to identify multi-omic signatures associated with childhood exposure to non-persistent EDCs. We used data from the HELIX Child Panel Study, which included 156 children aged 6 to 11. Children were followed for one week, in two time periods. Twenty-two non-persistent EDCs (10 phthalate, 7 phenol, and 5 organophosphate pesticide metabolites) were measured in two weekly pools of 15 urine samples each. Multi-omic profiles (methylome, serum and urinary metabolome, proteome) were measured in blood and in a pool urine samples. We developed visit-specific Gaussian Graphical Models based on pairwise partial correlations. The visit-specific networks were then merged to identify reproducible associations. Independent biological evidence was systematically sought to confirm some of these associations and assess their potential health implications. 950 reproducible associations were found among which 23 were direct associations between EDCs and omics. For 9 of them, we were able to find corroborating evidence from previous literature: DEP - serotonin, OXBE - cg27466129, OXBE - dimethylamine, triclosan - leptin, triclosan - serotonin, MBzP - Neu5AC, MEHP - cg20080548, oh-MiNP - kynurenine, oxo-MiNP − 5-oxoproline. We used these associations to explore possible mechanisms between EDCs and health outcomes, and found links to health outcomes for 3 analytes: serotonin and kynurenine in relation to neuro-behavioural development, and leptin in relation to obesity and insulin resistance. This multi-omics network analysis at two time points identified biologically relevant molecular signatures related to non-persistent EDC exposure in childhood, suggesting pathways related to neurological and metabolic outcomes., The research leading to these results was supported by the European Community’s Seventh Framework Programme [FP7/2007–2013] under grant agreement no. 308333 [the HELIX project], and by the European Union’s Horizon 2020 research and innovation programme under grant agreements no. 874583 [ATHLETE], and no. 733032 [HBM4EU]. We acknowledge the input of the entire HELIX consortium. We are grateful to all the participating families in the five cohorts (BiB, EDEN, INMA, MoBa, KANC, and RHEA cohorts) that took part in this study. We are equally grateful to all the fieldworkers for their dedication and efficiency in this study. LM is funded by a Juan de la Cierva-Incorporación fellowship (IJC2018-035394-I) awarded by the Spanish Ministerio de Economía, Industria y Competitividad. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019-2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Position paper on management of personal data in environment and health research in Europe

  • Govarts, Eva
  • Gilles, Liese
  • Bopp, Stephanie
  • Holub, Petr
  • Matalonga, Leslie
  • Vermeulen, Roel
  • Vrijheid, Martine
  • Beltran, Sergi
  • Hartlev, Mette
  • Jones, Sarah
  • Rodriguez Martin, Laura
  • Standaert, Arnout
  • Swertz, Morris A.
  • Theunis, Jan
  • Trier, Xenia
  • Vogel, Nina
  • Van Espen, Koert
  • Remy, Sylvie
  • Schoeters, Greet
Management of datasets that include health information and other sensitive personal information of European study participants has to be compliant with the General Data Protection Regulation (GDPR, Regulation (EU) 2016/679). Within scientific research, the widely subscribed'FAIR' data principles should apply, meaning that research data should be findable, accessible, interoperable and re-usable. Balancing the aim of open science driven FAIR data management with GDPR compliant personal data protection safeguards is now a common challenge for many research projects dealing with (sensitive) personal data. In December 2020 a workshop was held with representatives of several large EU research consortia and of the European Commission to reflect on how to apply the FAIR data principles for environment and health research (E&H). Several recent data intensive EU funded E&H research projects face this challenge and work intensively towards developing solutions to access, exchange, store, handle, share, process and use such sensitive personal data, with the aim to support European and transnational collaborations. As a result, several recommendations, opportunities and current limitations were formulated. New technical developments such as federated data management and analysis systems, machine learning together with advanced search software, harmonized ontologies and data quality standards should in principle facilitate the FAIRification of data. To address ethical, legal, political and financial obstacles to the wider re-use of data for research purposes, both specific expertise and underpinning infrastructure are needed. There is a need for the E&H research data to find their place in the European Open Science Cloud. Communities using health and population data, environmental data and other publicly available data have to interconnect and synergize. To maximize the use and re-use of environment and health data, a dedicated supporting European infrastructure effort, such as the EIRENE research infrastructure within the ESFRI roadmap 2021, is needed that would interact with existing infrastructures., HBM4EU is co-financed under Horizon 2020 (grant agreement No 733032). EUCAN-Connect is funded by the European Commission within the call topic SC1-BHC-05-2018: “International flagship collaboration with Canada for human data storage, integration and sharing to enable personalized medicine approaches” (Grant Agreement No 824989). The Canadian project partners have been funded by the Canadian Institutes of Health Research (CIHR) and the Fonds de recherche du Québec – Santé. The LifeCycle project received funding from the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No. 733206 LifeCycle). The HELIX project received funding from the European Community’s Seventh Framework Programme (grant agreement no 308333 HELIX). ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019-2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. Roel Vermeulen is supported by EXPOSOME-NL and EXPANSE. EXPOSOME-NL is funded through the Gravitation program of the Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (NWO grant number 024.004.017). EXPANSE has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874627. EOSC-Life project supported by EU Horizon 2020, grant agreement no. 824087. EJP-RD and Solve-RD projects have been financed under Horizon 2000 (grant numbers H2020 779257 and H2020 825575).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU

  • Tagne-Fotso, Romuald
  • Montazeri, Parisa, 1988-
  • Urquiza, José M.
  • Vrijheid, Martine
  • Rambaud, Loïc
Background: Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity. Objective: We used human biomonitoring (HBM) data to investigate the general level of BPA exposure from 2007 to 2014 of European women aged 18-73 years (n = 4,226) and its determinants. Methods: Fifteen studies from 12 countries (Austria, Belgium, Denmark, France, Germany, Greece, Israel, Luxembourg, Slovenia, Spain, Sweden, and the United Kingdom) were included in the BPA Study protocol developed within the European Joint Programme HBM4EU. Seventy variables related to the BPA exposure were collected through a rigorous post-harmonization process. Linear mixed regression models were used to investigate the determinants of total urine BPA in the combined population. Results: Total BPA was quantified in 85-100 % of women in 14 out of 15 contributing studies. Only the Austrian PBAT study (Western Europe), which had a limit of quantification 2.5 to 25-fold higher than the other studies (LOQ=2.5 µg/L), found total BPA in less than 5 % of the urine samples analyzed. The geometric mean (GM) of total urine BPA ranged from 0.77 to 2.47 µg/L among the contributing studies. The lowest GM of total BPA was observed in France (Western Europe) from the ELFE subset (GM=0.77 µg/L (0.98 µg/g creatinine), n = 1741), and the highest levels were found in Belgium (Western Europe) and Greece (Southern Europe), from DEMOCOPHES (GM=2.47 µg/L (2.26 µg/g creatinine), n = 129) and HELIX-RHEA (GM=2.47 µg/L (2.44 µg/g creatinine), n = 194) subsets, respectively. One hundred percent of women in 14 out of 15 data collections in this study exceeded the health-based human biomonitoring guidance value for the general population (HBM-GVGenPop) of 0.0115 µg total BPA/L urine derived from the updated EFSA's BPA TDI. Variables related to the measurement of total urine BPA and those related to the main socio-demographic characteristics (age, height, weight, education, smoking status) were collected in almost all studies, while several variables related to BPA exposure factors were not gathered in most of the original studies (consumption of beverages contained in plastic bottles, consumption of canned food or beverages, consumption of food in contact with plastic packaging, use of plastic film or plastic containers for food, having a plastic floor covering in the house, use of thermal paper…). No clear determinants of total urine BPA concentrations among European women were found. A broader range of data planned for collection in the original questionnaires of the contributing studies would have resulted in a more thorough investigation of the determinants of BPA exposure in European women. Conclusion: This study highlights the urgent need for action to further reduce exposure to BPA to protect the population, as is already the case in the European Union. The study also underscores the importance of pre-harmonizing HBM design and data for producing comparable data and interpretable results at a European-wide level, and to increase HBM uptake by regulatory agencies., This study was a part of the HBM4EU project receiving funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733032. Born in Bradford is funded from a variety of sources including A Wellcome Trust infrastructure grant (WT101597MA), a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC): MR/N024391/1; The British Heart Foundation (BHF) (CS/16/4/32482); The National Institute for Health and Care Research under its Applied Research Collaboration for Yorkshire and Humber NIHR200166; the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement 308333–the HELIX project. The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health and Care Research or the Department of Health and Social Care. DEMOCOPHES running in 2011–2012 was funded by the 7th European Union program (DG Research – No. 244237-COPHES), with a LIFE+2009 'Policy and governance' (DG Environment – LIFE09/ENV/BE/000410-DEMOCOPHES), with additional co-funding from DEMOCOPHES partners. The Belgian DEMOCOPHES study was co-financed by the Ministers of Environment and Health. It was coordinated by the Federal public service for health, food chain safety and environment (FOD) and followed up by the Belgian Cell Environment and Health including all federal, Flemish, Walloon and Brussels governmental entities working on Health and Environment. The Danish DEMOCOPHES study from 2011 to 2012 was co-financed by the Danish ministries of health, environment and food safety. The contribution of Luxembourg to DEMOCOPHES from 2011 to 2012 was co-financed by Luxembourg Institute of Science and Technology (LIST). The Slovenian DEMOCOPHES study was co-funded by the Slovenian Research Agency program P-0143. DEMOCOPHES in Spain was co-funded by the Spanish Ministry of Agricultures, Food and Environmental and the Instituto de Salud Carlos III (SEG 1251/07 and SEG 1112/10). The German ESB is funded by the Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection. The Israeli IBS study was supported by Research Grant Award No. RGA 902 from the Environment and Health Fund, Jerusalem, Israel. The Austrian PBAT study was partially financed by the former Austrian Federal Ministry of Agriculture, Forestry, Environment and Water Management and by the Environment Agency Austria. Samples were provided from the Austrian Study of Nutritional Status 2012, which was funded by the former Austrian Federal Ministry of Health. The French human biomonitoring program, of which the ELFE cohort was a component, was funded by the French Ministries of Health and the Environment. ELFE benefited from additional funding from the Ministry of Research, Committee on SHS data (CCDSHS) and Ministry of Culture and Communication (Deps), and as part of the RECONAI platform, from National Research Agency funding (ANR-11-EQPX-0038).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies

  • Mustieles, Vicente
  • Balogh, Ria K.
  • Axelstad, Marta
  • Montazeri, Parisa, 1988-
  • Márquez, Sandra
  • Vrijheid, Martine
  • Draskau, Monica K.
  • Taxvig, Camilla
  • Peinado, Francisco M.
  • Berman, Tamar
  • Frederiksen, Hanne
  • Fernández, Mariana F.
  • Vinggaard, Anne Marie
  • Andersson, Anna-Maria
Background: Benzophenone-3 (BP-3) and its major metabolite benzophenone-1 (BP-1) are widely used as UV filters in sunscreens and cosmetics to prevent sunburn and skin damage, or as stabilizers to prevent photodegradation in many commercial products. As a result, their presence is ubiquitous in the environment, wildlife and humans. Based on endocrine disruption concerns, international regulatory agencies are performing a closer evaluation. Objective and methods: This work aimed to comprehensively review the available human relevant evidence for safety issues in MEDLINE/PubMed in order to create a structured database of studies, as well as to conduct an integrative analysis as part of the Human Biomonitoring for Europe (HBM4EU) Initiative. Results: A total of 1,635 titles and abstracts were screened and 254 references were evaluated and tabulated in detail, and classified in different categories: i) exposure sources and predictors; ii) human biomonitoring (HBM) exposure levels to perform a meta-analysis; iii) toxicokinetic data in both experimental animals and humans; iv) in vitro and in vivo rodent toxicity studies; and v) human data on effect biomarkers and health outcomes. Our integrative analysis showed that internal peak BP-3 concentrations achieved after a single whole-body application of a commercially available sunscreen (4% w/w) may overlap with concentrations eliciting endocrine disrupting effects in vitro, and with internal concentrations causing in vivo adverse female reproductive effects in rodents that were supported by still limited human data. The adverse effects in rodents included prolonged estrous cycle, altered uterine estrogen receptor gene expression, endometrium hyperplasia and altered proliferation and histology of the mammary gland, while human data indicated menstrual cycle hormonal alterations and increased risk of uterine fibroids and endometriosis. Among the modes of action reported (estrogenic, anti-androgenic, thyroid, etc.), BP-3 and especially BP-1 showed estrogenic activity at human-relevant concentrations, in agreement with the observed alterations in female reproductive endpoints. The meta-analysis of HBM studies identified a higher concern for North Americans, showing urinary BP-3 concentrations on average 10 and 20 times higher than European and Asian populations, respectively. Discussion and conclusions: Our work supports that these benzophenones present endocrine disrupting properties, endorsing recent European regulatory efforts to limit human exposure. The reproducible and comprehensive database generated may constitute a point of departure in future risk assessments to support regulatory initiatives. Meanwhile, individuals should not refrain from sunscreen use. Commercially available formulations using inorganic UV filters that are practically not absorbed into systemic circulation may be recommended to susceptible populations., This work is a direct product of the Human Biomonitoring for Europe Project (European Union Commission H2020-EJP-HBM4EU Grant agreement No 733032). The funder had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. V. Mustieles and P. Montazeri were under contract within the HBM4EU Initiative.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

PFAS levels and exposure determinants in sensitive population groups

  • Fábelová, Lucia
  • Casas Sanahuja, Maribel
  • Vrijheid, Martine
  • Palkovičová Murínová, Lubica
Background: Per- and polyfluoroalkyl substances (PFAS) are persistent organic pollutants. The first exposure to PFAS occurs in utero, after birth it continues via breast milk, food intake, environment, and consumer products that contain these chemicals. Our aim was to identify determinants of PFAS concentrations in sensitive population subgroups- pregnant women and newborns. Methods: Nine European birth cohorts provided exposure data on PFAS in pregnant women (INMA-Gipuzkoa, Sabadell, Valencia, ELFE and MoBa; total N = 5897) or newborns (3xG study, FLEHS 2, FLEHS 3 and PRENATAL; total N = 940). PFOS, PFOA, PFHxS and PFNA concentrations were measured in maternal or cord blood, depending on the cohort (FLEHS 2 measured only PFOS and PFOA). PFAS concentrations were analysed according to maternal characteristics (age, BMI, parity, previous breastfeeding, smoking, and food consumption during pregnancy) and parental educational level. The association between potential determinants and PFAS concentrations was evaluated using multiple linear regression models. Results: We observed significant variations in PFAS concentrations among cohorts. Higher PFAS concentrations were associated with higher maternal age, primipara birth, and educational level, both for maternal blood and cord blood. Higher PFAS concentrations in maternal blood were associated with higher consumption of fish and seafood, meat, offal and eggs. In cord blood, higher PFHxS concentrations were associated with daily meat consumption and higher PFNA with offal consumption. Daily milk and dairy consumption were associated with lower concentrations of PFAS in both, pregnant women and newborns. Conclusion: High detection rates of the four most abundant PFAS demonstrate ubiquitous exposure of sensitive populations, which is of concern. This study identified several determinants of PFAS exposure in pregnant women and newborns, including dietary factors, and these findings can be used for proposing measures to reduce PFAS exposure, particularly from dietary sources., This work was supported by the European Union’s Horizon 2020 research and innovation programme under Grant agreement No 733032 HBM4EU (http://www.hbm4eu.eu), and received co-funding from the authors' organizations: 3xG: The 3xG study was financed and steered by NIRAS and the local partnerships MONA and STORA. ELFE: The Elfe survey is a joint project between the French Institute for Demographic Studies (INED) and the National Institute of Health and Medical Research (INSERM), in partnership with the French blood transfusion service (Etablissement français du sang, EFS), Santé publique France, the National Institute for Statistics and Economic Studies (INSEE), the Direction générale de la santé (DGS, part of the Ministry of Health and Social Affairs), the Direction générale de la prévention des risques (DGPR, Ministry for the Environment), the Direction de la recherche, des études, de l’évaluation et des statistiques (DREES, Ministry of Health and Social Affairs), the Département des études, de la prospective et des statistiques (DEPS, Ministry of Culture), and the Caisse nationale des allocations familiales (CNAF), with the support of the Ministry of Higher Education and Research and the Institut national de la jeunesse et de l’éducation populaire (INJEP). Via the RECONAI platform, it receives a government grant managed by the National Research Agency under the “Investissements d'avenir” programme (ANR-11-EQPX-0038 and ANR-19-COHO-0001). FLEHS: The Flemish Environment and Health studie (FLEHS) were commissioned, financed and steered by the Flemish Government (Department of Economy, Science and Innovations, Agency for Care and Health and Department of Environment). INMA Valencia: This study was funded by Grants from UE (FP7-ENV-2011 cod 282,957 and HEALTH.2010.2.4.5–1), Spain: ISCIII (Red INMA G03/176, CB06/02/0041; FIS-FEDER: PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, and PI17/00663; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), Generalitat Valenciana: FISABIO (UGP 15–230, UGP-15-244, and UGP-15-249), and Alicia Koplowitz Foundation 2017.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Unravelling sex-specific BPA toxicokinetics in children using a pediatric PBPK model

  • Deepika, Deepika
  • Sharma, Raju Prasad
  • Schuhmacher, Marta
  • Sakhi, Amrit Kaur
  • Thomsen, Cathrine
  • Chatzi, Leda
  • Vafeiadi, Marina, 1983-
  • Quentin, Joane
  • Slama, Rémy
  • Gražulevičienė, Regina
  • Andrušaitytė, Sandra
  • Waiblinger, Dagmar
  • Wright, John
  • Yang, Tiffany C.
  • Urquiza, José M.
  • Vrijheid, Martine
  • Casas Sanahuja, Maribel
  • Domingo, José L.
  • Kumar, Vikas
Bisphenol A (BPA) is a widely known endocrine disruptor (ED) found in many children's products such as toys, feeding utensils, and teething rings. Recent epidemiology association studies have shown postnatal BPA exposure resulted in developing various diseases such as diabetes, obesity, and neurodegeneration, etc., later in their lives. However, little is known about its sex-specific metabolism and consequently internal exposure. The aim of this study was to develop a sex-specific pediatric physiologically based pharmacokinetic model (PBPK) for BPA to compare their toxicokinetic differences. First, the published adult PBPK model was re-validated, and then this model was extended by interpolation to incorporate pediatric sex specific physiological and biochemical parameters. We used both the classical body weight and ontogeny-based scaling approach to interpolate the metabolic process. Then, the pharmacokinetic attributes of the models using the two-scaling approach mentioned above were compared with adult model. Further, a sex-specific PBPK model with an ontogeny scaling approach was preferred to evaluate the pharmacokinetic differences. Moreover, this model was used to reconstruct the BPA exposure from two cohorts (Helix and PBAT Cohort) from 7 EU countries. The half-life of BPA was found to be almost the same in boys and girls at the same exposure levels. Our model estimated BPA children's exposure to be about 1500 times higher than the tolerable daily intake (TDI) recently set by European Food Safety Authority (EFSA) i.e., 0.04 ng/kg BW/day. The model demonstrated feasibility of extending the adult PBPK to sex-specific pediatric, thus investigate a gender-specific health risk assessment., This study was financially supported by Marie Skłodowska-Curie “Neurosome Project” under the grant agreement No. 766251, the European Community funded H2020 HBM4EU project under Grant Agreements no. 733032, and the Instituto de Salud Carlos III (PI17/01194), and the European Community's Seventh Framework Programme (FP7/2007–206) under grant agreement no 308333 (HELIX project). Maribel Casas holds a Miguel Servet fellowship (CP16/00128) funded by Instituto de Salud Carlos III and co-funded by European Social Fund “Investing in your future”. We acknowledge support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. This publication reflects only the authors' views. The Community and other funding organizations are not liable for any use made of the information contained therein. Born in Bradford is only possible because of the enthusiasm and commitment of the children and parents in Born in Bradford. We are grateful to all participants, health professionals and researchers who have made Born in Bradford happen. BiB receives core infrastructure funding from the Wellcome Trust (WT101597MA) and a joint grant from the UK Medical Research Council (MRC) and Economic and Social Science Research Council (ESRC) (MR/N024397/1). This study has received support from European Research Council under the European Union's Seventh Framework Programme (FP7/2007–2013)/ERC grant agreement no 669545 and National Institute for Health Research Applied Research Collaboration Yorkshire and Humber (NIHR200166).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Association of exposure to mixture of chemicals during pregnancy with cognitive abilities and fine motor function of children

  • Brennan Kearns, Pavla
  • van den Dries, Michiel
  • Júlvez Calvo, Jordi
  • Kampouri, Mariza
  • López Vicente, Mònica, 1988-
  • Maitre, Léa
  • Philippat, Claire
  • Haug, Line Småstuen
  • Vafeiadi, Marina, 1983-
  • Thomsen, Cathrine
  • Yang, Tiffany C.
  • Vrijheid, Martine
  • Tiemeier, Henning
  • Guxens Junyent, Mònica
Chemical exposures often occur in mixtures and exposures during pregnancy may lead to adverse effects on the fetal brain, potentially reducing lower cognitive abilities and fine motor function of the child. We investigated the association of motheŕs exposure to a mixture of chemicals during pregnancy (i.e., organochlorine compounds, per- and polyfluoroalkyl substances, phenols, phthalates, organophosphate pesticides) with cognitive abilties and fine motor function in their children. We studied 1097 mother-child pairs from five European cohorts participating in the Human Early Life Exposome study (HELIX). Measurement of 26 biomarkers of exposure to chemicals was performed on urine or blood samples of pregnant women (mean age 31 years). Cognitive abilities and fine motor function were assessed in their children (mean age 8 years) with a battery of computerized tests administered in person (Raveńs Coloured Progressive Matrices, Attention Network Test, N-back Test, Trail Making Test, Finger Tapping Test). We estimated the joint effect of prenatal exposure to chemicals on cognitive abilities and fine motor function using the quantile-based g-computation method, adjusting for sociodemographic characteristics. A quartile increase in all the chemicals in the overall mixture was associated with worse fine motor function, specifically lower scores in the Finger Tapping Test [-8.5 points, 95 % confidence interval (CI) -13.6 to -3.4; -14.5 points, 95 % CI -22.4 to -6.6, and -18.0 points, 95 % CI -28.6 to -7.4) for the second, third and fourth quartile of the overal mixture, respectively, when compared to the first quartile]. Organochlorine compounds, phthalates, and per- and polyfluoroalkyl substances contributed most to this association. We did not find a relationship with cognitive abilities. We conclude that exposure to chemical mixtures during pregnancy may influence neurodevelopment, impacting fine motor function of the offspring., The study was supported by the European Community’s Seventh Framework Programme [FP7/2007–2013] under grant agreement no. 308333 [the HELIX project], and by the European Union’s Horizon 2020 research and innovation programme under grant agreements no. 874583 [ATHLETE], and no. 733032 [HBM4EU]. We further acknowledge funding from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds, CPII18/00018), CIBERESP, Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR (2009 SGR 501, 2014 SGR 822), Fundació La marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds, Juan de la Cierva-Incorporación fellowship IJC2018-035394-I), Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010), EU Commission (261357, 603794 and 634453), project IJC2020-045355-I, funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. We also acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/ 10.13039/501100011033, the European Union NextGenerationEU/PRTR and support from the Generalitat de Catalunya through the CERCA Program. BiB receives funding from by a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) [MR/N024391/1]; the British Heart Foundation [CS/16/4/32482]; a Wellcome Infrastructure Grant [WT101597MA]; The National Institute for Health Research under its Applied Research Collaboration for Yorkshire and Humber [NIHR200166]. The views expressed are those of the author(s), and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The authors acknowledge that BiB is only possible because of the enthusiasm and commitment of the children and parents in BiB. We are grateful to all participants, health professionals and researchers who have made BiB happen. MoBa is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. EDEN was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A), and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French-speaking association for the study of diabetes and metabolism (ALFEDIAM). RHEA was supported by the General Secretariat for Research and Technology in Greece and the Research Committee of the University of Crete, Greece. We acknowledge the input of the entire HELIX consortium. We are grateful to all the participating families in the cohorts that took part in this study and all fieldworkers. The funding sources had no role in the conceptualization of this manuscript.
Repisalud
Publicación Artículo científico (JournalArticle)

Personal care product use and lifestyle affect phthalate and DINCH metabolite levels in teenagers and young adults

  • Stuchlík Fišerová, Petra
  • Melymuk, Lisa
  • Komprdová, Klára
  • Domínguez-Romero, Elena
  • Scheringer, Martin
  • Kohoutek, Jiří
  • Přibylová, Petra
  • Andrýsková, Lenka
  • Piler, Pavel
  • Koch, Holger M
  • Zvonař, Martin
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Klánová, Jana
Humans are widely exposed to phthalates and their novel substitutes, and considering the negative health effects associated with some phthalates, it is crucial to understand population levels and exposure determinants. This study is focused on 300 urine samples from teenagers (aged 12-17) and 300 from young adults (aged 18-37) living in Czechia collected in 2019 and 2020 to assess 17 plasticizer metabolites as biomarkers of exposure. We identified widespread phthalate exposure in the study population. The diethyl phthalate metabolite monoethyl phthalate (MEP) and three di (2-ethylhexyl) phthalate metabolites were detected in the urine of >99% of study participants. The highest median concentrations were found for metabolites of low-molecular-weight (LMW) phthalates: mono-n-butyl phthalate (MnBP), monoisobutyl phthalate (MiBP) and MEP (60.7; 52.6 and 17.6 μg/L in young adults). 1,2-cyclohexanedicarboxylic acid diisononyl ester (DINCH) metabolites were present in 68.2% of the samples with a median of 1.24 μg/L for both cohorts. Concentrations of MnBP and MiBP were similar to other European populations, but 5-6 times higher than in populations in North America. We also observed large variability in phthalate exposures within the study population, with 2-3 orders of magnitude differences in urinary metabolites between high and low exposed individuals. The concentrations varied with season, gender, age, and lifestyle factors. A relationship was found between high levels of MEP and high overall use of personal care products (PCPs). Cluster analysis suggested that phthalate exposures depend on season and multiple lifestyle factors, like time spent indoors and use of PCPs, which combine to lead to the observed widespread presence of phthalate metabolites in both study populations. Participants who spent more time indoors, particularly noticeably during colder months, had higher levels of high-molecular weight phthalate metabolites, whereas participants with higher PCP use, particularly women, tended to have higher concentration of LMW phthalate metabolites.
Repisalud
Publicación Artículo científico (JournalArticle)

Setting up a collaborative European human biological monitoring study on occupational exposure to hexavalent chromium

  • Santonen, Tiina
  • Alimonti, Alessandro
  • Bocca, Beatrice
  • Duca, Radu Corneliu
  • Galea, Karen S
  • Godderis, Lode
  • Göen, Thomas
  • Gomes, Bruno
  • Hanser, Ogier
  • Iavicoli, Ivo
  • Janasik, Beata
  • Jones, Kate
  • Kiilunen, Mirja
  • Koch, Holger M
  • Leese, Elizabeth
  • Leso, Veruscka
  • Louro, Henriqueta
  • Ndaw, Sophie
  • Porras, Simo P
  • Robert, Alain
  • Ruggieri, Flavia
  • Scheepers, Paul T J
  • Silva, Maria J
  • Viegas, Susana
  • Wasowicz, Wojciech
  • Castaño, Argelia
  • Sepai, Ovnair
The EU human biomonitoring initiative, HBM4EU, aims to co-ordinate and advance human biomonitoring (HBM) across Europe. Within its remit, the project is gathering new, policy relevant, EU-wide data on occupational exposure to relevant priority chemicals and developing new approaches for occupational biomonitoring. In this manuscript, the hexavalent chromium [Cr(VI)] study design is presented as the first example of this HBM4EU approach. This study involves eight European countries and plans to recruit 400 workers performing Cr(VI) surface treatment e.g. electroplating or stainless steel welding activities. The aim is to collect new data on current occupational exposure to Cr(VI) in Europe and to test new methods for Cr biomonitoring, specifically the analysis of Cr(VI) in exhaled breath condensate (EBC) and Cr in red blood cells (RBC) in addition to traditional urinary total Cr analyses. Furthermore, exposure data will be complemented with early biological effects data, including genetic and epigenetic effects. Personal air samples and wipe samples are collected in parallel to help informing the biomonitoring results. We present standard operational procedures (SOPs) to support the harmonized methodologies for the collection of occupational hygiene and HBM samples in different countries.
Repisalud
Publicación Artículo científico (JournalArticle)

How to use human biomonitoring in chemical risk assessment: Methodological aspects, recommendations, and lessons learned from HBM4EU

  • Santonen, Tiina
  • Mahiout, Selma
  • Alvito, Paula
  • Apel, Petra
  • Bessems, Jos
  • Bil, Wieneke
  • Borges, Teresa
  • Bose-O'Reilly, Stephan
  • Buekers, Jurgen
  • Cañas Portilla, Ana Isabel
  • Castaño, Argelia
  • De Alba-González, Mercedes
  • Domínguez-Morueco, Noelia
  • Esteban-Lopez, Marta
  • Falnoga, Ingrid
  • Gerofke, Antje
  • González-Caballero, MCarmen
  • Horvat, Milena
  • Huuskonen, Pasi
  • Kadikis, Normunds
  • Kolossa-Gehring, Marike
  • Lange, Rosa
  • Louro, Henriqueta
  • Martins, Carla
  • Meslin, Matthieu
  • Niemann, Lars
  • Pedraza-Diaz, Susana
  • Plichta, Veronika
  • Porras, Simo P
  • Rousselle, Christophe
  • Scholten, Bernice
  • Silva, Maria João
  • Šlejkovec, Zdenka
  • Tratnik, Janja Snoj
  • Joksić, Agnes Šömen
  • Tarazona, Jose
  • Uhl, Maria
  • Van Nieuwenhuyse, An
  • Viegas, Susana
  • Vinggaard, Anne Marie
  • Woutersen, Marjolijn
  • Schoeters, Greet
One of the aims of the European Human Biomonitoring Initiative, HBM4EU, was to provide examples of and good practices for the effective use of human biomonitoring (HBM) data in human health risk assessment (RA). The need for such information is pressing, as previous research has indicated that regulatory risk assessors generally lack knowledge and experience of the use of HBM data in RA. By recognising this gap in expertise, as well as the added value of incorporating HBM data into RA, this paper aims to support the integration of HBM into regulatory RA. Based on the work of the HBM4EU, we provide examples of different approaches to including HBM in RA and in estimations of the environmental burden of disease (EBoD), the benefits and pitfalls involved, information on the important methodological aspects to consider, and recommendations on how to overcome obstacles. The examples are derived from RAs or EBoD estimations made under the HBM4EU for the following HBM4EU priority substances: acrylamide, o-toluidine of the aniline family, aprotic solvents, arsenic, bisphenols, cadmium, diisocyanates, flame retardants, hexavalent chromium [Cr(VI)], lead, mercury, mixture of per-/poly-fluorinated compounds, mixture of pesticides, mixture of phthalates, mycotoxins, polycyclic aromatic hydrocarbons (PAHs), and the UV-filter benzophenone-3. Although the RA and EBoD work presented here is not intended to have direct regulatory implications, the results can be useful for raising awareness of possibly needed policy actions, as newly generated HBM data from HBM4EU on the current exposure of the EU population has been used in many RAs and EBoD estimations.
Repisalud
Publicación Artículo científico (JournalArticle)

A Tiered Approach for Assessing Individual and Combined Risk of Pyrethroids Using Human Biomonitoring Data

  • Tarazona, Jose
  • Cattaneo, Irene
  • Niemann, Lars
  • Pedraza-Diaz, Susana
  • González-Caballero, MCarmen
  • De Alba-González, Mercedes
  • Cañas Portilla, Ana Isabel
  • Domínguez-Morueco, Noelia
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Borges, Teresa
  • Katsonouri, Andromachi
  • Makris, Konstantinos C
  • Ottenbros, Ilse
  • Mol, Hans
  • De Decker, Annelies
  • Morrens, Bert
  • Berman, Tamar
  • Barnett-Itzhaki, Zohar
  • Probst-Hensch, Nicole
  • Fuhrimann, Samuel
  • Tratnik, Janja Snoj
  • Horvat, Milena
  • Rambaud, Loïc
  • Riou, Margaux
  • Schoeters, Greet
  • Govarts, Eva
  • Kolossa-Gehring, Marike
  • Weber, Till
  • Apel, Petra
  • Namorado, Sónia
  • Santonen, Tiina
Pyrethroids are a major insecticide class, suitable for biomonitoring in humans. Due to similarities in structure and metabolic pathways, urinary metabolites are common to various active substances. A tiered approach is proposed for risk assessment. Tier I was a conservative screening for overall pyrethroid exposure, based on phenoxybenzoic acid metabolites. Subsequently, probabilistic approaches and more specific metabolites were used for refining the risk estimates. Exposure was based on 95th percentiles from HBM4EU aligned studies (2014-2021) covering children in Belgium, Cyprus, France, Israel, Slovenia, and The Netherlands and adults in France, Germany, Israel, and Switzerland. In all children populations, the 95th percentiles for 3-phenoxybenzoic acid (3-PBA) exceeded the screening value. The probabilistic refinement quantified the risk level of the most exposed population (Belgium) at 2% or between 1-0.1% depending on the assumptions. In the substance specific assessments, the 95th percentiles of urinary concentrations in the aligned studies were well below the respective human biomonitoring guidance values (HBM-GVs). Both information sets were combined for refining the combined risk. Overall, the HBM data suggest a low health concern, at population level, related to pyrethroid exposure for the populations covered by the studies, even though a potential risk for highly exposed children cannot be completely excluded. The proposed tiered approach, including a screening step and several refinement options, seems to be a promising tool of scientific and regulatory value in future.
Repisalud
Publicación Artículo científico (JournalArticle)

Proficiency and Interlaboratory Variability in the Determination of Phthalate and DINCH Biomarkers in Human Urine: Results from the HBM4EU Project

  • Mol, Hans G J
  • Elbers, Ingrid
  • Pälmke, Claudia
  • Bury, Daniel
  • Göen, Thomas
  • Esteban-Lopez, Marta
  • Nübler, Stefanie
  • Vaccher, Vincent
  • Antignac, Jean-Philippe
  • Dvorakova, Darina
  • Hajslova, Jana
  • Sakhi, Amrit Kaur
  • Thomsen, Cathrine
  • Vorkamp, Katrin
  • Castaño, Argelia
  • Koch, Holger M
A quality assurance/quality control program was implemented in the framework of the EU project HBM4EU to assess and improve the comparability of biomarker analysis and to build a network of competent laboratories. Four rounds of proficiency tests were organized for 15 phthalate and two DINCH urinary biomarkers (0.2-138 ng/mL) over a period of 18 months, with the involvement of 28 laboratories. A substantial improvement in performance was observed after the first round in particular, and by the end of the program, an average satisfactory performance rate of 90% was achieved. The interlaboratory reproducibility as derived from the participants' results varied for the various biomarkers and rounds, with an average of 24% for the biomarkers of eight single-isomer phthalates (e.g., DnBP and DEHP) and 43% for the more challenging biomarkers of the mixed-isomer phthalates (DiNP, DiDP) and DINCH. When the reproducibility was based only on the laboratories that consistently achieved a satisfactory performance, this improved to 17% and 26%, respectively, clearly demonstrating the success of the QA/QC efforts. The program thus aided in building capacity and the establishment of a network of competent laboratories able to generate comparable and accurate HBM data for phthalate and DINCH biomarkers in 14 EU countries. In addition, global comparability was ensured by including external expert laboratories.
Repisalud
Publicación Artículo científico (JournalArticle)

Time Patterns in Internal Human Exposure Data to Bisphenols, Phthalates, DINCH, Organophosphate Flame Retardants, Cadmium and Polyaromatic Hydrocarbons in Europe

  • Rodriguez Martin, Laura
  • Gilles, Liese
  • Helte, Emilie
  • Åkesson, Agneta
  • Tägt, Jonas
  • Covaci, Adrian
  • Sakhi, Amrit K
  • Van Nieuwenhuyse, An
  • Katsonouri, Andromachi
  • Andersson, Anna-Maria
  • Gutleb, Arno C
  • Janasik, Beata
  • Appenzeller, Brice
  • Gabriel, Catherine
  • Thomsen, Cathrine
  • Mazej, Darja
  • Sarigiannis, Denis
  • Anastasi, Elena
  • Barbone, Fabio
  • Tolonen, Hanna
  • Frederiksen, Hanne
  • Klánová, Jana
  • Koponen, Jani
  • Tratnik, Janja Snoj
  • Pack, Kim
  • Gudrun, Koppen
  • Ólafsdóttir, Kristin
  • Knudsen, Lisbeth E
  • Rambaud, Loïc
  • Strumylaite, Loreta
  • Palkovicova Murinova, Lubica
  • Fábelová, Lucia
  • Riou, Margaux
  • Berglund, Marika
  • Szabados, Maté
  • Imboden, Medea
  • Laeremans, Michelle
  • Eštóková, Milada
  • Janev Holcer, Natasa
  • Probst-Hensch, Nicole
  • Vodrazkova, Nicole
  • Vogel, Nina
  • Piler, Pavel
  • Schmidt, Phillipp
  • Lange, Rosa
  • Namorado, Sónia
  • Középesy, Szilvia
  • Szigeti, Tamás
  • Halldórsson, Thórhallur Ingi
  • Weber, Till
  • Jensen, Tina Kold
  • Rosolen, Valentina
  • Puklova, Vladimira
  • Wasowicz, Wojciech
  • Sepai, Ovnair
  • Stewart, Lorraine
  • Kolossa-Gehring, Marike
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Bessems, Jos
  • Schoeters, Greet
  • Govarts, Eva
Human biomonitoring (HBM) data in Europe are often fragmented and collected in different EU countries and sampling periods. Exposure levels for children and adult women in Europe were evaluated over time. For the period 2000-2010, literature and aggregated data were collected in a harmonized way across studies. Between 2011-2012, biobanked samples from the DEMOCOPHES project were used. For 2014-2021, HBM data were generated within the HBM4EU Aligned Studies. Time patterns on internal exposure were evaluated visually and statistically using the 50th and 90th percentiles (P50/P90) for phthalates/DINCH and organophosphorus flame retardants (OPFRs) in children (5-12 years), and cadmium, bisphenols and polycyclic aromatic hydrocarbons (PAHs) in women (24-52 years). Restricted phthalate metabolites show decreasing patterns for children. Phthalate substitute, DINCH, shows a non-significant increasing pattern. For OPFRs, no trends were statistically significant. For women, BPA shows a clear decreasing pattern, while substitutes BPF and BPS show an increasing pattern coinciding with the BPA restrictions introduced. No clear patterns are observed for PAHs or cadmium. Although the causal relations were not studied as such, exposure levels to chemicals restricted at EU level visually decreased, while the levels for some of their substitutes increased. The results support policy efficacy monitoring and the policy-supportive role played by HBM.
Repisalud
Publicación Artículo científico (JournalArticle)

Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring

  • Caballero-Casero, Noelia
  • Belova, Lidia
  • Vervliet, Philippe
  • Antignac, Jean-Philippe
  • Castaño, Argelia
  • Debrauwer, Laurent
  • Esteban-Lopez, Marta
  • Huber, Carolin
  • Klánová, Jana
  • Krauss, Martin
  • Lommen, Arjen
  • Mol, Hans G.J.
  • Oberacher, Herbert
  • Pardo, Olga
  • Price, Elliott J.
  • Reinstadler, Vera
  • Vitale, Chiara Maria
  • van Nuijs, Alexander L.N.
  • Covaci, Adrian
Although the exposure assessment of chemicals of emerging concern (CECs) has taken a decisive step forward through advances in (bio)informatics, statistics, and the development of highly sophisticated analytical instruments, the lack of standardisation and harmonisation of analytical workflows and method performance assessment for suspect and non-target screening hampers the interpretation of results, their comparability and thus, its transmission to policymakers. To date, unlike in other research fields such as forensics or food analysis, there is a lack of guidelines for non-target analysis in human risk assessment and quality assurance and quality control (QA/QC) protocols. Moreover, the majority of efforts have been focused on the development and implementation of QA/QC actions for data acquisition, data analysis and mining, largely neglecting the sample preparation necessary for determination of CECs by suspect and non-target screening methods. In this article, we propose a set of QA/QC measures that covers sampling, sample preparation and data acquisition, as an aspect of work conducted within the European Biomonitoring for Europe initiative (HBM4EU). These measures include the use of standardised terminology and the implementation of dedicated QA/QC actions in each stage of the analytical process. Moreover, a framework for the analytical performance assessment has been developed for the first time for the identification of CECs in human samples by suspect and non-target approaches. Adoption of the actions proposed here for the identification of CECs in human matrices can significantly improve the comparability of reported results and contribute to the (challenging) Exposome research field.
Repisalud
Publicación Artículo científico (JournalArticle)

HBM4EU chromates study - the measurement of hexavalent and trivalent chromium in exhaled breath condensate samples from occupationally exposed workers across Europe

  • Leese, Elizabeth
  • Jones, Kate
  • Bocca, Beatrice
  • Bousoumah, Radia
  • Castaño, Argelia
  • Galea, Karen S
  • Iavicoli, Ivo
  • Esteban-Lopez, Marta
  • Leso, Veruscka
  • Ndaw, Sophie
  • Porras, Simo P
  • Ruggieri, Flavia
  • Scheepers, Paul T J
  • Santonen, Tiina
  • HBM4EU chromates study team
The aim of this study was to investigate the practicability of exhaled breath condensate (EBC) as a biological matrix to detect and measure hexavalent chromium (Cr(VI)) and trivalent chromium (Cr(III)) in workers occupationally exposed to Cr(VI). EBC samples were collected from workers in France, Finland, Italy, The Netherlands and the United Kingdom from three different target activities: chrome platers, stainless steel welders and surface treatment workers. Pre and post working week EBC samples were collected from 177 exposed workers and 98 unexposed workers (control group). Hyphenated chromatography systems with inductively coupled plasma - mass spectrometry (ICP-MS) were for the analysis. The results showed that the occupationally exposed workers had significantly higher levels of Cr(VI) and Cr(III) than the control group. Chrome platers exhibited the highest Cr(VI) levels in their EBC samples, with a significant increase from their pre to post samples for both Cr(VI) and Cr(III). A significant difference was also found between pre and post EBC samples for Cr(III) in welders. This study has shown that EBC has the potential to be a valid, non-invasive biological matrix to assess occupational exposure to Cr(VI) and Cr(III) for biological monitoring assessment, with the ability to detect low level inhalation exposures.
Repisalud
Publicación Artículo científico (JournalArticle)

Assessment of exposure to pesticide mixtures in five European countries by a harmonized urinary suspect screening approach

  • Ottenbros, Ilse
  • Lebret, Erik
  • Huber, Carolin
  • Lommen, Arjen
  • Antignac, Jean-Philippe
  • Čupr, Pavel
  • Šulc, Libor
  • Mikeš, Ondřej
  • Szigeti, Tamás
  • Középesy, Szilvia
  • Martinsone, Inese
  • Martinsone, Žanna
  • Akulova, Lasma
  • Pardo, Olga
  • Fernández, Sandra F
  • Coscollá, Clara
  • Pedraza-Diaz, Susana
  • Krauss, Martin
  • Debrauwer, Laurent
  • Wagner, Kévin
  • Nijssen, Rosalie
  • Mol, Hans
  • Vitale, Chiara Maria
  • Klánová, Jana
  • Molina, Borja Garlito
  • León, Nuria
  • Vermeulen, Roel
  • Luijten, Mirjam
  • Vlaanderen, Jelle
Humans are exposed to a mixture of pesticides through diet as well as through the environment. We conducted a suspect-screening based study to describe the probability of (concomitant) exposure to a set of pesticide profiles in five European countries (Latvia, Hungary, Czech Republic, Spain and the Netherlands). We explored whether living in an agricultural area (compared to living in a peri-urban area), being a a child (compared to being an adult), and the season in which the urine sample was collected had an impact on the probability of detection of pesticides (-metabolites). In total 2088 urine samples were collected from 1050 participants (525 parent-child pairs) and analyzed through harmonized suspect screening by five different laboratories. Fourty pesticide biomarkers (either pesticide metabolites or the parent pesticides as such) relating to 29 pesticides were identified at high levels of confidence in samples across all study sites. Most frequently detected were biomarkers related to the parent pesticides acetamiprid and chlorpropham. Other biomarkers with high detection rates in at least four countries related to the parent pesticides boscalid, fludioxonil, pirimiphos-methyl, pyrimethanil, clothianidin, fluazifop and propamocarb. In 84% of the samples at least two different pesticides were detected. The median number of detected pesticides in the urine samples was 3, and the maximum was 13 pesticides detected in a single sample. The most frequently co-occurring substances were acetamiprid with chlorpropham (in 62 urine samples), and acetamiprid with tebuconazole (30 samples). Some variation in the probability of detection of pesticides (-metabolites) was observed with living in an agricultural area or season of urine sampling, though no consistent patterns were observed. We did observe differences in the probability of detection of a pesticide (metabolite) among children compared to adults, suggesting a different exposure and/or elimination patterns between adults and children. This survey demonstrates the feasibility of conducting a harmonized pan-European sample collection, combined with suspect screening to provide insight in the presence of exposure to pesticide mixtures in the European population, including agricultural areas. Future improvements could come from improved (harmonized) quantification of pesticide levels.
Repisalud
Publicación Artículo científico (JournalArticle)

Concurrent Assessment of Phthalates/HEXAMOLL® DINCH Exposure and Wechsler Intelligence Scale for Children Performance in Three European Cohorts of the HBM4EU Aligned Studies

  • Rosolen, Valentina
  • Giordani, Elisa
  • Mariuz, Marika
  • Parpinel, Maria
  • Ronfani, Luca
  • Vecchi Brumatti, Liza
  • Bin, Maura
  • Calamandrei, Gemma
  • Mustieles, Vicente
  • Gilles, Liese
  • Govarts, Eva
  • Baken, Kirsten
  • Rodriguez Martin, Laura
  • Schoeters, Greet
  • Sepai, Ovnair
  • Sovcikova, Eva
  • Fábelová, Lucia
  • Šidlovská, Miroslava
  • Kolena, Branislav
  • Kold Jensen, Tina
  • Frederiksen, Hanne
  • Kolossa-Gehring, Marike
  • Lange, Rosa
  • Apel, Petra
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Jacobs, Griet
  • Voorspoels, Stefan
  • Jurdáková, Helena
  • Górová, Renáta
  • Barbone, Fabio
Information about the effects of phthalates and non-phthalate substitute cyclohexane-1,2-dicarboxylic acid diisononyl ester (HEXAMOLL® DINCH) on children's neurodevelopment is limited. The aim of the present research is to evaluate the association between phthalate/HEXAMOLL® DINCH exposure and child neurodevelopment in three European cohorts involved in HBM4EU Aligned Studies. Participating subjects were school-aged children belonging to the Northern Adriatic cohort II (NAC-II), Italy, Odense Child Cohort (OCC), Denmark, and PCB cohort, Slovakia. In each cohort, children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score (FSIQ) of the Wechsler Intelligence Scale of Children test using three different editions. The children's urine samples, collected for one point in time concurrently with the neurodevelopmental evaluation, were analyzed for several phthalates/HEXAMOLL® DINCH biomarkers. The relation between phthalates/HEXAMOLL® DINCH and FSIQ was explored by applying separate multiple linear regressions in each cohort. The means and standard deviations of FSIQ were 109 ± 11 (NAC-II), 98 ± 12 (OCC), and 81 ± 15 (PCB cohort). In NAC-II, direct associations between FSIQ and DEHP's biomarkers were found: 5OH-MEHP+5oxo-MEHP (β = 2.56; 95% CI 0.58-4.55; N = 270), 5OH-MEHP+5cx-MEPP (β = 2.48; 95% CI 0.47-4.49; N = 270) and 5OH-MEHP (β = 2.58; 95% CI 0.65-4.51; N = 270). On the contrary, in the OCC the relation between DEHP's biomarkers and FSIQ tended to be inverse but imprecise (p-value ≥ 0.10). No associations were found in the PCB cohort. FSIQ was not associated with HEXAMOLL® DINCH in any cohort. In conclusion, these results do not provide evidence of an association between concurrent phthalate/DINCHHEXAMOLLR DINCH exposure and IQ in children.
Repisalud
Publicación Artículo científico (JournalArticle)

Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future

  • Louro, Henriqueta
  • Heinälä, Milla
  • Bessems, Jos
  • Buekers, Jurgen
  • Vermeire, Theo
  • Woutersen, Marjolijn
  • van Engelen, Jacqueline
  • Borges, Teresa
  • Rousselle, Christophe
  • Ougier, Eva
  • Alvito, Paula
  • Martins, Carla
  • Assunção, Ricardo
  • Silva, Maria João
  • Pronk, Anjoeka
  • Schaddelee-Scholten, Bernice
  • De Alba-González, Mercedes
  • Castaño, Argelia
  • Gonzalez, Carlos
  • Viegas, Susana
  • Humar-Juric, Tatjana
  • Kononenko, Lijana
  • Lampen, Alfonso
  • Vinggaard, Anne Marie
  • Schoeters, Greet
  • Kolossa-Gehring, Marike
  • Santonen, Tiina
Human biomonitoring (HBM) is an important tool to survey the internal exposure of humans which represents the real life chemical body burden to chemicals and/or their metabolites. It results from total exposure to chemical substances from different sources and via different routes. These substances may be regulated under different legislative frameworks on chemicals (e.g., environmental, occupational, food safety etc). In occupational health, HBM has long traditions to control the exposures at workplaces. By providing accurate data on internal exposure, HBM data can improve human health risk assessment (RA) for both the general population and workers. Although the past few years have shown good examples on the use of HBM in the RA of chemicals, there is still quite some work to be done to improve its use in a regulatory RA. Under the scope of the European Human Biomonitoring Initiative (project HBM4EU, 2017-2021), the current study reviews the state-of-the-art of HBM use in chemicals RA with a special focus in Europe, and attempts to identify hurdles and challenges faced by regulators. To gather information on the use of HBM, including the availability of guidance on how to use it in RA, the RA schemes applied by different European or international organizations were analysed. Examples of such use were identified for a few selected groups of chemicals of concern for human health. In addition, we present the results of a survey, aimed at collecting information from national regulatory risk assessors on their day-to-day RA practices, the use of HBM data, and the obstacles and challenges related to their use. The results evidenced and explained some of the current obstacles of using HBM data in RA. These included the lack of HBM guidance values or biomonitoring equivalents (BEs), limited toxicokinetic information to support the interpretation of HBM data and, in the occupational health and safety (OSH) field, the lack of legal enforcement. Therefore, to support the integration of HBM in regulatory RA, we recommend, on one hand, the elaboration of a EU level guidance on the use of HBM in RA and, on the other hand, the continuation of research efforts to integrate HBM with new RA approaches using in vitro/in silico data and Adverse Outcome Pathways (AOPs).
Repisalud
Publicación Artículo científico (JournalArticle)

Association of exposure to perfluoroalkyl substances (PFAS) and phthalates with thyroid hormones in adolescents from HBM4EU aligned studies

  • Rodríguez-Carrillo, Andrea
  • Salamanca-Fernández, Elena
  • Den Hond, Elly
  • Verheyen, Veerle J
  • Fábelová, Lucia
  • Palkovicova Murinova, Lubica
  • Pedraza-Diaz, Susana
  • Castaño, Argelia
  • García-Lario, José Vicente
  • Remy, Sylvie
  • Govarts, Eva
  • Schoeters, Greet
  • Olea, Nicolás
  • Freire, Carmen
  • Fernández, Mariana F
Background: Perfluoroalkyl substances (PFAS) and phthalates are synthetic chemicals widely used in various types of consumer products. There is epidemiological and experimental evidence that PFAS and phthalates may alter thyroid hormone levels; however, studies in children and adolescents are limited. Aim: To investigate the association of exposure to PFAS and phthalate with serum levels of thyroid hormones in European adolescents. Methods: A cross-sectional study was conducted in 406 female and 327 male adolescents (14-17 years) from Belgium, Slovakia, and Spain participating in the Aligned Studies of the HBM4EU Project (FLEHS IV, PCB cohort, and BEA, respectively). Concentrations of perfluorooctanoic acid (PFOA), perfluorooctane sulfonate (PFOS), perfluorononanoic acid (PFNA), free thyroxine (FT4), free triiodothyronine (FT3), and thyroid-stimulating hormone (TSH) were measured in sera from study participants, and urinary metabolites of six phthalates (DEP, DiBP, DnBP, BBzP, DEHP, and DiNP) and the non-phthalate plasticizer DINCH® were quantified in spot urine samples. Associations were assessed with linear regression and g-computational models for mixtures. Effect modification by sex was examined. Results: In females, serum PFOA and the PFAS mixture concentrations were associated with lower FT4 and higher FT3 levels; MEP and the sums of DEHP, DiNP, and DINCH® metabolites (∑DEHP, ∑DiNP, and ∑DINCH) were associated with higher FT4; ∑DEHP with lower FT3; and the phthalate/DINCH® metabolite mixture with higher FT4 and lower FT3. In males, PFOA was associated with lower FT4 and the PFAS mixture with higher TSH levels and lower FT4/TSH ratio; MEP and ∑DiNP were associated with higher FT4; and MBzP, ∑DEHP, and the phthalate/DINCH® metabolite mixture with lower TSH and higher FT4/TSH. PFOA, mono-(2-ethyl-5-hydroxyhexyl) phthalate (OH-MEHP), mono-(2-ethyl-5-oxohexyl) phthalate (oxo-MEHP), and monocarboxyoctyl phthalate (MCOP) made the greatest contribution to the mixture effect. Conclusions: Results suggest that exposure to PFAS and phthalates is associated with sex-specific differences in thyroid hormone levels in adolescents.
Repisalud
Publicación Artículo científico (JournalArticle)

Cognitive Performance and Exposure to Organophosphate Flame Retardants in Children: Evidence from a Cross-Sectional Analysis of Two European Mother-Child Cohorts

  • Rosolen, Valentina
  • Giordani, Elisa
  • Mariuz, Marika
  • Parpinel, Maria
  • Mustieles, Vicente
  • Gilles, Liese
  • Govarts, Eva
  • Rodriguez Martin, Laura
  • Baken, Kirsten
  • Schoeters, Greet
  • Sepai, Ovnair
  • Sovcikova, Eva
  • Fábelová, Lucia
  • Kohoutek, Jiří
  • Jensen, Tina Kold
  • Covaci, Adrian
  • Roggeman, Maarten
  • Melymuk, Lisa
  • Klánová, Jana
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Barbone, Fabio
The knowledge of the effects of organophosphate flame retardants on children's neurodevelopment is limited. The purpose of the present research is to evaluate the association between exposure to organophosphate flame retardants and children's neurodevelopment in two European cohorts involved in the Human Biomonitoring Initiative Aligned Studies. The participants were school-aged children belonging to the Odense Child Cohort (Denmark) and the PCB cohort (Slovakia). In each cohort, the children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score of the Wechsler Intelligence Scale for Children, using two different editions. The children's urine samples, collected at one point in time, were analyzed for several metabolites of organophosphate flame retardants. The association between neurodevelopment and each organophosphate flame retardant metabolite was explored by applying separate multiple linear regressions based on the approach of MM-estimation in each cohort. In the Danish cohort, the mean ± standard deviation for the neurodevelopment score was 98 ± 12; the geometric mean (95% confidence interval (95% CI)) of bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) standardized by creatinine (crt) was 0.52 µg/g crt (95% CI = 0.49; 0.60), while that of diphenyl phosphate (DPHP) standardized by crt was 1.44 µg/g crt (95% CI = 1.31; 1.58). The neurodevelopment score showed a small, negative, statistically imprecise trend with BDCIPP standardized by crt (β = -1.30; 95%CI = -2.72; 0.11; p-value = 0.07) and no clear association with DPHP standardized by crt (β = -0.98; 95%CI = -2.96; 0.99; p-value = 0.33). The neurodevelopment score showed a negative trend with BDCIPP (β = -1.42; 95% CI = -2.70; -0.06; p-value = 0.04) and no clear association with DPHP (β = -1.09; 95% CI = -2.87; 0.68; p-value = 0.23). In the Slovakian cohort, the mean ± standard deviation for the neurodevelopment score was 81 ± 15; the geometric mean of BDCIPP standardized by crt was 0.18 µg/g crt (95% CI = 0.16; 0.20), while that of DPHP standardized by crt was 2.24 µg/g crt (95% CI = 2.00; 3.52). The association of the neurodevelopment score with BDCIPP standardized by crt was -0.49 (95%CI = -1.85; 0.87; p-value = 0.48), and with DPHP standardized by crt it was -0.35 (95%CI = -1.90; 1.20; p-value = 0.66). No clear associations were observed between the neurodevelopment score and BDCIPP/DPHP concentrations that were not standardized by crt. No clear associations were observed with bis(1-chloro-2-propyl) phosphate (BCIPP) in either cohort, due to the low detection frequency of this compound. In conclusion, this study provides only limited evidence of an inverse association between neurodevelopment and exposure to BDCIPP and DPHP. The timing of exposure and effect modification of other organophosphate flame retardant metabolites and other substances should be the subject of further investigations that address this scientific hypothesis.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Current exposure to phthalates and DINCH in European children and adolescents - Results from the HBM4EU Aligned Studies 2014 to 2021

  • Vogel, Nina
  • Schmidt, Phillipp
  • Lange, Rosa
  • Gerofke, Antje
  • Sakhi, Amrit K
  • Haug, Line S
  • Jensen, Tina Kold
  • Frederiksen, Hanne
  • Szigeti, Tamás
  • Csákó, Zsófia
  • Palkovicova Murinova, Lubica
  • Šidlovská, Miroslava
  • Janasik, Beata
  • Wasowicz, Wojciech
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Gabriel, Catherine
  • Karakitsios, Spyros
  • Barbone, Fabio
  • Rosolen, Valentina
  • Rambaud, Loïc
  • Riou, Margaux
  • Murawski, Aline
  • Leseman, Daan
  • Koppen, Gudrun
  • Covaci, Adrian
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Zvonař, Martin
  • Andryskova, Lenka
  • Fábelová, Lucia
  • Richterová, Denisa
  • Horvat, Milena
  • Kosjek, Tina
  • Sarigiannis, Denis
  • Maroulis, Marios
  • Pedraza-Diaz, Susana
  • Cañas Portilla, Ana Isabel
  • Verheyen, Veerle J
  • Bastiaensen, Michiel
  • Gilles, Liese
  • Schoeters, Greet
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Govarts, Eva
  • Koch, Holger M
  • Kolossa-Gehring, Marike
Phthalates are mainly used as plasticizers for polyvinyl chloride (PVC). Exposure to several phthalates is associated with different adverse effects most prominently on the development of reproductive functions. The HBM4EU Aligned Studies (2014-2021) have investigated current European exposure to ten phthalates (DEP, BBzP, DiBP, DnBP, DCHP, DnPeP, DEHP, DiNP, DiDP, DnOP) and the substitute DINCH to answer the open policy relevant questions which were defined by HBM4EU partner countries and EU institutions as the starting point of the programme. The exposure dataset includes ∼5,600 children (6-11 years) and adolescents (12-18 years) from up to 12 countries per age group and covering the North, East, South and West European regions. Study data from participating studies were harmonised with respect to sample size and selection of participants, selection of biomarkers, and quality and comparability of analytical results to provide a comparable perspective of European exposure. Phthalate and DINCH exposure were deduced from urinary excretions of metabolites, where concentrations were expressed as their key descriptor geometric mean (GM) and 95th percentile (P95). This study aims at reporting current exposure levels and differences in these between European studies and regions, as well as comparisons to human biomonitoring guidance values (HBM-GVs). GMs for children were highest for ∑DEHP metabolites (33.6 μg/L), MiBP (26.6 μg/L), and MEP (24.4 μg/L) and lowest for∑DiDP metabolites (1.91 μg/L) and ∑DINCH metabolites (3.57 μg/L). In adolescents highest GMs were found for MEP (43.3 μg/L), ∑DEHP metabolites (28.8 μg/L), and MiBP (25.6 μg/L) and lowest for ∑DiDP metabolites (= 2.02 μg/L) and ∑DINCH metabolites (2.51 μg/L). In addition, GMs and P95 stratified by European region, sex, household education level, and degree of urbanization are presented. Differences in average biomarker concentrations between sampling sites (data collections) ranged from factor 2 to 9. Compared to the European average, children in the sampling sites OCC (Denmark), InAirQ (Hungary), and SPECIMEn (The Netherlands) had the lowest concentrations across all metabolites and ESTEBAN (France), NAC II (Italy), and CROME (Greece) the highest. For adolescents, comparably higher metabolite concentrations were found in NEB II (Norway), PCB cohort (Slovakia), and ESTEBAN (France), and lower concentrations in POLAES (Poland), FLEHS IV (Belgium), and GerES V-sub (Germany). Multivariate analyses (Survey Generalized Linear Models) indicate compound-specific differences in average metabolite concentrations between the four European regions. Comparison of individual levels with HBM-GVs revealed highest rates of exceedances for DnBP and DiBP, with up to 3 and 5%, respectively, in children and adolescents. No exceedances were observed for DEP and DINCH. With our results we provide current, detailed, and comparable data on exposure to phthalates in children and - for the first time - in adolescents, and - for the first time - on DINCH in children and adolescents of all four regions of Europe which are particularly suited to inform exposure and risk assessment and answer open policy relevant questions.
Repisalud
Publicación Artículo científico (JournalArticle)

The European human biomonitoring platform - Design and implementation of a laboratory quality assurance/quality control (QA/QC) programme for selected priority chemicals

  • Esteban-Lopez, Marta
  • Göen, Thomas
  • Mol, Hans
  • Nübler, Stefanie
  • Haji-Abbas-Zarrabi, Karin
  • Koch, Holger M
  • Kasper-Sonnenberg, Monika
  • Dvorakova, Darina
  • Hajslova, Jana
  • Antignac, Jean-Philippe
  • Vaccher, Vincent
  • Elbers, Ingrid
  • Thomsen, Cathrine
  • Vorkamp, Katrin
  • Pedraza-Diaz, Susana
  • Kolossa-Gehring, Marike
  • Castaño, Argelia
A fundamental objective of the human biomonitoring for Europe initiative (HBM4EU) is to progress toward comparable and robust exposure data for a wide variety of prioritized chemicals in human samples. A programme for Quality Assurance/Quality Control (QA/QC) was designed in HBM4EU with the purpose of creating a network of European laboratories providing comparable analytical data of high quality. Two approaches were chosen for two sets of prioritized chemicals with different timelines: (i) Scheme 1, where interested candidate laboratories participated in multiple rounds of proficiency tests (ii) Scheme 2, where selected expert laboratories participated in three rounds of interlaboratory comparison investigations. In both cases, the results were used to identify laboratories capable of generating consistent and comparable results for sample analysis in the frame of HBM4EU. In total, 84 laboratories from 26 countries were invited to participate in Scheme 1 that covered up to 73 biomarkers from Hexamoll® DINCH, phthalates, bisphenols, per- and polyfluoroalkyl substances, halogenated flame retardants (HFRs), organophosporous flame retardants (OPFRs), polycyclic aromatic hydrocarbons (PAH), cadmium, chromium and aromatic amines. 74 of the participants were successful for at least one biomarker in Scheme 1. Scheme 2 involved 22 biomarkers and successful results were obtained by 2 expert laboratories for arsenic, 5 for acrylamide, 4 for mycotoxins, 2 for pesticides and 2 for UV-filters in skin care products. The QA/QC programme allowed the identification of major difficulties and needs in HBM analysis as well of gaining insight in the analytical capacities of European laboratories. Furthermore, it is the first step towards the establishment of a sustainable European network of HBM laboratories.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Exposure to flame retardants in European children - Results from the HBM4EU aligned studies

  • van der Schyff, Veronica
  • Kalina, Jiři
  • Govarts, Eva
  • Gilles, Liese
  • Schoeters, Greet
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Kohoutek, Jiří
  • Kukučka, Petr
  • Covaci, Adrian
  • Koppen, Gudrun
  • Andrýsková, Lenka
  • Piler, Pavel
  • Klánová, Jana
  • Jensen, Tina Kold
  • Rambaud, Loïc
  • Riou, Margaux
  • Lamoree, Marja
  • Kolossa-Gehring, Marike
  • Vogel, Nina
  • Weber, Till
  • Göen, Thomas
  • Gabriel, Catherine
  • Sarigiannis, Dimosthenis A
  • Sakhi, Amrit Kaur
  • Haug, Line Småstuen
  • Palkovicova Murinova, Lubica
  • Fábelová, Lucia
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Melymuk, Lisa
Many legacy and emerging flame retardants (FRs) have adverse human and environmental health effects. This study reports legacy and emerging FRs in children from nine European countries from the HBM4EU aligned studies. Studies from Belgium, Czech Republic, Germany, Denmark, France, Greece, Slovenia, Slovakia, and Norway conducted between 2014 and 2021 provided data on FRs in blood and urine from 2136 children. All samples were collected and analyzed in alignment with the HBM4EU protocols. Ten halogenated FRs were quantified in blood, and four organophosphate flame retardants (OPFR) metabolites quantified in urine. Hexabromocyclododecane (HBCDD) and decabromodiphenyl ethane (DBDPE) were infrequently detected (<16% of samples). BDE-47 was quantified in blood from Greece, France, and Norway, with France (0.36 ng/g lipid) having the highest concentrations. BDE-153 and -209 were detected in <40% of samples. Dechlorane Plus (DP) was quantified in blood from four countries, with notably high median concentrations of 16 ng/g lipid in Slovenian children. OPFR metabolites had a higher detection frequency than other halogenated FRs. Diphenyl phosphate (DPHP) was quantified in 99% of samples across 8 countries at levels ∼5 times higher than other OPFR metabolites (highest median in Slovenia of 2.43 ng/g lipid). FR concentrations were associated with lifestyle factors such as cleaning frequency, employment status of the father of the household, and renovation status of the house, among others. The concentrations of BDE-47 in children from this study were similar to or lower than FRs found in adult matrices in previous studies, suggesting lower recent exposure and effectiveness of PBDE restrictions.
Repisalud
Publicación Artículo científico (JournalArticle)

Towards Harmonized Biobanking for Biomonitoring: A Comparison of Human Biomonitoring-Related and Clinical Biorepositories

  • Lermen, Dominik
  • Gwinner, Frederik
  • Bartel-Steinbach, Martina
  • Mueller, Sabine C
  • Habermann, Jens K
  • Balwir, Matharoo-Ball
  • Smits, Elke
  • Virgolino, Ana
  • Fiddicke, Ulrike
  • Berglund, Marika
  • Åkesson, Agneta
  • Bergstrom, Anna
  • Leander, Karin
  • Horvat, Milena
  • Snoj Tratnik, Janja
  • Posada De la Paz, Manuel
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • von Briesen, Hagen
  • Zimmermann, Heiko
  • Kolossa-Gehring, Marike
Human biomonitoring (HBM) depends on high-quality human samples to identify status and trends in exposure and ensure comparability of results. In this context, much effort has been put into the development of standardized processes and quality assurance for sampling and chemical analysis, while effects of sample storage and shipment on sample quality have been less thoroughly addressed. To characterize the currently applied storage and shipment procedures within the consortium of the European Human Biomonitoring Initiative (HBM4EU), which aims at harmonization of HBM in Europe, a requirement analysis based on data from an online survey was conducted. In addition, the online survey was addressed to professionals in clinical biobanking represented by members of the European, Middle Eastern and African Society for Biopreservation and Biobanking (ESBB) to identify the current state-of-the-art in terms of sample storage and shipment. Results of this survey conducted in these two networks were compared to detect processes with potential for optimization and harmonization. In general, many similarities exist in sample storage and shipment procedures applied by ESBB members and HBM4EU partners and many requirements for ensuring sample quality are already met also by HBM4EU partners. Nevertheless, a need for improvement was identified for individual steps in sample storage, shipment, and related data management with potential impact on sample and data quality for HBM purposes. Based on these findings, recommendations for crucial first steps to further strengthen sample quality, and thus foster advancement in HBM on a pan-European level are given.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021)

  • Govarts, Eva
  • Gilles, Liese
  • Rodriguez Martin, Laura
  • Santonen, Tiina
  • Apel, Petra
  • Alvito, Paula
  • Anastasi, Elena
  • Andersen, Helle Raun
  • Andersson, Anna-Maria
  • Andryskova, Lenka
  • Antignac, Jean-Philippe
  • Appenzeller, Brice
  • Barbone, Fabio
  • Barnett-Itzhaki, Zohar
  • Barouki, Robert
  • Berman, Tamar
  • Bil, Wieneke
  • Borges, Teresa
  • Buekers, Jurgen
  • Cañas Portilla, Ana Isabel
  • Covaci, Adrian
  • Csákó, Zsófia
  • Den Hond, Elly
  • Dvorakova, Darina
  • Fábelová, Lucia
  • Fletcher, Tony
  • Frederiksen, Hanne
  • Gabriel, Catherine
  • Ganzleben, Catherine
  • Göen, Thomas
  • Halldórsson, Thórhallur Ingi
  • Haug, Line S
  • Horvat, Milena
  • Huuskonen, Pasi
  • Imboden, Medea
  • Jagodic Hudobivnik, Marta
  • Janasik, Beata
  • Janev Holcer, Natasa
  • Karakitsios, Spyros
  • Katsonouri, Andromachi
  • Klánová, Jana
  • Kokaraki, Venetia
  • Kold Jensen, Tina
  • Koponen, Jani
  • Laeremans, Michelle
  • Laguzzi, Federica
  • Lange, Rosa
  • Lemke, Nora
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Lobo Vicente, Joana
  • Luijten, Mirjam
  • Makris, Konstantinos C
  • Mazej, Darja
  • Melymuk, Lisa
  • Meslin, Matthieu
  • Mol, Hans
  • Montazeri, Parisa
  • Murawski, Aline
  • Namorado, Sónia
  • Niemann, Lars
  • Nübler, Stefanie
  • Nunes, Baltazar
  • Ólafsdóttir, Kristin
  • Palkovicova Murinova, Lubica
  • Papaioannou, Nafsika
  • Pedraza-Diaz, Susana
  • Piler, Pavel
  • Plichta, Veronika
  • Poteser, Michael
  • Probst-Hensch, Nicole
  • Rambaud, Loïc
  • Rauscher-Gabernig, Elke
  • Rausova, Katarina
  • Remy, Sylvie
  • Riou, Margaux
  • Rosolen, Valentina
  • Rousselle, Christophe
  • Rüther, Maria
  • Sarigiannis, Denis
  • Silva, Maria J
  • Šlejkovec, Zdenka
  • Snoj Tratnik, Janja
  • Stajnko, Anja
  • Szigeti, Tamás
  • Tarazona, Jose
  • Thomsen, Cathrine
  • Tkalec, Žiga
  • Tolonen, Hanna
  • Trnovec, Tomas
  • Uhl, Maria
  • Van Nieuwenhuyse, An
  • Vasco, Elsa
  • Verheyen, Veerle J
  • Viegas, Susana
  • Vinggaard, Anne Marie
  • Vogel, Nina
  • Vorkamp, Katrin
  • Wasowicz, Wojciech
  • Weber, Till
  • Wimmerova, Sona
  • Woutersen, Marjolijn
  • Zimmermann, Philipp
  • Zvonař, Martin
  • Koch, Holger M
  • Kolossa-Gehring, Marike
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Stewart, Lorraine
  • Sepai, Ovnair
  • Schoeters, Greet
As one of the core elements of the European Human Biomonitoring Initiative (HBM4EU) a human biomonitoring (HBM) survey was conducted in 23 countries to generate EU-wide comparable HBM data. This survey has built on existing HBM capacity in Europe by aligning national or regional HBM studies, referred to as the HBM4EU Aligned Studies. The HBM4EU Aligned Studies included a total of 10,795 participants of three age groups: (i) 3,576 children aged 6-12 years, (ii) 3,117 teenagers aged 12-18 years and (iii) 4,102 young adults aged 20-39 years. The participants were recruited between 2014 and 2021 in 11-12 countries per age group, geographically distributed across Europe. Depending on the age group, internal exposure to phthalates and the substitute DINCH, halogenated and organophosphorus flame retardants, per- and polyfluoroalkyl substances (PFASs), cadmium, bisphenols, polycyclic aromatic hydrocarbons (PAHs), arsenic species, acrylamide, mycotoxins (deoxynivalenol (total DON)), benzophenones and selected pesticides was assessed by measuring substance specific biomarkers subjected to stringent quality control programs for chemical analysis. For substance groups analyzed in different age groups higher average exposure levels were observed in the youngest age group, i.e., phthalates/DINCH in children versus teenagers, acrylamide and pesticides in children versus adults, benzophenones in teenagers versus adults. Many biomarkers in teenagers and adults varied significantly according to educational attainment, with higher exposure levels of bisphenols, phthalates, benzophenones, PAHs and acrylamide in participants (from households) with lower educational attainment, while teenagers from households with higher educational attainment have higher exposure levels for PFASs and arsenic. In children, a social gradient was only observed for the non-specific pyrethroid metabolite 3-PBA and di-isodecyl phthalate (DiDP), with higher levels in children from households with higher educational attainment. Geographical variations were seen for all exposure biomarkers. For 15 biomarkers, the available health-based HBM guidance values were exceeded with highest exceedance rates for toxicologically relevant arsenic in teenagers (40%), 3-PBA in children (36%), and between 11 and 14% for total DON, Σ (PFOA + PFNA + PFHxS + PFOS), bisphenol S and cadmium. The infrastructure and harmonized approach succeeded in obtaining comparable European wide internal exposure data for a prioritized set of 11 chemical groups. These data serve as a reference for comparison at the global level, provide a baseline to compare the efficacy of the European Commission's chemical strategy for sustainability and will give leverage to national policy makers for the implementation of targeted measures.
Repisalud
Publicación Artículo científico (JournalArticle)

Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU

  • Tagne-Fotso, Romuald
  • Riou, Margaux
  • Saoudi, Abdessattar
  • Zeghnoun, Abdelkrim
  • Frederiksen, Hanne
  • Berman, Tamar
  • Montazeri, Parisa
  • Andersson, Anna-Maria
  • Rodriguez-Martin, Laura
  • Åkesson, Agneta
  • Berglund, Marika
  • Biot, Pierre
  • Castaño, Argelia
  • Charles, Marie-Aline
  • Cocco, Emmanuelle
  • Den Hond, Elly
  • Dewolf, Marie-Christine
  • Esteban-Lopez, Marta
  • Gilles, Liese
  • Govarts, Eva
  • Guignard, Cedric
  • Gutleb, Arno C
  • Hartmann, Christina
  • Kold Jensen, Tina
  • Koppen, Gudrun
  • Kosjek, Tina
  • Lambrechts, Nathalie
  • McEachan, Rosemary
  • Sakhi, Amrit K
  • Snoj Tratnik, Janja
  • Uhl, Maria
  • Urquiza, Jose
  • Vafeiadi, Marina
  • Van Nieuwenhuyse, An
  • Vrijheid, Martine
  • Weber, Till
  • Zaros, Cécile
  • Tarroja-Aulina, Elena
  • Knudsen, Lisbeth E
  • Covaci, Adrian
  • Barouki, Robert
  • Kolossa-Gehring, Marike
  • Schoeters, Greet
  • Denys, Sebastien
  • Fillol, Clémence
  • Rambaud, Loïc
Background: Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity. Objective: We used human biomonitoring (HBM) data to investigate the general level of BPA exposure from 2007 to 2014 of European women aged 18-73 years (n = 4,226) and its determinants. Methods: Fifteen studies from 12 countries (Austria, Belgium, Denmark, France, Germany, Greece, Israel, Luxembourg, Slovenia, Spain, Sweden, and the United Kingdom) were included in the BPA Study protocol developed within the European Joint Programme HBM4EU. Seventy variables related to the BPA exposure were collected through a rigorous post-harmonization process. Linear mixed regression models were used to investigate the determinants of total urine BPA in the combined population. Results: Total BPA was quantified in 85-100 % of women in 14 out of 15 contributing studies. Only the Austrian PBAT study (Western Europe), which had a limit of quantification 2.5 to 25-fold higher than the other studies (LOQ=2.5 µg/L), found total BPA in less than 5 % of the urine samples analyzed. The geometric mean (GM) of total urine BPA ranged from 0.77 to 2.47 µg/L among the contributing studies. The lowest GM of total BPA was observed in France (Western Europe) from the ELFE subset (GM=0.77 µg/L (0.98 µg/g creatinine), n = 1741), and the highest levels were found in Belgium (Western Europe) and Greece (Southern Europe), from DEMOCOPHES (GM=2.47 µg/L (2.26 µg/g creatinine), n = 129) and HELIX-RHEA (GM=2.47 µg/L (2.44 µg/g creatinine), n = 194) subsets, respectively. One hundred percent of women in 14 out of 15 data collections in this study exceeded the health-based human biomonitoring guidance value for the general population (HBM-GVGenPop) of 0.0115 µg total BPA/L urine derived from the updated EFSA's BPA TDI. Variables related to the measurement of total urine BPA and those related to the main socio-demographic characteristics (age, height, weight, education, smoking status) were collected in almost all studies, while several variables related to BPA exposure factors were not gathered in most of the original studies (consumption of beverages contained in plastic bottles, consumption of canned food or beverages, consumption of food in contact with plastic packaging, use of plastic film or plastic containers for food, having a plastic floor covering in the house, use of thermal paper…). No clear determinants of total urine BPA concentrations among European women were found. A broader range of data planned for collection in the original questionnaires of the contributing studies would have resulted in a more thorough investigation of the determinants of BPA exposure in European women. Conclusion: This study highlights the urgent need for action to further reduce exposure to BPA to protect the population, as is already the case in the European Union. The study also underscores the importance of pre-harmonizing HBM design and data for producing comparable data and interpretable results at a European-wide level, and to increase HBM uptake by regulatory agencies.
Repisalud
Publicación Artículo científico (JournalArticle)

European interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for the analysis of bisphenol A, S and F in human urine: Results from the HBM4EU project

  • Vaccher, Vincent
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Mol, Hans
  • Haji-Abbas-Zarrabi, Karin
  • Bury, Daniel
  • Koch, Holger M
  • Dvorakova, Darina
  • Hajslova, Jana
  • Nübler, Stefanie
  • Kaur Sakhi, Amrit
  • Thomsen, Cathrine
  • Vorkamp, Katrin
  • Göen, Thomas
  • Antignac, Jean-Philippe
The Human Biomonitoring for Europe initiative (HBM4EU) aims to study the exposure of citizens to chemicals and potentially associated health effects. One objective of this project has been to build a network of laboratories able to answer to the requirements of European human biomonitoring studies. Within the HBM4EU quality assurance and quality control scheme (QA/QC), a number of interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs) were organized to ensure data consistency, comparability and reliability. Bisphenols are among the prioritized substance groups in HBM4EU, including bisphenol A (BPA), bisphenol S (BPS) and bisphenol F (BPF) in human urine. In four rounds of ICI/EQUAS, two target concentration levels were considered, related to around P25 and P95 of the typical exposure distribution observed in the European general population. Special attention was paid to the conjugated phase II metabolites known to be most dominant in samples of environmentally exposed individuals, through the analysis of both native samples and samples fortified with glucuronide forms. For the low level, the average percentage of satisfactory results across the four rounds was 83% for BPA, 71% for BPS and 62% for BPF. For the high level, the percentages of satisfactory results increased to 93% for BPA, 89% for BPS and 86% for BPF. 24 out of 32 participating laboratories (75%) were approved for the analyses of BPA in the HBM4EU project according to the defined criterion of Z-scores for both low and high concentration levels in at least two ICI/EQUAS rounds. For BPS and BPF, the number of qualified laboratories was 18 out of 27 (67%) and 13 out of 28 (46%), respectively. These results demonstrate a strong analytical capability for BPA and BPS in Europe, while improvements may be needed for BPF.
Repisalud
Publicación Artículo científico (JournalArticle)

Cumulative risk assessment of five phthalates in European children and adolescents

  • Lange, Rosa
  • Vogel, Nina
  • Schmidt, Phillipp
  • Gerofke, Antje
  • Luijten, Mirjam
  • Bil, Wieneke
  • Santonen, Tiina
  • Schoeters, Greet
  • Gilles, Liese
  • Sakhi, Amrit K
  • Haug, Line S
  • Jensen, Tina K
  • Frederiksen, Hanne
  • Koch, Holger M
  • Szigeti, Tamás
  • Szabados, Máté
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Gabriel, Catherine
  • Sarigiannis, Dimosthenis
  • Dzhedzheia, Vazha
  • Karakitsios, Spyros
  • Rambaud, Loïc
  • Riou, Margaux
  • Koppen, Gudrun
  • Covaci, Adrian
  • Zvonař, Martin
  • Piler, Pavel
  • Klánová, Jana
  • Fábelová, Lucia
  • Richterová, Denisa
  • Kosjek, Tina
  • Runkel, Agneta
  • Pedraza-Diaz, Susana
  • Verheyen, Veerle
  • Bastiaensen, Michiel
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Kolossa-Gehring, Marike
The European Human Biomonitoring Initiative (HBM4EU) assessed human biomonitoring data on phthalates in children and adolescents, that were sampled between 2014 and 2021, in a harmonised way. These so-called “HBM4EU Aligned Studies” revealed that almost all children and adolescents were exposed to multiple phthalates concurrently. Some phthalates have been shown to act in a dose-additive manner, thus, a mixture risk assessment is warranted. In our study, we determine the risk from combined exposure to five anti-androgenic phthalates, namely DEHP, DiBP, DnBP, BBzP and DiNP by making use of the hazard index (HI) approach. Toxicologically-based human biomonitoring guidance values (HBM-GVs) derived within the framework of HBM4EU served as basis. Our results show that exposures of 17% of children and adolescents from twelve European countries resulted in hazard indices (HI) > 1 with an HI of 1.77 at the 95th percentile (geometric mean, GM = 0.44). Main drivers for the mixture risk are DnBP and DiBP. Generalized Linear Model (GLM) analysis including four major exposure determinants (age, sex, European region, sampling year) simultaneously reveal differences for the European regions and between sampling years. Children and adolescents living in the Eastern region of Europe have on average, higher HIs (GM=0.58) than in the Southern region (GM = 0.36) and Western region (GM = 0.42). Moreover, participants from which urine samples were taken in the earlier years (2014–2016) seem to have higher average HI levels than participants from studies with later sampling periods. Strikingly, the majority (63%) of participants with HIs > 1 would have gone unnoticed in single substance risk assessments as individual phthalates levels were below corresponding HBM-GVs. Thus, our results underline the importance of mixture risk assessment approaches to adequately address risks from concurrent chemical exposure.
Repisalud
Publicación Artículo científico (JournalArticle)

Methylmercury Risk Assessment Based on European Human Biomonitoring Data

  • Domínguez-Morueco, Noelia
  • Pedraza-Diaz, Susana
  • González-Caballero, MCarmen
  • Esteban-Lopez, Marta
  • De Alba-González, Mercedes
  • Katsonouri, Andromachi
  • Santonen, Tiina
  • Cañas Portilla, Ana Isabel
  • Castaño, Argelia
A risk assessment (RA) was conducted to estimate the risk associated with methylmercury (MeHg) exposure of vulnerable European populations, using Human Biomonitoring (HBM) data. This RA was performed integrating published data from European HBM surveys and earlier EFSA approaches (EFSA 2012). Children/adolescents (3 to 17 years old) and women of childbearing age (18 to 50 years old) were selected as relevant study population groups for this RA. Two types of HBM datasets were selected: HBM studies (n = 18) with mercury (Hg) levels (blood and hair, total Hg and/or MeHg) in the general population in different EU countries and the DEMOCOPHES harmonized study in child-mother pairs (hair, total Hg) in 17 EU countries as a reference. Two approaches were included in the RA strategy: the first one was based on estimations of the fraction of children/adolescents and women of childbearing age, respectively, from the EU general population exceeding the HBM-I value established by the German Human Biomonitoring Commission, measured as Hazard Quotients (HQ); and the second approach was based on estimations of the fraction of the two population groups exceeding the Tolerable Weekly Intake (TWI) (or their equivalent to Tolerable Daily Intake (TDI)) defined by EFSA in 2012. The HQ approach showed that for both groups, the risk varies across EU countries and that some EU areas are close to or exceeding the exposure guidance values. This is the case of Spain and Portugal, which showed the highest HQ (GM and/or P95), probably due to their higher fish consumption. Results from the EFSA approach show that hair values of children/adolescents and women of childbearing age (both in selected HBM studies and in DEMOCOPHES study) are below the TDI of 1.9 µg/g; therefore, in general, the European population does not exceed the daily average/intake dose for MeHg and/or Hg. A possible risk underestimation was identified in our assessment since for many studies no data on P95 were available, causing loss of relevant information for risk characterization on the upper bound. In addition, data from other European countries also with high seafood consumption, such as France, Greece or Iceland, were not available. For this reason, further RA refinement is needed with harmonized and more widespread HBM data to account for differences in European exposure and associated risks, so that interventions to protect vulnerable citizens, can be applied.
Repisalud
Publicación Artículo científico (JournalArticle)

PFAS levels and determinants of variability in exposure in European teenagers - Results from the HBM4EU aligned studies (2014-2021)

  • Richterová, D
  • Govarts, E
  • Fábelová, Lucia
  • Rausová, K
  • Rodriguez Martin, L
  • Gilles, L
  • Remy, S
  • Colles, A
  • Rambaud, L
  • Riou, M
  • Gabriel, C
  • Sarigiannis, D
  • Pedraza-Diaz, Susana
  • Ramos, Juan Jose
  • Kosjek, T
  • Snoj Tratnik, J
  • Lignell, S
  • Gyllenhammar, I
  • Thomsen, C
  • Haug, L S
  • Kolossa-Gehring, Marike
  • Vogel, N
  • Franken, C
  • Vanlarebeke, N
  • Bruckers, L
  • Stewart, L
  • Sepai, O
  • Schoeters, G
  • Uhl, M
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Göen, T
  • Palkovicova Murinova, Lubica
Background: Perfluoroalkyl substances (PFAS) are man-made fluorinated chemicals, widely used in various types of consumer products, resulting in their omnipresence in human populations. The aim of this study was to describe current PFAS levels in European teenagers and to investigate the determinants of serum/plasma concentrations in this specific age group. Methods: PFAS concentrations were determined in serum or plasma samples from 1957 teenagers (12-18 years) from 9 European countries as part of the HBM4EU aligned studies (2014-2021). Questionnaire data were post-harmonized by each study and quality checked centrally. Only PFAS with an overall quantification frequency of at least 60% (PFOS, PFOA, PFHxS and PFNA) were included in the analyses. Sociodemographic and lifestyle factors were analysed together with food consumption frequencies to identify determinants of PFAS exposure. The variables study, sex and the highest educational level of household were included as fixed factors in the multivariable linear regression models for all PFAS and each dietary variable was added to the fixed model one by one and for each PFAS separately. Results: The European exposure values for PFAS were reported as geometric means with 95% confidence intervals (CI): PFOS [2.13 μg/L (1.63-2.78)], PFOA ([0.97 μg/L (0.75-1.26)]), PFNA [0.30 μg/L (0.19-0.45)] and PFHxS [0.41 μg/L (0.33-0.52)]. The estimated geometric mean exposure levels were significantly higher in the North and West versus the South and East of Europe. Boys had significantly higher concentrations of the four PFAS compared to girls and significantly higher PFASs concentrations were found in teenagers from households with a higher education level. Consumption of seafood and fish at least 2 times per week was significantly associated with 21% (95% CI: 12-31%) increase in PFOS concentrations and 20% (95% CI: 10-31%) increase in PFNA concentrations as compared to less frequent consumption of seafood and fish. The same trend was observed for PFOA and PFHxS but not statistically significant. Consumption of eggs at least 2 times per week was associated with 11% (95% CI: 2-22%) and 14% (95% CI: 2-27%) increase in PFOS and PFNA concentrations, respectively, as compared to less frequent consumption of eggs. Significantly higher PFOS concentrations were observed for participants consuming offal (14% (95% CI: 3-26%)), the same trend was observed for the other PFAS but not statistically significant. Local food consumption at least 2 times per week was associated with 40% (95% CI: 19-64%) increase in PFOS levels as compared to those consuming local food less frequently. Conclusion: This work provides information about current levels of PFAS in European teenagers and potential dietary sources of exposure to PFAS in European teenagers. These results can be of use for targeted monitoring of PFAS in food.
Repisalud
Publicación Artículo científico (JournalArticle)

Improving the Risk Assessment of Pesticides through the Integration of Human Biomonitoring and Food Monitoring Data: A Case Study for Chlorpyrifos

  • Tarazona, Jose
  • González-Caballero, MCarmen
  • De Alba-González, Mercedes
  • Pedraza-Diaz, Susana
  • Cañas Portilla, Ana Isabel
  • Domínguez-Morueco, Noelia
  • Esteban-Lopez, Marta
  • Cattaneo, Irene
  • Katsonouri, Andromachi
  • Makris, Konstantinos C
  • Halldórsson, Thórhallur Ingi
  • Ólafsdóttir, Kristin
  • Zock, Jan-Paul
  • Dias, Jonatan
  • Decker, Annelies De
  • Morrens, Bert
  • Berman, Tamar
  • Barnett-Itzhaki, Zohar
  • Lindh, Christian
  • Gilles, Liese
  • Govarts, Eva
  • Schoeters, Greet
  • Weber, Till
  • Kolossa-Gehring, Marike
  • Santonen, Tiina
  • Castaño, Argelia
The risk assessment of pesticide residues in food is a key priority in the area of food safety. Most jurisdictions have implemented pre-marketing authorization processes, which are supported by prospective risk assessments. These prospective assessments estimate the expected residue levels in food combining results from residue trials, resembling the pesticide use patterns, with food consumption patterns, according to internationally agreed procedures. In addition, jurisdictions such as the European Union (EU) have implemented large monitoring programs, measuring actual pesticide residue levels in food, and are supporting large-scale human biomonitoring programs for confirming the actual exposure levels and potential risk for consumers. The organophosphate insecticide chlorpyrifos offers an interesting case study, as in the last decade, its acceptable daily intake (ADI) has been reduced several times following risk assessments by the European Food Safety Authority (EFSA). This process has been linked to significant reductions in the use authorized in the EU, reducing consumers' exposure progressively, until the final ban in 2020, accompanied by setting all EU maximum residue levels (MRL) in food at the default value of 0.01 mg/kg. We present a comparison of estimates of the consumer's internal exposure to chlorpyrifos based on the urinary marker 3,5,6-trichloro-2-pyridinol (TCPy), using two sources of monitoring data: monitoring of the food chain from the EU program and biomonitoring of European citizens from the HB4EU project, supported by a literature search. Both methods confirmed a drastic reduction in exposure levels from 2016 onwards. The margin of exposure approach is then used for conducting retrospective risk assessments at different time points, considering the evolution of our understanding of chlorpyrifos toxicity, as well as of exposure levels in EU consumers following the regulatory decisions. Concerns are presented using a color code, and have been identified for almost all studies, particularly for the highest exposed group, but at different levels, reaching the maximum level, red code, for children in Cyprus and Israel. The assessment uncertainties are highlighted and integrated in the identification of levels of concern.
Repisalud
Publicación Artículo científico (JournalArticle)

Approaches to mixture risk assessment of PFASs in the European population based on human hazard and biomonitoring data

  • Bil, W
  • Govarts, E
  • Zeilmaker, M J
  • Woutersen, M
  • Bessems, J
  • Ma, Y
  • Thomsen, C
  • Haug, L S
  • Lignell, S
  • Gyllenhammar, I
  • Palkovicova Murinova, Lubica
  • Fábelová, Lucia
  • Tratnik, J Snoj
  • Kosjek, T
  • Gabriel, C
  • Sarigiannis, D
  • Pedraza-Diaz, Susana
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Rambaud, L
  • Riou, M
  • Franken, C
  • Colles, A
  • Vogel, N
  • Kolossa-Gehring, Marike
  • Halldórsson, Thórhallur Ingi
  • Uhl, M
  • Schoeters, G
  • Santonen, T
  • Vinggaard, A M
Per- and polyfluoroalkyl substances (PFASs) are a highly persistent, mobile, and bioaccumulative class of chemicals, of which emissions into the environment result in long-lasting contamination with high probability for causing adverse effects to human health and the environment. Within the European Biomonitoring Initiative HBM4EU, samples and data were collected in a harmonized way from human biomonitoring (HBM) studies in Europe to derive current exposure data across a geographic spread. We performed mixture risk assessments based on recent internal exposure data of PFASs in European teenagers generated in the HBM4EU Aligned Studies (dataset with N = 1957, sampling years 2014-2021). Mixture risk assessments were performed based on three hazard-based approaches: the Hazard Index (HI) approach, the sum value approach as used by the European Food Safety Authority (EFSA) and the Relative Potency Factor (RPF) approach. The HI approach resulted in the highest risk estimates, followed by the RPF approach and the sum value approach. The assessments indicate that PFAS exposure may result in a health risk in a considerable fraction of individuals in the HBM4EU teenager study sample, thereby confirming the conclusion drawn in the recent EFSA scientific opinion. This study underlines that HBM data are of added value in assessing the health risks of aggregate and cumulative exposure to PFASs, as such data are able to reflect exposure from different sources and via different routes.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

A step towards harmonising human biomonitoring study setup on European level: Materials provided and lessons learnt in HBM4EU

  • Pack, L Kim
  • Gilles, Liese
  • Cops, Jirka
  • Tolonen, Hanna
  • van Kamp, Irene
  • Esteban-Lopez, Marta
  • Pedraza-Diaz, Susana
  • Lacasaña, Marina
  • González Alzaga, Beatríz
  • Lermen, Dominik
  • Bartel-Steinbach, Martina
  • Katsonouri, Andromachi
  • Fiddicke, Ulrike
  • Castaño, Argelia
  • Kolossa-Gehring, Marike
Internal exposure of the human body to potentially harmful chemical substances can be assessed by Human Biomonitoring (HBM). HBM can be used to generate conclusive data that may provide an overview of exposure levels in entire or specific population groups. This knowledge can promote the understanding of potential risks of the substances of interest or help monitoring the success of regulatory measures taken on the political level. Study planning and design are key elements of any epidemiologic study to generate reliable data. In the field of HBM, this has been done using differing approaches on various levels of population coverage so far. Comparison and combined usage of the resulting data would contribute to understanding exposure and its factors on a larger scale, however, the differences between studies make this a challenging and somewhat limited endeavour. This article presents templates for documents that are required to set up an HBM study, thus facilitating the generation of harmonised HBM data as a step towards standardisation of HBM in Europe. They are designed to be modular and adaptable to the specific needs of a single study while emphasising minimum requirements to ensure comparability. It further elaborates on the challenges encountered during the process of creating these documents during the runtime of the European Joint Programme HBM4EU in a multi-national expert team and draws up lessons learnt in the context of knowledge management.
Repisalud
Publicación Artículo científico (JournalArticle)

Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants

  • Gilles, Liese
  • Govarts, Eva
  • Rodriguez Martin, Laura
  • Andersson, Anna-Maria
  • Appenzeller, Brice M R
  • Barbone, Fabio
  • Castaño, Argelia
  • Coertjens, Dries
  • Den Hond, Elly
  • Dzhedzheia, Vazha
  • Eržen, Ivan
  • Esteban-Lopez, Marta
  • Fábelová, Lucia
  • Fillol, Clémence
  • Franken, Carmen
  • Frederiksen, Hanne
  • Gabriel, Catherine
  • Haug, Line Småstuen
  • Horvat, Milena
  • Halldórsson, Thórhallur Ingi
  • Janasik, Beata
  • Holcer, Nataša Janev
  • Kakucs, Réka
  • Karakitsios, Spyros
  • Katsonouri, Andromachi
  • Klánová, Jana
  • Kold Jensen, Tina
  • Kolossa-Gehring, Marike
  • Konstantinou, Corina
  • Koponen, Jani
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Makris, Konstantinos C
  • Mazej, Darja
  • Morrens, Bert
  • Palkovicova Murinova, Lubica
  • Namorado, Sónia
  • Pedraza-Diaz, Susana
  • Peisker, Jasmin
  • Probst-Hensch, Nicole
  • Rambaud, Loïc
  • Rosolen, Valentina
  • Rucic, Enrico
  • Rüther, Maria
  • Sarigiannis, Dimosthenis
  • Tratnik, Janja Snoj
  • Standaert, Arnout
  • Stewart, Lorraine
  • Szigeti, Tamás
  • Thomsen, Cathrine
  • Tolonen, Hanna
  • Eiríksdóttir, Ása
  • Van Nieuwenhuyse, An
  • Verheyen, Veerle J
  • Vlaanderen, Jelle
  • Vogel, Nina
  • Wasowicz, Wojciech
  • Weber, Till
  • Zock, Jan-Paul
  • Sepai, Ovnair
  • Schoeters, Greet
Human biomonitoring has become a pivotal tool for supporting chemicals' policies. It provides information on real-life human exposures and is increasingly used to prioritize chemicals of health concern and to evaluate the success of chemical policies. Europe has launched the ambitious REACH program in 2007 to improve the protection of human health and the environment. In October 2020 the EU commission published its new chemicals strategy for sustainability towards a toxic-free environment. The European Parliament called upon the commission to collect human biomonitoring data to support chemical's risk assessment and risk management. This manuscript describes the organization of the first HBM4EU-aligned studies that obtain comparable human biomonitoring (HBM) data of European citizens to monitor their internal exposure to environmental chemicals. The HBM4EU-aligned studies build on existing HBM capacity in Europe by aligning national or regional HBM studies. The HBM4EU-aligned studies focus on three age groups: children, teenagers, and adults. The participants are recruited between 2014 and 2021 in 11 to 12 primary sampling units that are geographically distributed across Europe. Urine samples are collected in all age groups, and blood samples are collected in children and teenagers. Auxiliary information on socio-demographics, lifestyle, health status, environment, and diet is collected using questionnaires. In total, biological samples from 3137 children aged 6-12 years are collected for the analysis of biomarkers for phthalates, HEXAMOLL® DINCH, and flame retardants. Samples from 2950 teenagers aged 12-18 years are collected for the analysis of biomarkers for phthalates, Hexamoll® DINCH, and per- and polyfluoroalkyl substances (PFASs), and samples from 3522 adults aged 20-39 years are collected for the analysis of cadmium, bisphenols, and metabolites of polyaromatic hydrocarbons (PAHs). The children's group consists of 50.4% boys and 49.5% girls, of which 44.1% live in cities, 29.0% live in towns/suburbs, and 26.8% live in rural areas. The teenagers' group includes 50.6% girls and 49.4% boys, with 37.7% of residents in cities, 31.2% in towns/suburbs, and 30.2% in rural areas. The adult group consists of 52.6% women and 47.4% men, 71.9% live in cities, 14.2% in towns/suburbs, and only 13.4% live in rural areas. The study population approaches the characteristics of the general European population based on age-matched EUROSTAT EU-28, 2017 data; however, individuals who obtained no to lower educational level (ISCED 0-2) are underrepresented. The data on internal human exposure to priority chemicals from this unique cohort will provide a baseline for Europe's strategy towards a non-toxic environment and challenges and recommendations to improve the sampling frame for future EU-wide HBM surveys are discussed.
Repisalud
Publicación Artículo científico (JournalArticle)

HBM4EU chromates study - Overall results and recommendations for the biomonitoring of occupational exposure to hexavalent chromium

  • Santonen, Tiina
  • Porras, Simo P
  • Bocca, Beatrice
  • Bousoumah, Radia
  • Duca, Radu Corneliu
  • Galea, Karen S
  • Godderis, Lode
  • Göen, Thomas
  • Hardy, Emilie
  • Iavicoli, Ivo
  • Janasik, Beata
  • Jones, Kate
  • Leese, Elizabeth
  • Leso, Veruscka
  • Louro, Henriqueta
  • Majery, Nicole
  • Ndaw, Sophie
  • Pinhal, Hermínia
  • Ruggieri, Flavia
  • Silva, Maria J
  • van Nieuwenhuyse, An
  • Verdonck, Jelle
  • Viegas, Susana
  • Wasowicz, Wojciech
  • Sepai, Ovnair
  • Scheepers, Paul T J
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • HBM4EU chromates study team
Exposure to hexavalent chromium [Cr(VI)] may occur in several occupational activities, e.g., welding, Cr(VI) electroplating and other surface treatment processes. The aim of this study was to provide EU relevant data on occupational Cr(VI) exposure to support the regulatory risk assessment and decision-making. In addition, the capability and validity of different biomarkers for the assessment of Cr(VI) exposure were evaluated. The study involved nine European countries and involved 399 workers in different industry sectors with exposures to Cr(VI) such as welding, bath plating, applying or removing paint and other tasks. We also studied 203 controls to establish a background in workers with no direct exposure to Cr(VI). We applied a cross-sectional study design and used chromium in urine as the primary biomonitoring method for Cr(VI) exposure. Additionally, we studied the use of red blood cells (RBC) and exhaled breath condensate (EBC) for biomonitoring of exposure to Cr(VI). Personal measurements were used to study exposure to inhalable and respirable Cr(VI) by personal air sampling. Dermal exposure was studied by taking hand wipe samples. The highest internal exposures were observed in the use of Cr(VI) in electrolytic bath plating. In stainless steel welding the internal Cr exposure was clearly lower when compared to plating activities. We observed a high correlation between chromium urinary levels and air Cr(VI) or dermal total Cr exposure. Urinary chromium showed its value as a first approach for the assessment of total, internal exposure. Correlations between urinary chromium and Cr(VI) in EBC and Cr in RBC were low, probably due to differences in kinetics and indicating that these biomonitoring approaches may not be interchangeable but rather complementary. This study showed that occupational biomonitoring studies can be conducted successfully by multi-national collaboration and provide relevant information to support policy actions aiming to reduce occupational exposure to chemicals.
Repisalud
Publicación Artículo científico (JournalArticle)

Cross-sectional associations between exposure to per- and polyfluoroalkyl substances and body mass index among European teenagers in the HBM4EU aligned studies

  • Schillemans, Tessa
  • Iszatt, Nina
  • Remy, Sylvie
  • Schoeters, Greet
  • Fernández, Mariana F
  • D'Cruz, Shereen Cynthia
  • Desalegn, Anteneh
  • Haug, Line S
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Fábelová, Lucia
  • Palkovicova Murinova, Lubica
  • Kosjek, Tina
  • Tkalec, Žiga
  • Gabriel, Catherine
  • Sarigiannis, Denis
  • Pedraza-Diaz, Susana
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Rambaud, Loïc
  • Riou, Margaux
  • Pauwels, Sara
  • Vanlarebeke, Nik
  • Kolossa-Gehring, Marike
  • Vogel, Nina
  • Uhl, Maria
  • Govarts, Eva
  • Åkesson, Agneta
Per- and polyfluoroalkyl substances (PFAS) are widespread pollutants that may impact youth adiposity patterns. We investigated cross-sectional associations between PFAS and body mass index (BMI) in teenagers/adolescents across nine European countries within the Human Biomonitoring for Europe (HBM4EU) initiative. We used data from 1957 teenagers (12-18 yrs) that were part of the HBM4EU aligned studies, consisting of nine HBM studies (NEBII, Norway; Riksmaten Adolescents 2016-17, Sweden; PCB cohort (follow-up), Slovakia; SLO CRP, Slovenia; CROME, Greece; BEA, Spain; ESTEBAN, France; FLEHS IV, Belgium; GerES V-sub, Germany). Twelve PFAS were measured in blood, whilst weight and height were measured by field nurse/physician or self-reported in questionnaires. We assessed associations between PFAS and age- and sex-adjusted BMI z-scores using linear and logistic regression adjusted for potential confounders. Random-effects meta-analysis and mixed effects models were used to pool studies. We assessed mixture effects using molar sums of exposure biomarkers with toxicological/structural similarities and quantile g-computation. In all studies, the highest concentrations of PFAS were PFOS (medians ranging from 1.34 to 2.79 μg/L). There was a tendency for negative associations with BMI z-scores for all PFAS (except for PFHxS and PFHpS), which was borderline significant for the molar sum of [PFOA and PFNA] and significant for single PFOA [β-coefficient (95% CI) per interquartile range fold change = -0.06 (-0.17, 0.00) and -0.08 (-0.15, -0.01), respectively]. Mixture assessment indicated similar negative associations of the total mixture of [PFOA, PFNA, PFHxS and PFOS] with BMI z-score, but not all compounds showed associations in the same direction: whilst [PFOA, PFNA and PFOS] were negatively associated, [PFHxS] associated positively with BMI z-score. Our results indicated a tendency for associations of relatively low PFAS concentrations with lower BMI in European teenagers. More prospective research is needed to investigate this potential relationship and its implications for health later in life.
Repisalud
Publicación Artículo científico (JournalArticle)

Learning from previous work and finding synergies in the domains of public and environmental health: EU-funded projects BRIDGE Health and HBM4EU

  • David, Madlen
  • Schwedler, Gerda
  • Reiber, Lena
  • Tolonen, Hanna
  • Andersson, Anna-Maria
  • Esteban-Lopez, Marta
  • Joas, Anke
  • Schöpel, Miriam
  • Polcher, Alexandra
  • Kolossa-Gehring, Marike
Background: During the last decade, the European Union initiated several projects in the domains of public and environmental health. Within this framework, BRIDGE Health (Bridging Information and Data Generation for Evidence-based Health policy and Research) and HBM4EU (European human biomonitoring initiative) have been implemented. Whereas, the focus of BRIDGE Health was towards a sustainable and integrated health information system (HIS), the aim of HBM4EU is to improve evidence of the internal exposure of European citizens to environmental chemicals by human biomonitoring (HBM) and the impact of internal exposure on health. As both, environmental and public health determinants are important for health promotion, disease prevention and policy, BRIDGE Health and HBM4EU have overlapping aims and outcomes. In order to improve health information regarding public health and environmental health issues, best use and exchange of respective networks and project results is necessary. Methods: Both projects have implemented health information (HI) and HBM tasks in order to provide adequate environmental and public health information of the European population. Synergies of the projects were identified in the working progress and because of overlapping networks and experts a focused analysis of both projects was envisaged. This paper elaborates on the aims and outcomes of both projects and the benefit of merging and channelling research results for the use of better health information and policy making that may be of relevance for any other project in these research fields. Results: The need for focused exchanges and collaborations between the projects were identified and benefits of exchanges were highlighted for the specific areas of indicator development, linkage of data repositories and the combination of HBM studies and health examination surveys (HES). Further recommendations for a European wide harmonisation among different tasks in the fields of public health and environmental health are being developed. Conclusions: Lessons learned from HBM4EU and BRIDGE Health show that continuous efforts must be undertaken, also by succeeding projects, to guarantee the exchange between public health and environmental health issues. Networks covering both are essential to provide better evidence of knowledge. The experiences from BRIDGE Health and HBM4EU give a valuable input for any future activity in these domains. Avoiding overlaps and streamlining further exchange of public health and environmental health contributes to best use of research results and allows to develop new strategies and tools for improvement of health information and thus enhances people's health and well-being.
Repisalud
Publicación Artículo científico (JournalArticle)

Interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs) for flame retardant analysis in biological matrices: Results from the HBM4EU project

  • Dvorakova, Darina
  • Pulkrabova, Jana
  • Gramblicka, Tomas
  • Polachova, Andrea
  • Buresova, Martina
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Nübler, Stefanie
  • Haji-Abbas-Zarrabi, Karin
  • Klausner, Nadine
  • Göen, Thomas
  • Mol, Hans
  • Koch, Holger M
  • Vaccher, Vincent
  • Antignac, Jean-Philippe
  • Haug, Line Småstuen
  • Vorkamp, Katrin
  • Hajslova, Jana
The European Human Biomonitoring Initiative (HBM4EU) is coordinating and advancing human biomonitoring (HBM). For this purpose, a network of laboratories delivering reliable analytical data on human exposure is fundamental. The analytical comparability and accuracy of laboratories analysing flame retardants (FRs) in serum and urine were investigated by a quality assurance/quality control (QA/QC) scheme comprising interlaboratory comparison investigations (ICIs) and external quality assurance schemes (EQUASs). This paper presents the evaluation process and discusses the results of four ICI/EQUAS rounds performed from 2018 to 2020 for the determination of ten halogenated flame retardants (HFRs) represented by three congeners of polybrominated diphenyl ethers (BDE-47, BDE-153 and BDE-209), two isomers of hexabromocyclododecane (α-HBCD and γ-HBCD), two dechloranes (anti-DP and syn-DP), tetrabromobisphenol A (TBBPA), decabromodiphenylethane (DBDPE), and 2,4,6-tribromophenol (2,4,6-TBP) in serum, and four metabolites of organophosphorus flame retardants (OPFRs) in urine, at two concentration levels. The number of satisfactory results reported by laboratories increased during the four rounds. In the case of HFRs, the scope of the participating laboratories varied substantially (from two to ten) and in most cases did not cover the entire target spectrum of chemicals. The highest participation rate was reached for BDE-47 and BDE-153. The majority of participants achieved more than 70% satisfactory results for these two compounds over all rounds. For other HFRs, the percentage of successful laboratories varied from 44 to 100%. The evaluation of TBBPA, DBDPE, and 2,4,6-TBP was not possible because the number of participating laboratories was too small. Only seven laboratories participated in the ICI/EQUAS scheme for OPFR metabolites and five of them were successful for at least two biomarkers. Nevertheless, the evaluation of laboratory performance using Z-scores in the first three rounds required an alternative approach compared to HFRs because of the small number of participants and the high variability of experts' results. The obtained results within the ICI/EQUAS programme showed a significant core network of comparable European laboratories for HBM of BDE-47, BDE-153, BDE-209, α-HBCD, γ-HBCD, anti-DP, and syn-DP. On the other hand, the data revealed a critically low analytical capacity in Europe for HBM of TBBPA, DBDPE, and 2,4,6-TBP as well as for the OPFR biomarkers.
Repisalud
Publicación Artículo científico (JournalArticle)

Urinary concentrations of phthalate/DINCH metabolites and body mass index among European children and adolescents in the HBM4EU Aligned Studies: A cross-sectional multi-country study

  • Desalegn, Anteneh
  • Schillemans, Tessa
  • Papadopoulou, Eleni
  • Sakhi, Amrit K
  • Haug, Line S
  • Henriette Caspersen, Ida
  • Rodríguez-Carrillo, Andrea
  • Remy, Sylvie
  • Schoeters, Greet
  • Covaci, Adrian
  • Laeremans, Michelle
  • Fernández, Mariana F
  • Pedraza-Diaz, Susana
  • Kold Jensen, Tina
  • Frederiksen, Hanne
  • Åkesson, Agneta
  • Cox, Bianca
  • Cynthia D'Cruz, Shereen
  • Rambaud, Loïc
  • Riou, Margaux
  • Kolossa-Gehring, Marike
  • Gerofke, Antje
  • Murawski, Aline
  • Vogel, Nina
  • Gabriel, Catherine
  • Karakitsios, Spyros
  • Papaioannou, Nafsika
  • Sarigiannis, Dimosthenis
  • Barbone, Fabio
  • Rosolen, Valentina
  • Lignell, Sanna
  • Karin Lindroos, Anna
  • Snoj Tratnik, Janja
  • Stajnko, Anja
  • Kosjek, Tina
  • Tkalec, Žiga
  • Fábelová, Lucia
  • Palkovicova Murinova, Lubica
  • Kolena, Branislav
  • Wimmerova, Sona
  • Szigeti, Tamás
  • Középesy, Szilvia
  • van den Brand, Annick
  • Zock, Jan-Paul
  • Janasik, Beata
  • Wasowicz, Wojciech
  • De Decker, Annelies
  • De Henauw, Stefaan
  • Govarts, Eva
  • Iszatt, Nina
Background: Phthalates are ubiquitous in the environment. Despite short half-lives, chronic exposure can lead to endocrine disruption. The safety of phthalate substitute DINCH is unclear. Objective: To evaluate associations between urinary concentrations of phthalate/DINCH metabolites and body mass index (BMI) z-score among children and adolescents. Method: We used Human Biomonitoring for Europe Aligned Studies data from 2876 children (12 studies, 6-12 years, 2014-2021) and 2499 adolescents (10 studies, 12-18 years, 2014-2021) with up to 14 phthalate/DINCH urinary metabolites. We used multilevel linear regression to assess associations between phthalate/DINCH concentrations and BMI z-scores, testing effect modification by sex. In a subset, Bayesian kernel machine regression (BKMR) and quantile-based g-computation assessed important predictors and mixture effects. Results: In children, we found few associations in single pollutant models and no interactions by sex (p-interaction > 0.1). BKMR detected no relevant exposures (posterior inclusion probabilities, PIPs < 0.25), nor joint mixture effect. In adolescent single pollutant analysis, mono-ethyl phthalate (MEP) concentrations were associated with higher BMI z-score in males (β = 0.08, 95 % CI: 0.001,0.15, per interquartile range increase in ln-transformed concentrations, p-interaction = 0.06). Conversely, mono-isobutyl phthalate (MiBP) was associated with a lower BMI z-score in both sexes (β = -0.13, 95 % CI: -0.19, -0.07, p-interaction = 0.74), as was sum of di(2-ethylhexyl) phthalate (∑DEHP) metabolites in females only (β = -0.08, 95 % CI: -0.14, -0.02, p-interaction = 0.01). In BKMR, higher BMI z-scores were predicted by MEP (PIP=0.90) and MBzP (PIP=0.84) in males. Lower BMI z-scores were predicted by MiBP (PIP=0.999), OH-MIDP (PIP=0.88) and OH-MINCH (PIP=0.72) in both sexes, less robustly by DEHP (PIP=0.61) in females. In quantile g-computation, the overall mixture effect was null for males, and trended negative for females (β = -0.11, 95 % CI: -0.25, 0.03, per joint exposure quantile). Conclusion: In this large Europe-wide study, we found age/sex-specific differences between phthalate metabolites and BMI z-score, stronger in adolescents. Longitudinal studies with repeated phthalate measurements are needed.
Repisalud
Publicación Artículo científico (JournalArticle)

Critical review of analytical methods for the determination of flame retardants in human matrices

  • Hajeb, Parvaneh
  • Castaño, Argelia
  • Cequier, Enrique
  • Covaci, Adrian
  • Esteban-Lopez, Marta
  • Gonzalez Antuña, Ana
  • Haug, Line Småstuen
  • Henríquez-Hernández, Luis Alberto
  • Melymuk, Lisa
  • Pérez Luzardo, Octavio
  • Thomsen, Cathrine
  • Vorkamp, Katrin
Human biomonitoring is a powerful approach in assessing exposure to environmental pollutants. Flame retardants (FRs) are of particular concern due to their wide distribution in the environment and adverse health effects. This article reviews studies published in 2009-2020 on the chemical analysis of FRs in a variety of human samples and discusses the characteristics of the analytical methods applied to different FR biomarkers of exposure, including polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane (HBCD), novel halogenated flame retardants (NHFRs), bromophenols, incl. tetrabromobisphenol A (TBBPA), and organophosphorous flame retardants (PFRs). Among the extraction techniques, liquid-liquid extraction (LLE) and solid phase extraction (SPE) were used most frequently due to the good efficiencies in the isolation of the majority of the FR biomarkers, but with challenges for highly lipophilic FRs. Gas chromatography-mass spectrometry (GC-MS) is mainly applied in the instrumental analysis of PBDEs and most NHFRs, with recent inclusions of GC-MS/MS and high resolution MS techniques. Liquid chromatography-MS/MS is mainly applied to HBCD, bromophenols, incl. TBBPA, and PFRs (including metabolites), however, GC-based analysis following derivatization has also been used for phenolic compounds and PFR metabolites. Developments are noticed towards more universal analytical methods, which enable widening method scopes in the human biomonitoring of FRs. Challenges exist with regard to sensitivity required for the low concentrations of FRs in the general population and limited sample material for some human matrices. A strong focus on quality assurance/quality control (QA/QC) measures is required in the analysis of FR biomarkers in human samples, related to their variety of physical-chemical properties, low levels in most human samples and the risk of contamination.
Repisalud
Publicación Artículo científico (JournalArticle)

Cadmium exposure in adults across Europe: Results from the HBM4EU Aligned Studies survey 2014-2020

  • Snoj Tratnik, Janja
  • Kocman, David
  • Horvat, Milena
  • Andersson, Anna-Maria
  • Juul, Anders
  • Jacobsen, Eva
  • Ólafsdóttir, Kristin
  • Klánová, Jana
  • Andryskova, Lenka
  • Janasik, Beata
  • Wasowicz, Wojciech
  • Janev Holcer, Natasa
  • Namorado, Sónia
  • Coelho, Inês
  • Rambaud, Loïc
  • Riou, Margaux
  • Van Nieuwenhuyse, An
  • Appenzeller, Brice
  • Kolossa-Gehring, Marike
  • Weber, Till
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Gilles, Liese
  • Rodriguez Marti, Laura
  • Schoeters, Greet
  • Sepai, Ovnair
  • Govarts, Eva
The objectives of the study were to estimate the current exposure to cadmium (Cd) in Europe, potential differences between the countries and geographic regions, determinants of exposure and to derive European exposure levels. The basis for this work was provided by the European Human Biomonitoring Initiative (HBM4EU) which established a framework for alignment of national or regional HBM studies. For the purpose of Cd exposure assessment, studies from 9 European countries (Iceland, Denmark, Poland, Czech Republic, Croatia, Portugal, Germany, France, Luxembourg) were included and urine of 20-39 years old adults sampled in the years 2014-2021 (n = 2510). The measurements in urine were quality assured by the HBM4EU quality assurance/quality control scheme, study participants' questionnaire data were post-harmonized. Spatially resolved external data, namely Cd concentrations in soil, agricultural areas, phosphate fertilizer application, traffic density and point source Cd release were collected for the respective statistical territorial unit (NUTS). There were no distinct geographic patterns observed in Cd levels in urine, although the data revealed some differences between the specific study sites. The levels of exposure were otherwise similar between two time periods within the last decade (DEMOCOPHES - 2011-2012 vs. HBM4EU Aligned Studies, 2014-2020). The age-dependent alert values for Cd in urine were exceeded by 16% of the study participants. Exceedances in the different studies and locations ranged from 1.4% up to 42%. The studies with largest extent of exceedance were from France and Poland. Association analysis with individual food consumption data available from participants' questionnaires showed an important contribution of vegetarian diet to the overall exposure, with 35% higher levels in vegetarians as opposed to non-vegetarians. For comparison, increase in Cd levels due to smoking was 25%. Using NUTS2-level external data, positive associations between HBM data and percentage of cropland and consumption of Cd-containing mineral phosphate fertilizer were revealed, which indicates a significant contribution of mineral phosphate fertilizers to human Cd exposure through diet. In addition to diet, traffic and point source release were identified as significant sources of exposure in the study population. The findings of the study support the recommendation by EFSA to reduce Cd exposure as also the estimated mean dietary exposure of adults in the EU is close or slightly exceeding the tolerable weekly intake. It also indicates that regulations are not protecting the population sufficiently.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Phthalates and substitute plasticizers: Main achievements from the European human biomonitoring initiative HBM4EU

  • Gerofke, Antje
  • Lange, Rosa
  • Vogel, Nina
  • Schmidt, Phillipp
  • Weber, Till
  • David, Madlen
  • Frederiksen, Hanne
  • Baken, Kirsten
  • Govarts, Eva
  • Gilles, Liese
  • Rodriguez Martin, Laura
  • Martinsone, Žanna
  • Santonen, Tiina
  • Schoeters, Greet
  • Scheringer, Martin
  • Domínguez-Romero, Elena
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Koch, Holger M
  • Apel, Petra
  • Kolossa-Gehring, Marike
Phthalates and the substitute plasticizer DINCH belong to the first group of priority substances investigated by the European Human Biomonitoring Initiative (HBM4EU) to answer policy-relevant questions and safeguard an efficient science-to-policy transfer of results. Human internal exposure levels were assessed using two data sets from all European regions and Israel. The first collated existing human biomonitoring (HBM) data (2005-2019). The second consisted of new data generated in the harmonized "HBM4EU Aligned Studies" (2014-2021) on children and teenagers for the ten most relevant phthalates and DINCH, accompanied by a quality assurance/quality control (QA/QC) program for 17 urinary exposure biomarkers. Exposures differed between countries, European regions, age groups and educational levels. Toxicologically derived Human biomonitoring guidance values (HBM-GVs) were exceeded in up to 5% of the participants of the HBM4EU Aligned Studies. A mixture risk assessment (MRA) including five reprotoxic phthalates (DEHP, DnBP, DiBP, BBzP, DiNP) revealed that for about 17% of the children and teenagers, health risks cannot be excluded. Concern about male reproductive health emphasized the need to include other anti-androgenic substances for MRA. Contaminated food and the use of personal care products were identified as relevant exposure determinants paving the way for new regulatory measures. Time trend analyses verified the efficacy of regulations: especially for the highly regulated phthalates exposure dropped significantly, while levels of the substitutes DINCH and DEHTP increased. The HBM4EU e-waste study, however, suggests that workers involved in e-waste management may be exposed to higher levels of restricted phthalates. Exposure-effect association studies indicated the relevance of a range of endpoints. A set of HBM indicators was derived to facilitate and accelerate science-to-policy transfer. Result indicators allow different groups and regions to be easily compared. Impact indicators allow health risks to be directly interpreted. The presented results enable successful science-to-policy transfer and support timely and targeted policy measures.
Repisalud
Publicación Artículo científico (JournalArticle)

Human urinary arsenic species, associated exposure determinants and potential health risks assessed in the HBM4EU Aligned Studies

  • Buekers, Jurgen
  • Baken, Kirsten
  • Govarts, Eva
  • Rodriguez Martin, Laura
  • Vogel, Nina
  • Kolossa-Gehring, Marike
  • Šlejkovec, Zdenka
  • Falnoga, Ingrid
  • Horvat, Milena
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Rambaud, Loïc
  • Riou, Margaux
  • Pedraza-Diaz, Susana
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Den Hond, Elly
  • Baeyens, Willy
  • Santonen, Tiina
  • Schoeters, Greet
The European Joint Programme HBM4EU coordinated and advanced human biomonitoring (HBM) in Europe in order to provide science-based evidence for chemical policy development and improve chemical management. Arsenic (As) was selected as a priority substance under the HBM4EU initiative for which open, policy relevant questions like the status of exposure had to be answered. Internal exposure to inorganic arsenic (iAs), measured as Toxic Relevant Arsenic (TRA) (the sum of As(III), As(V), MMA, DMA) in urine samples of teenagers differed among the sampling sites (BEA (Spain) > Riksmaten adolescents (Sweden), ESTEBAN (France) > FLEHS IV (Belgium), SLO CRP (Slovenia)) with geometric means between 3.84 and 8.47 μg/L. The ratio TRA to TRA + arsenobetaine or the ratio TRA to total arsenic varied between 0.22 and 0.49. Main exposure determinants for TRA were the consumption of rice and seafood. When all studies were combined, Pearson correlation analysis showed significant associations between all considered As species. Higher concentrations of DMA, quantitatively a major constituent of TRA, were found with increasing arsenobetaine concentrations, a marker for organic As intake, e.g. through seafood, indicating that other sources of DMA than metabolism of inorganic As exist, e.g. direct intake of DMA or via the intake of arsenosugars or -lipids. Given the lower toxicity of DMA(V) versus iAs, estimating the amount of DMA not originating from iAs, or normalizing TRA for arsenobetaine intake could be useful for estimating iAs exposure and risk. Comparing urinary TRA concentrations with formerly derived biomonitoring equivalent (BE) for non-carcinogenic effects (6.4 μg/L) clearly shows that all 95th percentile exposure values in the different studies exceeded this BE. This together with the fact that cancer risk may not be excluded even at lower iAs levels, suggests a possible health concern for the general population of Europe.
Repisalud
Publicación Artículo científico (JournalArticle)

Glyphosate and AMPA in Human Urine of HBM4EU Aligned Studies: Part A Children

  • Buekers, Jurgen
  • Remy, Sylvie
  • Bessems, Jos
  • Govarts, Eva
  • Rambaud, Loïc
  • Riou, Margaux
  • Tratnik, Janja Snoj
  • Stajnko, Anja
  • Katsonouri, Andromachi
  • Makris, Konstantinos C
  • De Decker, Annelies
  • Morrens, Bert
  • Vogel, Nina
  • Kolossa-Gehring, Marike
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Andersen, Helle Raun
  • Schoeters, Greet
Few data are available on the exposure of children to glyphosate (Gly) in Europe. Within HBM4EU, new HBM exposure data were collected from aligned studies at five sampling sites distributed over Europe (studies: SLO CRP (SI); ORGANIKO (CY); GerES V-sub (DE); 3XG (BE); ESTEBAN (FR)). Median Gly concentrations in urine were below or around the detection limit (0.1 µg/L). The 95th percentiles ranged between 0.18 and 1.03 µg Gly/L. The ratio of AMPA (aminomethylphosphonic acid; main metabolite of Gly) to Gly at molar basis was on average 2.2 and the ratio decreased with higher Gly concentrations, suggesting that other sources of AMPA, independent of metabolism of Gly to AMPA in the monitored participants, may concurrently operate. Using reverse dosimetry and HBM exposure data from five European countries (east, west and south Europe) combined with the proposed ADI (acceptable daily intake) of EFSA for Gly of 0.1 mg/kg bw/day (based on histopathological findings in the salivary gland of rats) indicated no human health risks for Gly in the studied populations at the moment. However, the absence of a group ADI for Gly+AMPA and ongoing discussions on e.g., endocrine disrupting effects cast some uncertainty in relation to the current single substance ADI for Gly. The carcinogenic effects of Gly are still debated in the scientific community. These outcomes would influence the risk conclusions presented here. Finally, regression analyses did not find clear associations between urinary exposure biomarkers and analyzed potential exposure determinants. More information from questionnaires targeting exposure-related behavior just before the sampling is needed.
Repisalud
Publicación Artículo científico (JournalArticle)

HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - The HBM4EU survey

  • Gilles, Liese
  • Govarts, Eva
  • Rambaud, Loïc
  • Vogel, Nina
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Rodriguez Martin, Laura
  • Koppen, Gudrun
  • Remy, Sylvie
  • Vrijheid, Martine
  • Montazeri, Parisa
  • Birks, Laura
  • Sepai, Ovnair
  • Stewart, Lorraine
  • Fiddicke, Ulrike
  • Loots, Ilse
  • Knudsen, Lisbeth E
  • Kolossa-Gehring, Marike
  • Schoeters, Greet
As part of the Human Biomonitoring for Europe (HBM4EU) initiative a human biomonitoring (HBM) survey is conducted in 21 countries. This survey builds on existing HBM capacity in Europe by aligning national or regional HBM studies. The survey targets 3 age groups (i) children aged 6-11 years, (ii) teenagers aged 12-19 years and (iii) young adults aged 20-39 years and includes a total of 9493 participants (3151 children, 2953 teenagers and 3389 young adults). Depending on the age group, internal exposure to phthalates and substitute Hexamoll® DINCH, brominated and organophosphorus flame retardants, per-/poly-fluorinated compounds, cadmium, bisphenols and/or polycyclic aromatic hydrocarbons are assessed. The main goal of the programme is to obtain quality controlled and comparable HBM data of exposure to chemicals, prioritized under HBM4EU, with European wide coverage to inform the development of environment and health policies. This paper describes the framework of the HBM4EU survey and the approach that has been applied to align European HBM initiatives across Europe.
Repisalud
Publicación Artículo científico (JournalArticle)

From science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure

  • Gerofke, Antje
  • David, Madlen
  • Schmidt, Phillipp
  • Lobo Vicenta, Joana
  • Buekers, Jurgen
  • Gilles, Liese
  • Colles, Ann
  • Bessems, Jos
  • Bastiaensen, Michiel
  • Covaci, Adrian
  • Den Hond, Elly
  • Koppen, Gudrun
  • Laeremans, Michelle
  • Verheyen, Veerle J
  • Černá, Milena
  • Klánová, Jana
  • Krskova, Andrea
  • Zvonař, Martin
  • Knudsen, Lisbeth E
  • Koch, Holger M
  • Jensen, Tina Kold
  • Rambaud, Loïc
  • Riou, Margaux
  • Vogel, Nina
  • Gabriel, Catherine
  • Karakitsios, Spyros
  • Papaioannou, Nafsika
  • Sarigiannis, Denis
  • Kakucs, Réka
  • Középesy, Szilvia
  • Rudnai, Péter
  • Szigeti, Tamás
  • Barbone, Fabio
  • Rosolen, Valentina
  • Guignard, Cedric
  • Gutleb, Arno C
  • Sakhi, Amrit Kaur
  • Haug, Line Småstuen
  • Janasik, Beata
  • Ligocka, Danuta
  • Eštóková, Milada
  • Fábelová, Lucia
  • Kolena, Branislav
  • Palkovicova Murinova, Lubica
  • Petrovičová, Ida
  • Richterová, Denisa
  • Horvat, Milena
  • Mazej, Darja
  • Tratnik, Janja Snoj
  • Runkel, Agneta Annika
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Pedraza-Diaz, Susana
  • Åkesson, Agneta
  • Lignell, Sanna
  • Vlaanderen, Jelle
  • Zock, Jan-Paul
  • Schoeters, Greet
  • Kolossa-Gehring, Marike
Within the European Human Biomonitoring (HBM) Initiative HBM4EU we derived HBM indicators that were designed to help answering key policy questions and support chemical policies. The result indicators convey information on chemicals exposure of different age groups, sexes, geographical regions and time points by comparing median exposure values. If differences are observed for one group or the other, policy measures or risk management options can be implemented. Impact indicators support health risk assessment by comparing exposure values with health-based guidance values, such as human biomonitoring guidance values (HBM-GVs). In general, the indicators should be designed to translate complex scientific information into short and clear messages and make it accessible to policy makers but also to a broader audience such as stakeholders (e.g. NGO's), other scientists and the general public. Based on harmonized data from the HBM4EU Aligned Studies (2014-2021), the usefulness of our indicators was demonstrated for the age group children (6-11 years), using two case examples: one phthalate (Diisobutyl phthalate: DiBP) and one non-phthalate substitute (Di-isononyl cyclohexane-1,2- dicarboxylate: DINCH). For the comparison of age groups, these were compared to data for teenagers (12-18 years), and time periods were compared using data from the DEMOCOPHES project (2011-2012). Our result indicators proved to be suitable for demonstrating the effectiveness of policy measures for DiBP and the need of continuous monitoring for DINCH. They showed similar exposure for boys and girls, indicating that there is no need for gender focused interventions and/or no indication of sex-specific exposure patterns. They created a basis for a targeted approach by highlighting relevant geographical differences in internal exposure. An adequate data basis is essential for revealing differences for all indicators. This was particularly evident in our studies on the indicators on age differences. The impact indicator revealed that health risks based on exposure to DiBP cannot be excluded. This is an indication or flag for risk managers and policy makers that exposure to DiBP still is a relevant health issue. HBM indicators derived within HBM4EU are a valuable and important complement to existing indicator lists in the context of environment and health. Their applicability, current shortcomings and solution strategies are outlined.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

HBM4EU-MOM: Prenatal methylmercury-exposure control in five countries through suitable dietary advice for pregnancy - Study design and characteristics of participants

  • Katsonouri, Andromachi
  • Gabriel, Catherine
  • Esteban-Lopez, Marta
  • Namorado, Sónia
  • Halldórsson, Thórhallur Ingi
  • Snoj Tratnik, Janja
  • Rodriguez Martin, Laura
  • Karakoltzidis, Achilleas
  • Chatzimpaloglou, Anthoula
  • Giannadaki, Despina
  • Anastasi, Elena
  • Thoma, Anthi
  • Domínguez-Morueco, Noelia
  • Cañas Portilla, Ana Isabel
  • Jacobsen, Eva
  • Assunção, Ricardo
  • Peres, Maria
  • Santiago, Susana
  • Nunes, Carla
  • Pedraza-Diaz, Susana
  • Iavicoli, Ivo
  • Leso, Veruscka
  • Lacasaña, Marina
  • González-Alzaga, Beatriz
  • Horvat, Milena
  • Sepai, Ovnair
  • Castaño, Argelia
  • Kolossa-Gehring, Marike
  • Karakitsios, Spyros
  • Sarigiannis, Dimosthenis
Background: Seafood is a major source of vital nutrients for optimal fetal growth, but at the same time is the main source of exposure to methylmercury (MeHg), an established neurodevelopmental toxicant. Pregnant women must be provided with dietary advice so as to include safely fish in their diet for nutrition and mercury control. The aim of this work is to present the design of a multicentre randomized control trial (RCT), which combines human biomonitoring (HBM) with dietary interventions using seafood consumption advice to pregnant women for MeHg control, and to collect information about other possible sources of exposure to mercury. It also presents the materials developed for the implementation of the study and the characteristics of the study participants, which were self-reported in the first trimester of pregnancy. Methods: The "HBM4EU-MOM" RCT was performed in the frame of the European Human Biomonitoring Initiative (HBM4EU) in five coastal, high fish-consuming European countries (Cyprus, Greece, Spain, Portugal and Iceland). According to the study design, pregnant women (≥120/country, ≤20 weeks gestational age) provided a hair sample for total mercury assessment (THg) and personal information relevant to the study (e.g., lifestyle, pregnancy status, diet before and during the pregnancy, information on seafood and factors related to possible non-dietary exposures to mercury) during the first trimester of pregnancy. After sampling, participants were randomly assigned to "control" (habitual practices) or "intervention" (received the harmonized HBM4EU-MOM dietary advice for fish consumption during the pregnancy and were encouraged to follow it). Around child delivery, participants provided a second hair sample and completed another tailored questionnaire. Results: A total of 654 women aged 18-45 years were recruited in 2021 in the five countries, primarily through their health-care providers. The pre-pregnancy BMI of the participants ranged from underweight to obese, but was on average within the healthy range. For 73% of the women, the pregnancy was planned. 26% of the women were active smokers before the pregnancy and 8% continued to smoke during the pregnancy, while 33% were passive smokers before pregnancy and 23% remained passively exposed during the pregnancy. 53% of the women self-reported making dietary changes for their pregnancy, with 74% of these women reporting making the changes upon learning of their pregnancy. Of the 43% who did not change their diet for the pregnancy, 74% reported that their diet was already balanced, 6% found it difficult to make changes and 2% were unsure of what changes to make. Seafood consumption did not change significantly before and during the first trimester of pregnancy (overall average ∼8 times per month), with the highest frequency reported in Portugal (≥15 times per month), followed by Spain (≥7 times per month). During the first-trimester of pregnancy, 89% of the Portuguese women, 85% of the Spanish women and <50% of Greek, Cypriot and Icelandic women reported that they had consumed big oily fish. Relevant to non-dietary exposure sources, most participants (>90%) were unaware of safe procedures for handling spillage from broken thermometers and energy-saving lamps, though >22% experienced such an incident (>1 year ago). 26% of the women had dental amalgams. ∼1% had amalgams placed and ∼2% had amalgams removed during peri-pregnancy. 28% had their hair dyed in the past 3 months and 40% had body tattoos. 8% engaged with gardening involving fertilizers/pesticides and 19% with hobbies involving paints/pigments/dyes. Conclusions: The study design materials were fit for the purposes of harmonization and quality-assurance. The harmonized information collected from pregnant women suggests that it is important to raise the awareness of women of reproductive age and pregnant women about how to safely include fish in their diet and to empower them to make proper decisions for nutrition and control of MeHg, as well as other chemical exposures.
Repisalud
Publicación Artículo científico (JournalArticle)

A simple method for direct mercury analysis in dried blood spots (DBS) samples for human biomonitoring studies

  • González-Rubio, Juana María
  • Domínguez-Morueco, Noelia
  • Pedraza-Diaz, Susana
  • Cañas Portilla, Ana Isabel
  • Lucena-Lozano, Miguel Angel
  • Rodriguez, Ana
  • Castaño, Argelia
  • Esteban-Lopez, Marta
Human exposure to mercury can have serious health effects, especially in vulnerable groups such as children and fetuses. The use of dried blood spot (DBS) samples to collect capillary blood greatly facilitates sample collection and fieldwork, being a less invasive alternative to blood collection by venipuncture, needing a small volume of sample, and does not require specialized medical staff. Moreover, DBS sampling reduces logistical and financial barriers related to transport and storage of blood samples. We propose here a novel method to analyze total mercury in DBS samples in a Direct Mercury Analyzer (DMA) that allow the control of the volume of the DBS samples. This method has shown good results in terms of precision (<6% error), accuracy (<10% coefficient of variation) and recovery (75-106%). The applicability of the method in human biomonitoring (HBM) was demonstrated in a pilot study involving 41 adults aged 18-65. Mercury concentrations of DBS samples from capillary blood collected by finger prick (real DBS samples) were determined in the DMA and compared with those determined in whole blood (venous blood) by ICP-MS, the method usually used in HBM. The sampling procedure was also validated by comparison of real DBS samples and DBS generated artificially in the laboratory by depositing venous samples in cellulose cards (laboratory DBS). There were no statistically significant differences in the results obtained using both methodologies (DMA: Geometric Mean (confidence interval 95%) = 3.87 (3.12-4.79) µg/L; ICP-MS: Geometric Mean (confidence interval 95%) = 3.46 (2.80-4.27) µg/L). The proposed method is an excellent alternative to be applied in clinical settings as screening methodology for assessing mercury exposure in vulnerable groups, such us pregnant woman, babies and children.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Coordination of chemical analyses under the European Human Biomonitoring Initiative (HBM4EU): Concepts, procedures and lessons learnt

  • Vorkamp, Katrin
  • Esteban-Lopez, Marta
  • Gilles, Liese
  • Göen, Thomas
  • Govarts, Eva
  • Hajeb, Parvaneh
  • Katsonouri, Andromachi
  • Knudsen, Lisbeth E
  • Kolossa-Gehring, Marike
  • Lindh, Christian
  • Nübler, Stefanie
  • Pedraza-Diaz, Susana
  • Santonen, Tiina
  • Castaño, Argelia
The European Human Biomonitoring Initiative (HBM4EU) ran from 2017 to 2022 with the aim of advancing and harmonizing human biomonitoring in Europe. More than 40,000 analyses were performed on human samples in different human biomonitoring studies in HBM4EU, addressing the chemical exposure of the general population, temporal developments, occupational exposure and a public health intervention on mercury in populations with high fish consumption. The analyses covered 15 priority groups of organic chemicals and metals and were carried out by a network of laboratories meeting the requirements of a comprehensive quality assurance and control system. The coordination of the chemical analyses included establishing contacts between sample owners and qualified laboratories and monitoring the progress of the chemical analyses during the analytical phase, also addressing status and consequences of Covid-19 measures. Other challenges were related to the novelty and complexity of HBM4EU, including administrative and financial matters and implementation of standardized procedures. Many individual contacts were necessary in the initial phase of HBM4EU. However, there is a potential to develop more streamlined and standardized communication and coordination in the analytical phase of a consolidated European HBM programme.
Repisalud
Publicación Artículo científico (JournalArticle)

Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiative

  • Vorkamp, Katrin
  • Castaño, Argelia
  • Antignac, Jean-Philippe
  • Boada, Luis D
  • Cequier, Enrique
  • Covaci, Adrian
  • Esteban-Lopez, Marta
  • Haug, Line S
  • Kasper-Sonnenberg, Monika
  • Koch, Holger M
  • Pérez Luzardo, Octavio
  • Osīte, Agnese
  • Rambaud, Loïc
  • Pinorini, Maria-Teresa
  • Sabbioni, Gabriele
  • Thomsen, Cathrine
The major purpose of human biomonitoring is the mapping and assessment of human exposure to chemicals. The European initiative HBM4EU has prioritized seven substance groups and two metals relevant for human exposure: Phthalates and substitutes (1,2-cyclohexane dicarboxylic acid diisononyl ester, DINCH), bisphenols, per- and polyfluoroalkyl substances (PFASs), halogenated and organophosphorous flame retardants (HFRs and OPFRs), polycyclic aromatic hydrocarbons (PAHs), arylamines, cadmium and chromium. As a first step towards comparable European-wide data, the most suitable biomarkers, human matrices and analytical methods for each substance group or metal were selected from the scientific literature, based on a set of selection criteria. The biomarkers included parent compounds of PFASs and HFRs in serum, of bisphenols and arylamines in urine, metabolites of phthalates, DINCH, OPFRs and PAHs in urine as well as metals in blood and urine, with a preference to measure Cr in erythrocytes representing Cr (VI) exposure. High performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) was the method of choice for bisphenols, PFASs, the HFR hexabromocyclododecane (HBCDD), phenolic HFRs as well as the metabolites of phthalates, DINCH, OPFRs and PAHs in urine. Gas chromatographic (GC) methods were selected for the remaining compounds, e.g. GC-low resolution MS with electron capture negative ionization (ECNI) for HFRs. Both GC-MS and LC-MS/MS were suitable for arylamines. New developments towards increased applications of GC-MS/MS may offer alternatives to GC-MS or LC-MS/MS approaches, e.g. for bisphenols. The metals were best determined by inductively coupled plasma (ICP)-MS, with the particular challenge of avoiding interferences in the Cd determination in urine. The evaluation process revealed research needs towards higher sensitivity and non-invasive sampling as well as a need for more stringent quality assurance/quality control applications and assessments.
Repisalud
Publicación Artículo científico (JournalArticle)

Literature review and evaluation of biomarkers, matrices and analytical methods for chemicals selected in the research program Human Biomonitoring for the European Union (HBM4EU)

  • Sabbioni, Gabriele
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Göen, Thomas
  • Mol, Hans
  • Riou, Margaux
  • Tagne-Fotso, Romuald
Humans are potentially exposed to a large amount of chemicals present in the environment and in the workplace. In the European Human Biomonitoring initiative (Human Biomonitoring for the European Union = HBM4EU), acrylamide, mycotoxins (aflatoxin B1, deoxynivalenol, fumonisin B1), diisocyanates (4,4'-methylenediphenyl diisocyanate, 2,4- and 2,6-toluene diisocyanate), and pyrethroids were included among the prioritized chemicals of concern for human health. For the present literature review, the analytical methods used in worldwide biomonitoring studies for these compounds were collected and presented in comprehensive tables, including the following parameter: determined biomarker, matrix, sample amount, work-up procedure, available laboratory quality assurance and quality assessment information, analytical techniques, and limit of detection. Based on the data presented in these tables, the most suitable methods were recommended. According to the paradigm of biomonitoring, the information about two different biomarkers of exposure was evaluated: a) internal dose = parent compounds and metabolites in urine and blood; and b) the biologically effective = dose measured as blood protein adducts. Urine was the preferred matrix used for deoxynivalenol, fumonisin B1, and pyrethroids (biomarkers of internal dose). Markers of the biological effective dose were determined as hemoglobin adducts for diisocyanates and acrylamide, and as serum-albumin-adducts of aflatoxin B1 and diisocyanates. The analyses and quantitation of the protein adducts in blood or the metabolites in urine were mostly performed with LC-MS/MS or GC-MS in the presence of isotope-labeled internal standards. This review also addresses the critical aspects of the application, use and selection of biomarkers. For future biomonitoring studies, a more comprehensive approach is discussed to broaden the selection of compounds.
Repisalud
Publicación Artículo científico (JournalArticle)

Interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS) for cadmium in urine and blood: Results from the HBM4EU project

  • Nübler, Stefanie
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Mol, Hans
  • Schäfer, Moritz
  • Haji-Abbas-Zarrabi, Karin
  • Bury, Daniel
  • Koch, Holger M
  • Vaccher, Vincent
  • Antignac, Jean-Philippe
  • Dvorakova, Darina
  • Hajslova, Jana
  • Thomsen, Cathrine
  • Vorkamp, Katrin
  • Göen, Thomas
Human biomonitoring (HBM) of cadmium is essential to assess and prevent toxic exposure. Generally, low cadmium levels in urine and blood of the general population place particularly high demands on quality assurance and control measures (QA/QC) for cadmium determination. One of the aims of the HBM4EU project is to harmonize and advance HBM in Europe. Cadmium is one of the chemicals selected as a priority substance for HBM implementation in the 30 European countries under HBM4EU. For this purpose, analytical comparability and accuracy of the analytical laboratories of participating countries was investigated in a QA/QC programme comprising interlaboratory comparison investigations (ICI) and external quality assurance schemes (EQUAS). This paper presents the evaluation process and discusses the results of four ICI/EQUAS rounds for the determination of cadmium in urine and blood. The majority of the 43 participating laboratories achieved satisfactory results, although low limits of quantification were required to quantify Cd concentrations at general population exposure levels. The relative standard deviation of the participants' results obtained from all ICI and EQUAS runs ranged from 8 to 36% for cadmium in urine and 8-28% for cadmium in blood. Applying inductively-coupled plasma mass spectrometry (ICP-MS), using an internal standard, and eliminating molybdenum oxide interferences was favourable for the accurate determination of cadmium in urine and blood. Furthermore, the analysis of cadmium in urine was found to have a critical point at approximately 0.05 μg/l, below which variability increased and laboratory proficiency decreased. This QA/QC programme succeeded in establishing a network of laboratories with high analytical comparability and accuracy for the analysis of cadmium across 20 European countries.
Repisalud
Publicación Artículo científico (JournalArticle)

Associations between Urinary Phthalate Metabolites with BDNF and Behavioral Function among European Children from Five HBM4EU Aligned Studies

  • Salamanca-Fernández, Elena
  • Espín-Moreno, Lydia
  • Olivas-Martínez, Alicia
  • Pérez-Cantero, Ainhoa
  • Martín-Rodríguez, José L
  • Poyatos, Rafael M
  • Barbone, Fabio
  • Rosolen, Valentina
  • Mariuz, Marika
  • Ronfani, Luca
  • Palkovicova Murinova, Lubica
  • Fábelová, Lucia
  • Szigeti, Tamás
  • Kakucs, Réka
  • Sakhi, Amrit K
  • Haug, Line S
  • Lindeman, Birgitte
  • Snoj Tratnik, Janja
  • Kosjek, Tina
  • Jacobs, Griet
  • Voorspoels, Stefan
  • Jurdáková, Helena
  • Górová, Renáta
  • Petrovičová, Ida
  • Kolena, Branislav
  • Esteban-Lopez, Marta
  • Pedraza-Diaz, Susana
  • Kolossa-Gehring, Marike
  • Remy, Sylvie
  • Govarts, Eva
  • Schoeters, Greet
  • Fernández, Mariana F
  • Mustieles, Vicente
Based on toxicological evidence, children's exposure to phthalates may contribute to altered neurodevelopment and abnormal regulation of brain-derived neurotrophic factor (BDNF). We analyzed data from five aligned studies of the Human Biomonitoring for Europe (HBM4EU) project. Ten phthalate metabolites and protein BDNF levels were measured in the urine samples of 1148 children aged 6-12 years from Italy (NACII-IT cohort), Slovakia (PCB-SK cohort), Hungary (InAirQ-HU cohort) and Norway (NEBII-NO). Serum BDNF was also available in 124 Slovenian children (CRP-SLO cohort). Children's total, externalizing and internalizing behavioral problems were assessed using the Child Behavior Checklist at 7 years of age (only available in the NACII-IT cohort). Adjusted linear and negative binomial regression models were fitted, together with weighted quantile sum (WQS) regression models to assess phthalate mixture associations. Results showed that, in boys but not girls of the NACII-IT cohort, each natural-log-unit increase in mono-n-butyl phthalate (MnBP) and Mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) was cross-sectionally associated with higher externalizing problems [incidence rate ratio (IRR): 1.20; 95% CI: 1.02, 1.42 and 1.26; 95% CI: 1.03, 1.55, respectively]. A suggestive mixture association with externalizing problems was also observed per each tertile mixture increase in the whole population (WQS-IRR = 1.15; 95% CI: 0.97, 1.36) and boys (IRR = 1.20; 95% CI: 0.96, 1.49). In NACII-IT, PCB-SK, InAirQ-HU and NEBII-NO cohorts together, urinary phthalate metabolites were strongly associated with higher urinary BDNF levels, with WQS regression confirming a mixture association in the whole population (percent change (PC) = 25.9%; 95% CI: 17.6, 34.7), in girls (PC = 18.6%; 95% CI: 7.92, 30.5) and mainly among boys (PC = 36.0%; 95% CI: 24.3, 48.9). Among CRP-SLO boys, each natural-log-unit increase in ∑DINCH concentration was associated with lower serum BDNF levels (PC: -8.8%; 95% CI: -16.7, -0.3). In the NACII-IT cohort, each natural-log-unit increase in urinary BDNF levels predicted worse internalizing scores among all children (IRR: 1.15; 95% CI: 1.00, 1.32). Results suggest that (1) children's exposure to di-n-butyl phthalate (DnBP) and di(2-ethylhexyl) phthalate (DEHP) metabolites is associated with more externalizing problems in boys, (2) higher exposure to DINCH may associate with lower systemic BDNF levels in boys, (3) higher phthalate exposure is associated with higher urinary BDNF concentrations (although caution is needed since the possibility of a "urine concentration bias" that could also explain these associations in noncausal terms was identified) and (4) higher urinary BDNF concentrations may predict internalizing problems. Given this is the first study to examine the relationship between phthalate metabolite exposure and BDNF biomarkers, future studies are needed to validate the observed associations.
Repisalud
Publicación Artículo científico (JournalArticle)

Exposure assessment of the European adult population to deoxynivalenol - Results from the HBM4EU Aligned Studies.

  • Namorado, Sónia
  • Martins, Carla
  • Ogura, Joana
  • Assunção, Ricardo
  • Vasco, Elsa
  • Appenzeller, Brice
  • Halldórsson, Thórhallur Ingi
  • Janasik, Beata
  • Kolossa-Gehring, Marike
  • Van Nieuwenhuyse, An
  • Ólafsdóttir, Kristin
  • Rambaud, Loïc
  • Riou, Margaux
  • Silva, Susana
  • Wasowicz, Wojciech
  • Weber, Till
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Gilles, Liese
  • Rodriguez Martin, Laura
  • Govarts, Eva
  • Schoeters, Greet
  • Viegas, Susana
  • Silva, Maria João
  • Alvito, Paula
Mycotoxins are natural toxins produced by fungi that may cause adverse health effects thus constituting a public health concern. Deoxynivalenol (DON), a mycotoxin affecting the immune system and causing intestinal disorders, was selected as a priority under the European Human Biomonitoring Initiative (HBM4EU). Urinary total DON levels (tDON) of 1270 participants from six countries were used to characterize the internal exposure of the adult European population and identify the most relevant determinants of exposure. tDON concentrations' P50 and P95 were in the range of 0.41-10.16 µg/L (0.39-9.05 µg/g crt) and 3.25-46.58 µg/L (2.12-33.50 µg/g crt) respectively. Higher tDON levels were observed for (i) male participants from France and Germany, (ii) samples collected in spring and summer, (iii) participants with a lower educational level, (iv) participants living in rural areas, (v) individuals without a job in France and Luxembourg, while in Portugal higher exposure was observed in working individuals, (vi) individuals with higher consumption of cereals and bread. The proportion of individuals with exposure levels exceeding the HBM-GV of 23 µg/L was 12.3 %, ranging from 0.8 % to 20.7 % in the individual countries. This study on mycotoxins exposure has used post harmonized questionnaire data and validated analytical methodologies for analysis and covered countries representing the four geographical regions of Europe, having produced much needed knowledge on the exposure of the European adult population to deoxynivalenol.
Repisalud
Publicación Artículo científico (JournalArticle)

A Phased Approach for preparation and organization of human biomonitoring studies

  • Fiddicke, Ulrike
  • Pack, L Kim
  • Tolonen, Hanna
  • Sepai, Ovnair
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Schoeters, Greet
  • Kolossa-Gehring, Marike
Background: Human biomonitoring (HBM) studies like other epidemiological studies are costly and time-consuming. They require the administration of questionnaires and collection of biological samples, putting substantial burden on the participants which may result in low participation rates. The growing importance of HBM studies in epidemiology, exposure assessment and risk assessment underline the importance of optimizing study planning, designing and implementation thus minimizing the above-mentioned difficulties. Methods: Based on frameworks from survey design and fieldwork preparation of the European Joint Program HBM4EU, the German Environment Surveys and the COPHES/DEMOCOPHES twin projects combined with elements of project management strategies, a Phased Approach has been developed, introducing a step-by-step guideline for the development of epidemiological studies. Results: The Phased Approach splits the process of developing a study into six phases: Phase 0 (Scoping and Planning): All aspects that are necessary to conduct a study are compiled and put on the agenda for decision-making. Phase 1 (Preparation and Testing): Instruments (e.g. questionnaires), materials (e.g. guidelines, information), and ethics and data management issues, needing thorough preparation and testing before a study can start. Phase 2 (Initiation): Organization and acquisition of necessary equipment and engaging and training personnel. Phase 3 (Implementation): All procedures that require temporal proximity to the start date of fieldwork, such as obtaining contact information of invitees. Phase 4 (Fieldwork and Analysis): Involvement of participants and chemical analysis of the collected samples. Phase 5 (Results and Evaluation): Final procedures leading to closure of the project, such as providing and communicating results. Conclusions: The separation of the planning and conduct of human biomonitoring studies into different phases creates the basis for a structured procedure and facilitates a step-by-step approach reducing costs, warranting high participation rates and increasing quality of conduct. Emphasis is put on a comprehensive scoping phase ensuring high quality of the study design, which is indispensable for reliable results.
Repisalud
Publicación Artículo científico (JournalArticle)

Challenges to Evidence Synthesis and Identification of Data Gaps in Human Biomonitoring

  • Virgolino, Ana
  • Santos, Osvaldo
  • Costa, Joana
  • Fialho, Mónica
  • Iavicoli, Ivo
  • Santonen, Tiina
  • Tolonen, Hanna
  • Samoli, Evangelia
  • Katsouyanni, Klea
  • Baltatzis, Georgios
  • Ruggieri, Flavia
  • Abballe, Annalisa
  • Petrovičová, Ida
  • Kolena, Branislav
  • Šidlovská, Miroslava
  • Ancona, Carla
  • Eržen, Ivan
  • Sepai, Ovnair
  • Castaño, Argelia
  • Kolossa-Gehring, Marike
  • Fiddicke, Ulrike
The increasing number of human biomonitoring (HBM) studies undertaken in recent decades has brought to light the need to harmonise procedures along all phases of the study, including sampling, data collection and analytical methods to allow data comparability. The first steps towards harmonisation are the identification and collation of HBM methodological information of existing studies and data gaps. Systematic literature reviews and meta-analyses have been traditionally put at the top of the hierarchy of evidence, being increasingly applied to map available evidence on health risks linked to exposure to chemicals. However, these methods mainly capture peer-reviewed articles, failing to comprehensively identify other important, unpublished sources of information that are pivotal to gather a complete map of the produced evidence in the area of HBM. Within the framework of the European Human Biomonitoring Initiative (HBM4EU) initiative-a project that joins 30 countries, 29 from Europe plus Israel, the European Environment Agency and the European Commission-a comprehensive work of data triangulation has been made to identify existing HBM studies and data gaps across countries within the consortium. The use of documentary analysis together with an up-to-date platform to fulfil this need and its implications for research and practice are discussed.
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

The NORMAN Suspect List Exchange (NORMAN‑SLE): facilitating European and worldwide collaboration on suspect screening in high resolution mass spectrometry

  • Taha, Hiba Mohammed
  • Postigo, Cristina
Background: The NORMAN Association (https:// www. norman-​netwo rk. com/) initiated the NORMAN Suspect List Exchange (NORMAN-SLE; https:// www. norman-​netwo rk. com/ nds/ SLE/) in 2015, following the NORMAN collaborative trial on non-target screening of environmental water samples by mass spectrometry. Since then, this exchange of information on chemicals that are expected to occur in the environment, along with the accompanying expert knowledge and references, has become a valuable knowledge base for “suspect screening” lists. The NORMAN-SLE now serves as a FAIR (Findable, Accessible, Interoperable, Reusable) chemical information resource worldwide. Results: The NORMAN-SLE contains 99 separate suspect list collections (as of May 2022) from over 70 contributors around the world, totalling over 100,000 unique substances. The substance classes include per- and polyfluoroalkyl substances (PFAS), pharmaceuticals, pesticides, natural toxins, high production volume substances covered under the European REACH regulation (EC: 1272/2008), priority contaminants of emerging concern (CECs) and regulatory lists from NORMAN partners. Several lists focus on transformation products (TPs) and complex features detected in the environment with various levels of provenance and structural information. Each list is available for separate download. The merged, curated collection is also available as the NORMAN Substance Database (NORMAN SusDat). Both the NORMAN-SLE and NORMAN SusDat are integrated within the NORMAN Database System (NDS). The individual NORMAN-SLE lists receive digital object identifiers (DOIs) and traceable versioning via a Zenodo community (https:// zenodo. org/ commu nities/ norman-​sle), with a total of > 40,000 unique views, > 50,000 unique downloads and 40 citations (May 2022). NORMAN-SLE content is progressively integrated into large open chemical databases such as PubChem (https:// pubch em. ncbi. nlm. nih. gov/) and the US EPA’s CompTox Chemicals Dashboard (https:// compt ox. epa. gov/ dashb oard/), enabling further access to these lists, along with the additional functionality and calculated properties these resources offer. PubChem has also integrated significant annotation content from the NORMAN-SLE, including a classification browser (https:// pubch em. ncbi. nlm. nih. gov/ class ifica tion/# hid= 101). Conclusions: The NORMAN-SLE offers a specialized service for hosting suspect screening lists of relevance for the environmental community in an open, FAIR manner that allows integration with other major chemical resources. These efforts foster the exchange of information between scientists and regulators, supporting the paradigm shift to the “one substance, one assessment” approach. New submissions are welcome via the contacts provided on the NORMAN-SLE website (https:// www. norman-​netwo rk. com/ nds/ SLE/)., NORMAN Association, Luxembourg National Research Fund A18/BM/12341006, European Union's Horizon 2020 research and innovation programme 101036756, National Center for Biotechnology Information of the National Library of Medicine (NLM), National Institutes of Health (NIH), National Health and Medical Research Council (NHMRC) of Australia EL1 2009209, Australian Research Council DP190102476 Queensland Department of Health, Instituto de Salud Carlos III European Commission CP19/00060 European Union through Fondo Europeo de Desarrollo Regional (FEDER), Federal Ministry of Education & Research (BMBF) FKz: 02WRS1495 A/B/E, FWO 11G1821N, NIH via grant NIH NIGMS R01GM092218 NIH via grant NIH NCI 1R03CA222452-01, Vanderbilt Chemical Biology Interface training program 5T32GM065086-16, Netherlands Organization for Scientific Research (NWO) 15747, SOLUTIONS project (European Union's Seventh Framework Programme for research, technological development and demonstration) 603437, HBM4EU (European Union's Horizon 2020 research and innovation programme 733032, German Research Foundation (DFG) 441958208, NaToxAq (European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant 722493, German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) (FKZ) 3716 67 416 0, German Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection (BMUV) Project (FKZ) 3719 65 408 0, EU Cohesion Funds within the project Monitoring and assessment of water body status 310011A366, Swiss Federal Office for the Environment (FOEN), Canadian Institutes of Health Research (CIHR) Genome Canada, MAVA foundation, Valery Foundation, National Science Foundation (NSF) RUI-1306074 National Natural Science Foundation of China (NSFC) 22193051 21906177, China Postdoctoral Science Foundation 2019M650863, Environmental Protection Administration, Executive Yuan, R.O.C. Taiwan (Taiwan EPA) 108C002871, Swiss Federal Office for the Environment, United States Environmental Protection Agency, Center for Forestry Research & Experimentation (CIEF), European Commission 2019/040, Marie Sklodowska-Curie grant 859891 European Commission European Commission Joint Research Centre 308610 289511, Joint Programming Initiative FOODBALL 2014-17 MCIN/AEI RYC2020-028901-I, ESF investing in your future, August T Larsson Guest Researcher Programme from the Swedish University of Agricultural Sciences, German Federal Ministry of Education and Research within the RiSKWa program 02WRS1273 02WRS1354, RECETOX research infrastructure (the Czech Ministry of Education, Youth and Sports) LM2018121, CETOCOEN PLUS project CZ.02.1.01/0.0/0.0/15_ 003/0000469 CETOCOEN EXCELLENCE Teaming 2 project - Czech ministry of Education, Youth and Sports CZ.02.1.01/0.0/0.0/1 7_043/0009632
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008–2020

  • Ventura, Célia
  • Mustieles Miralles, Vicente
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
This research was supported by funding from the European Union's Horizon 2020 research and innovation Programme under grant agreement No 733032 HBM4EU., A number of human biomonitoring (HBM) studies have presented data on exposure to hexavalent chromium [Cr (VI)] and cadmium (Cd), but comparatively few include results on effect biomarkers. The latter are needed to identify associations between exposure and adverse outcomes (AOs) in order to assess public health implications. To support improved derivation of EU regulation and policy making, it is of great importance to identify the most reliable effect biomarkers for these heavy metals that can be used in HBM studies. In the framework of the Human Biomonitoring for Europe (HBM4EU) initiative, our study aim was to identify effect biomarkers linking Cr(VI) and Cd exposure to selected AOs including cancer, immunotoxicity, oxidative stress, and omics/epigenetics. A comprehensive PubMed search identified recent HBM studies, in which effect biomarkers were examined. Validity and applicability of the markers in HBM studies are discussed. The most frequently analysed effect biomarkers regarding Cr(VI) exposure and its association with cancer were those indicating oxidative stress (e.g., 8-hydroxy-2 & rsquo;-deoxyguanosine (8-OHdG), malondialdehyde (MDA), glutathione (GSH)) and DNA or chromosomal damage (comet and micronucleus assays). With respect to Cd and to some extent Cr, 0-2-microglobulin (B2-MG) and N-acetyl-0-D-glucosaminidase (NAG) are well-established, sensitive, and the most common effect biomarkers to relate Cd or Cr exposure to renal tubular dysfunction. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule (KIM)-1 could serve as sensitive biomarkers of acute kidney injury in response to both metals, but need further investigation in HBM studies. Omics-based biomarkers, i.e., changes in the (epi-)genome, transcriptome, proteome, and metabolome associated with Cr and/or Cd exposure, are promising effect biomarkers, but more HBM data are needed to confirm their significance. The combination of established effect markers and omics biomarkers may represent the strongest approach, especially if based on knowledge of mechanistic principles. To this aim, also mechanistic data were collected to provide guidance on the use of more sensitive and specific effect biomarkers. This also led to the identification of knowledge gaps relevant to the direction of future research., European Commission 733032 HBM4EU
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Exploring the relationship between metal exposure, BDNF, and behavior in adolescent males

  • Rodríguez Carrillo, Andrea
  • Mustieles Miralles, Vicente
  • Gil Hernández, Fernando|||0000-0001-9816-8618
  • Olmedo Palma, Pablo
  • Reina Pérez, Iris
  • Mundo, Antonio
  • Molina, Marina
  • Freire, Carmen
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
This research would not have been achieved without the selfless collaboration of the INMA-Granada adolescents and families who took part in the study. The authors also acknowledge the Human Genotyping Laboratory at the Spanish National Cancer Research Center, CeGen-PRB3, which is supported by grant no. PT17/0019, of the PE I+D+i 2013-2016, funded by the Instituto de Salud Carlos III (ISCIII) and ERDF. They thank the European Union's Horizon 2020 research and innovation program HBM4EU for financial support under Grant Agree-ment No. 733032. The study was also supported by the ISCIII with grant no. CP16/00085. The authors also acknowledge the funding received from the University of Granada for the open access publishing costs and the support of the Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP) , and the ISCIII (FIS 17/01526, FIS-PI16/01820 and FIS-PI16/01858) . Vicente Mustieles and Shereen Cynthia D'Cruz were under contract with the HBM4EU project. A. Rodriguez-Carrillo received a predoctoral fellowship (FPU 16/03011) from the Spanish Ministry of Education and C. Freire (grant no. MS16/00085) received a grant under the Miguel Servet Type I program of the ISCIII "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) . This article forms part of the doctoral thesis developed by Andrea Rodriguez-Carrillo in the context of the "Clinical Medicine and Public Health Program" of the University of Granada (Spain) ., Background: Brain-derived neurotrophic factor (BDNF) plays an important role in brain development by regulating multiple pathways within the central nervous system. In the Human Biomonitoring for Europe Project (HBM4EU), this neurotrophin is being implemented as a novel effect biomarker to evaluate the potential threats of environmental chemicals on neurodevelopment. Objectives: To explore the relationships among exposure to environmental metals, BDNF biomarkers at two levels of biological complexity, and behavioral function in adolescent males. Methods: Data were gathered from 125 adolescents on: spot urine sample total concentrations of the neurotoxic metal(oid)s arsenic (As), cadmium (Cd), mercury (Hg), and lead (Pb); serum BDNF protein concentrations; and concurrent behavioral functioning according to the Child Behavior Check List (CBCL/6–18). In 113 of the participants, information was also collected on blood BDNF DNA methylation at six CpGs. Associations were evaluated by multivariate linear regression analysis adjusted for confounders. Results: As, Cd, Hg, and Pb were detected in 100%, 98.5%, 97.0%, and 89.5% of urine samples, respectively. Median serum BDNF concentration was 32.6 ng/mL, and total percentage of BDNF gene methylation was 3.8%. In the adjusted models, urinary As was non-linearly associated with more internalizing problems and Cd with more externalizing behaviors. The percentage BDNF DNA methylation at CPGs #5 and the mean percentage CpG methylation increased across As tertiles (p-trend = 0.04 and 0.03, respectively), while 2nd tertile and 3rd tertile of Cd concentrations were associated with lower serum BDNF and higher CpG3 methylation percentage. Additionally, when BDNF was categorized in tertiles, serum BDNF at the 3rd tertile was associated with fewer behavioral problems, particularly withdrawn (p-trend = 0.04), social problems (p-trend = 0.12), and thought problems (p-trend = 0.04). Conclusion: Exposure to As and Cd was associated with BDNF gene DNA methylation BDNF gene and serum BDNF, respectively. Associations with DNA methylation may be attributable to a higher variability over time in circulating BDNF concentrations than in the methylation status of this gene. Caution should be taken when interpreting the results relating postnatal Pb and Hg to behavioral functioning. Further studies are needed to verify these findings., Instituto de Salud Carlos III European Commission PT17/0019, European Commission, European Union's Horizon 2020 research and innovation program HBM4EU 733032, Instituto de Salud Carlos III CP16/00085 FIS 17/01526 FIS-PI16/01820 FIS-PI16/01858, University of Granada, Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP), Spanish Government FPU 16/03011, Miguel Servet Type I program of the ISCIII "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) MS16/00085
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

The questionnaire design process in the European Human Biomonitoring Initiative (HBM4EU)

  • González Alzaga, Beatriz
  • Hernández Jérez, Antonio Francisco|||0000-0003-2983-5418
  • Lacasaña Navarro, Marina
This document was created for the HBM4EU project. HBM4EU has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 733032. The Swiss participation in this European Program is funded by the Swiss State Secretary for Education Research and Innovation (SERI)., Background: Designing questionnaires is a key point of epidemiological studies assessing human exposure to chemicals. The lack of validated questionnaires can lead to the use of previously developed and sub-optimally adapted questionnaires, which may result in information biases that affect the study’s validity. On this ground, a multidisciplinary group of researchers developed a series of tools to support data collection within the HBM4EU initiative. The objective of this paper is to share the process of developing HBM4EU questionnaires, as well as to provide researchers with harmonized procedures that could help them to design future questionnaires to assess environmental exposures. Methods: In the frame of the work package on survey design and fieldwork of the HBM4EU, researchers carried out procedures necessary for the development of quality questionnaires and related data collection tools. These procedures consisted of a systematic search to identify questionnaires used in previous human biomonitoring (HBM) studies, as well as the development of a checklist and evaluation sheet to assess the questionnaires identified. The results of these evaluations were taken into consideration for the development of the final questionnaires. Results: The main points covered by each of the sections included in HBM4EU questionnaires are described and discussed in detail. Additional tools developed for data collection in the HBM4EU (e.g. non-responder questionnaire, satisfaction questionnaire, matrix-specific questionnaire) are also addressed. Special attention is paid to the limitations faced and hurdles overcome during the process of questionnaire development. Conclusions: Designing questionnaires for use in HBM studies requires substantial effort by a multidisciplinary team to guarantee that the quality of the information collected meets the study’s objectives. The process of questionnaire development described herein will contribute to improve the harmonization of HBM studies within the social and environmental context of the EU countries., European Union's Horizon 2020 research and innovation programme 733032, Swiss State Secretary for Education Research and Innovation (SERI)
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Concurrent Assessment of Phthalates/HEXAMOLL® DINCH Exposure and Wechsler Intelligence Scale for Children Performance in Three European Cohorts of the HBM4EU Aligned Studies

  • Rosolen, Valentina
  • Mustieles Miralles, Vicente
Information about the effects of phthalates and non-phthalate substitute cyclohexane-1,2-dicarboxylic acid diisononyl ester (HEXAMOLL (R) DINCH) on children's neurodevelopment is limited. The aim of the present research is to evaluate the association between phthalate /HEXAMOLL (R) DINCH exposure and child neurodevelopment in three European cohorts involved in HBM4EU Aligned Studies. Participating subjects were school-aged children belonging to the Northern Adriatic cohort II (NAC-II), Italy, Odense Child Cohort (OCC), Denmark, and PCB cohort, Slovakia. In each cohort, children's neurodevelopment was assessed through the Full-Scale Intelligence Quotient score (FSIQ) of the Wechsler Intelligence Scale of Children test using three different editions. The children's urine samples, collected for one point in time concurrently with the neurodevelopmental evaluation, were analyzed for several phthalates/HEXAMOLL (R) DINCH biomarkers. The relation between phthalates/HEXAMOLL (R) DINCH and FSIQ was explored by applying separate multiple linear regressions in each cohort. The means and standard deviations of FSIQ were 109 +/- 11 (NAC-II), 98 +/- 12 (OCC), and 81 +/- 15 (PCB cohort). In NAC-II, direct associations between FSIQ and DEHP's biomarkers were found: 50H-MEHP+5oxo-MEHP ((3 = 2.56; 95% CI 0.58-4.55; N = 270), 50H-MEHP+5cx-MEPP (beta = 2.48; 95% CI 0.47-4.49; N = 270) and 5OH-MEHP (beta = 2.58; 95% CI 0.65-4.51; N = 270). On the contrary, in the OCC the relation between DEHP's biomarkers and FSIQ tended to be inverse but imprecise (p-value >= 0.10). No associations were found in the PCB cohort. FSIQ was not associated with HEXAMOLL (R) DINCH in any cohort. In conclusion, these results do not provide evidence of an association between concurrent phthalate/DINCHHEXAMOLLR DINCH exposure and IQ in children., European Commission 733032 European Union through its Sixth Framework Program for RTD FOOD-CT-2006-016253, Institute for Maternal and Child Health IRCCS "Burlo Garofolo", Trieste, Italy (Ministry of Health-Italy) RC 12/12, CROME LIFE Project "Cross-Mediterranean Environment and Health Network" LIFE12 ENV/GR/001040, Odense University Hospital, Denmark, University of Southern Denmark Mental Health Service of the Region of Southern Denmark Odense Patient data Exploratory Network (OPEN), Denmark Danish Center for Hormone Disrupting Chemicals MST-611-00012, Det Frie Forskningsrad (DFF) 4004-00352B_FSS, Novo Nordisk Foundation NNF19OC0058266 NNF17OC0029404, Sygeforsikring Danmark 2021-0173, Odense University Hospital, Helsefonden Beckettfonden, Danish Mental Health Fund, Health Insurance Denmark, Velux Fonden, Slovak Research and Development Agency APVV-0571-12, Ministry of Health of the Slovak Republic 2014/47-SZU-11, Region of Southern Denmark, The Municipality of Odense, Denmark, Rigshospitalet
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Application of AOPs to assist regulatory assessment of chemical risks – Case studies, needs and recommendations

  • Bajard, Lola
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Hernández Jérez, Antonio Francisco|||0000-0003-2983-5418
  • Mustieles Miralles, Vicente
While human regulatory risk assessment (RA) still largely relies on animal studies, new approach methodologies (NAMs) based on in vitro, in silico or non-mammalian alternative models are increasingly used to evaluate chemical hazards. Moreover, human epidemiological studies with biomarkers of effect (BoE) also play an invaluable role in identifying health effects associated with chemical exposures. To move towards the next generation risk assessment (NGRA), it is therefore crucial to establish bridges between NAMs and standard approaches, and to establish processes for increasing mechanistically-based biological plausibility in human studies. The Adverse Outcome Pathway (AOP) framework constitutes an important tool to address these needs but, despite a significant increase in knowledge and awareness, the use of AOPs in chemical RA remains limited. The objective of this paper is to address issues related to using AOPs in a regulatory context from various perspectives as it was discussed in a workshop organized within the European Union partnerships HBM4EU and PARC in spring 2022. The paper presents examples where the AOP framework has been proven useful for the human RA process, particularly in hazard prioritization and characterization, in integrated approaches to testing and assessment (IATA), and in the identification and validation of BoE in epidemiological studies. Nevertheless, several limitations were identified that hinder the optimal usability and acceptance of AOPs by the regulatory community including the lack of quantitative information on response-response relationships and of efficient ways to map chemical data (exposure and toxicity) onto AOPs. The paper summarizes suggestions, ongoing initiatives and third-party tools that may help to overcome these obstacles and thus assure better implementation of AOPs in the NGRA., European Commission 733032 857560 101057014, Ministry of Education, Youth and Sports by the RECETOX Research Infrastructure LM2018121, OP RDE project CETOCOEN Excellence CZ.02.1.01/0.0/0.0/17_043/0009632, Japan Agency for Medical Research and Development (AMED) JP21mk0101216 JP22mk0101216, Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI) 21K12133
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Cross-sectional associations between exposure to per- and polyfluoroalkyl substances and body mass index among European teenagers in the HBM4EU aligned studies

  • Schillemans, Tessa
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
Per-and polyfluoroalkyl substances (PFAS) are widespread pollutants that may impact youth adiposity patterns. We investigated cross-sectional associations between PFAS and body mass index (BMI) in teenagers/adolescents across nine European countries within the Human Biomonitoring for Europe (HBM4EU) initiative. We used data from 1957 teenagers (12-18 yrs) that were part of the HBM4EU aligned studies, consisting of nine HBM studies (NEBII, Norway; Riksmaten Adolescents 2016-17, Sweden; PCB cohort (follow-up), Slovakia; SLO CRP, Slovenia; CROME, Greece; BEA, Spain; ESTEBAN, France; FLEHS IV, Belgium; GerES V-sub, Germany). Twelve PFAS were measured in blood, whilst weight and height were measured by field nurse/physician or self-reported in ques-tionnaires. We assessed associations between PFAS and age-and sex-adjusted BMI z-scores using linear and logistic regression adjusted for potential confounders. Random-effects meta-analysis and mixed effects models were used to pool studies. We assessed mixture effects using molar sums of exposure biomarkers with toxicological/structural similarities and quantile g-computation. In all studies, the highest concentrations of PFAS were PFOS (medians ranging from 1.34 to 2.79 mu g/L). There was a tendency for negative associations with BMI z-scores for all PFAS (except for PFHxS and PFHpS), which was borderline significant for the molar sum of [PFOA and PFNA] and significant for single PFOA [beta-coefficient (95% CI) per interquartile range fold change =-0.06 (-0.17, 0.00) and-0.08 (-0.15,-0.01), respectively]. Mixture assessment indicated similar negative associations of the total mixture of [PFOA, PFNA, PFHxS and PFOS] with BMI z-score, but not all compounds showed associations in the same direction: whilst [PFOA, PFNA and PFOS] were negatively associated, [PFHxS] associated positively with BMI z-score. Our results indicated a tendency for associations of relatively low PFAS concentrations with lower BMI in European teenagers. More prospective research is needed to investigate this potential relationship and its implications for health later in life., European Commission 733032, Swedish Research Council European Commission 2017-00822
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Lead (Pb) and neurodevelopment: A review on exposure and biomarkers of effect (BDNF, HDL) and susceptibility

  • Gundacker, Claudia
  • Mustieles Miralles, Vicente
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
This research was supported by funding from the European Unions' Horizon 2020 research and innovation Programme under grant agreement No 733032 HBM4EU., Lead (Pb) is a ubiquitous environmental pollutant and a potent toxic compound. Humans are exposed to Pb through inhalation, ingestion, and skin contact via food, water, tobacco smoke, air, dust, and soil. Pb accumulates in bones, brain, liver and kidney. Fetal exposure occurs via transplacental transmission. The most critical health effects are developmental neurotoxicity in infants and cardiovascular effects and nephrotoxicity in adults. Pb exposure has been steadily decreasing over the past decades, but there are few recent exposure data from the general European population; moreover, no safe Pb limit has been set. Sensitive biomarkers of exposure, effect and susceptibility, that reliably and timely indicate Pb-associated toxicity are required to assess human exposure-health relationships in a situation of low to moderate exposure. Therefore, a systematic literature review based on PubMed entries published before July 2019 that addressed Pb exposure and biomarkers of effect and susceptibility, neurodevelopmental toxicity, epigenetic modifications, and transcriptomics was conducted. Finally included were 58 original papers on Pb exposure and 17 studies on biomarkers. The biomarkers that are linked to Pb exposure and neurodevelopment were grouped into effect biomarkers (serum brain-derived neurotrophic factor (BDNF) and serum/saliva cortisol), susceptibility markers (epigenetic markers and gene sequence variants) and other biomarkers (serum high-density lipoprotein (HDL), maternal iron (Fe) and calcium (Ca) status). Serum BDNF and plasma HDL are potential candidates to be further validated as effect markers for routine use in HBM studies of Pb, complemented by markers of Fe and Ca status to also address nutritional interactions related to neurodevelopmental disorders. For several markers, a causal relationship with Pb-induced neurodevelopmental toxicity is likely. Results on BDNF are discussed in relation to Adverse Outcome Pathway (AOP) 13 ("Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities”) of the AOP-Wiki. Further studies are needed to validate sensitive, reliable, and timely effect biomarkers, especially for low to moderate Pb exposure scenarios., European Unions' Horizon 2020 research and innovation Programme 733032 HBM4EU
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Xeno-estrogenic activity of real-life mixtures of perfluoroalkylated substances in human placenta homogenates

  • Wielsøe, Maria
  • Molina Molina, José Manuel
  • Rodríguez Carrillo, Andrea
  • Mustieles Miralles, Vicente
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
The authors thank the European Union's Horizon 2020 research and innovation programme HBM4EU under Grant Agreement No. 733032 for its financial support, as well as the Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP) , and the Instituto de Salud Carlos III (ISCIII) (FIS-PI16/01820) . We thank pre-vious and current colleagues at Centre for Arctic Health and Molecular Epidemiology, Aarhus University for their valuable scientist support. The authors also thank the Spanish Ministry of Education for the pre-doctoral fellowship (FPU) granted to A. Rodriguez-Carrillo (FPU 16/03011) ., Humans are simultaneously exposed to complex chemical mixtures, and its combined effect can affect human health. As part of the HBM4EU project, the actual mixture of perfluoroalkylated substances (PFAS) in 25 human placenta samples was extracted by chromatographic methods and assessed for xeno-estrogenic activity using two in-vitro bioassays: the estrogen receptor transactivity and the E-Screen assay. Most of the PFAS extracts displayed xeno-estrogenic activity, in one or both assays. The xeno-estrogenic activities in the two bioassays were not correlated, but both assays showed an overall negative correlation with placenta concentrations of single PFAS. Xeno-estrogenic activities were significantly related to maternal characteristics; being higher in young, smokers and primiparous women, but not with fetal growth (birth weight, birth length, head circumference, gestational age, placenta weight). The presented extraction method can be used to study the combined effect of real-life mixtures of PFAS in relation to health outcomes in large-scale human biomonitoring studies., European Union's Horizon 2020 research and innovation programme HBM4EU 733032, Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Pblica (CIBERESP), Instituto de Salud Carlos III Spanish Government FIS-PI16/01820, Spanish Government FPU 16/03011
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Endocrine disrupting potential of replacement flame retardants – Review of current knowledge for nuclear receptors associated with reproductive outcomes

  • Bajard, Lola
  • Mustieles Miralles, Vicente
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
The research was supported by funding from the European Unions ' Horizon 2020 Research and Innovation Programme under grant agreements No 733032 (HBM4EU) , No. 859891 (PRORISK) , and No. 857560 (CETOCOEN EXCELLENCE Teaming 2 project) . The RECETOX Research infrastructure was further supported by the Czech Ministry of Education, Youth and Sports (LM2018121; CZ02.1.01/0.0/0.0/18_046/0015975) ., Background and aim: Endocrine disrupting chemicals (EDCs) constitute a major public health concern because they can induce a large spectrum of adverse effects by interfering with the hormonal system. Rapid identification of potential EDCs using in vitro screenings is therefore critical, particularly for chemicals of emerging concerns such as replacement flame retardants (FRs). The review aimed at identifying (1) data gaps and research needs regarding endocrine disrupting (ED) properties of replacement FRs and (2) potential EDCs among these emerging chemicals. Methods: A systematic search was performed from open literature and ToxCast/Tox21 programs, and results from in vitro tests on the activities of 52 replacement FRs towards five hormone nuclear receptors (NRs) associated with reproductive outcomes (estrogen, androgen, glucocorticoid, progesterone, and aryl hydrocarbon receptors) were compiled and organized into tables. Findings were complemented with information from structure-based in silico model predictions and in vivo information when relevant. Results: For the majority of the 52 replacement FRs, experimental in vitro data on activities towards these five NRs were either incomplete (15 FRs) or not found (24 FRs). Within the replacement FRs for which effect data were found, some appeared as candidate EDCs, such as triphenyl phosphate (TPhP) and tris(1,3-dichloropropyl) phosphate (TDCIPP). The search also revealed shared ED profiles. For example, anti-androgenic activity was reported for 19 FRs and predicted for another 21 FRs. Discussion: This comprehensive review points to critical gaps in knowledge on ED potential for many replacement FRs, including chemicals to which the general population is likely exposed. Although this review does not cover all possible characteristics of ED, it allowed the identification of potential EDCs associated with reproductive outcomes, calling for deeper evaluation and possibly future regulation of these chemicals. By identifying shared ED profiles, this work also raises concerns for mixture effects since the population is co-exposed to several FRs and other chemicals., European Commission 733032 859891 857560, Ministry of Education, Youth & Sports - Czech Republic LM2018121 CZ02.1.01/0.0/0.0/18_046/0015975
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Exposure to non-persistent pesticides, BDNF, and behavioral function in adolescent males: Exploring a novel effect biomarker approach

  • Rodríguez Carrillo, Andrea
  • Mustieles Miralles, Vicente
  • Suárez, Beatriz
  • Peinado, Francisco
  • Artacho Cordón, Francisco|||0000-0003-3850-6173
  • López García, Luis Carlos|||0000-0003-3355-0298
  • Arrebola Moreno, Juan Pedro
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Freire Warden, Carmen
This research would not have been achieved without the selfless collaboration of the INMA-Granada adolescents and families who took part in the study. The authors acknowledge the European Union's Horizon 2020 research and innovation program HBM4EUfor the financial support under Grant Agreement #733032. The study was also supported by the ISCIII with grants no. CP16/00085 and FIS 17/01526, and the Human Genotyping Laboratory at the Spanish National Cancer Research Center (CeGen-PRB3). The authors also thank the support of the Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP), and the University of Granada (Grant "UNETE," UCE-PP2017-06). A. Rodriguez-Carrillo received a predoctoral fellowship (FPU 16/03011) from the Spanish Ministry of Education, Spain, and Vicente Mustieles and Shereen Cynthia D'Cruz were under contract with the HBM4EUproject. C. Freire received a grant under the Miguel Servet Type I program of the ISCIII "Fondo Europeo de Desarrollo Regional" (MS16/00085; ISCIII/FEDER). This article forms part of the doctoral thesis developed by Andrea Rodriguez-Carrillo in the context of the "Clinical Medicine and Public Health Program" of the University of Granada (Spain)., Background: Numerous contemporary non-persistent pesticides may elicit neurodevelopmental impairments. Brain-derived neurotrophic factor (BDNF) has been proposed as a novel effect biomarker of neurological function that could help to understand the biological responses of some environmental exposures. Objectives: To investigate the relationship between exposure to various non-persistent pesticides, BDNF, and behavioral functioning among adolescents. Methods: The concentrations of organophosphate (OP) insecticide metabolites 3,5,6-trichloro-2-pyridinol (TCPy), 2-isopropyl-4-methyl-6-hydroxypyrimidine (IMPy), malathion diacid (MDA), and diethyl thiophosphate (DETP); metabolites of pyrethroids 3-phenoxybenzoic acid (3-PBA) and dimethylcyclopropane carboxylic acid (DCCA), the metabolite of insecticide carbaryl 1-naphthol (1-N), and the metabolite of ethylene-bis-dithiocarbamate fungicides ethylene thiourea (ETU) were measured in spot urine samples, as well as serum BDNF protein levels and blood DNA methylation of Exon IV of BDNF gene in 15–17-year-old boys from the INMA-Granada cohort in Spain. Adolescents’ behavior was reported by parents using the Child Behavior Check List (CBCL/ 6–18). This study included 140 adolescents of whom 118 had data on BDNF gene DNA methylation. Multivariable linear regression, weighted quantile sum (WQS) for mixture effects, and mediation models were fit. Results: IMPy, MDA, DCCA, and ETU were detected in more than 70% of urine samples, DETP in 53%, and TCPy, 3-PBA, and 1-N in less than 50% of samples. Higher levels of IMPy, TCPy, and ETU were significantly associated with more behavioral problems as social, thought problems, and rule-breaking symptoms. IMPy, MDA, DETP, and 1-N were significantly associated with decreased serum BDNF levels, while MDA, 3-PBA, and ETU were associated with higher DNA methylation percentages at several CpGs. WQS models suggest a mixture effect on more behavioral problems and BDNF DNA methylation at several CpGs. A mediated effect of serum BDNF within IMPy-thought and IMPy-rule breaking associations was suggested. Conclusion: BDNF biomarkers measured at different levels of biological complexity provided novel information regarding the potential disruption of behavioral function due to contemporary pesticides, highlighting exposure to diazinon (IMPy) and the combined effect of IMPy, MDA, DCCA, and ETU. However, further research is warranted., European Union's Horizon 2020 research and innovation program HBM4EU 733032, Instituto de Salud Carlos III CP16/00085 FIS 17/01526, Human Genotyping Laboratory at the Spanish National Cancer Research Center (CeGen-PRB3), Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP), University of Granada UCE-PP2017-06, Spanish Government FPU 16/03011, Miguel Servet Type I program of the ISCIII "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) MS16/00085
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Development and validation of brain-derived neurotrophic factor measurement in human urine samples as a non-invasive effect biomarker

  • Olivas Martínez, Alicia
  • Suárez, Beatriz
  • Salamanca Fernández, Elena|||0000-0002-1795-2206
  • Reina Pérez, Iris
  • Rodríguez Carrillo, Andrea
  • Mustieles Miralles, Vicente
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
  • Freire, Carmen
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
Background: Brain-derived neurotrophic factor (BDNF), a neurotrophic growth factor mainly expressed in the brain, has been proposed as a potential effect biomarker; that is, as a measurable biomarker whose values could be associated with several diseases, including neurological impairments. The European Human Biomonitoring Initiative (HBM4EU) has also recognized effect biomarkers as a useful tool for establishing link between exposure to environmental pollutants and human health. Despite the well-establish protocol for measuring serum BDNF, there is a need to validate its assessment in urine, a non-invasive sample that can be easily repeated over time. The aim of this study was to develop, standardize and validate a methodology to quantify BDNF protein levels in urine samples before its implementation in biomonitoring studies. Methods: Different experimental conditions and non-competitive commercial enzyme-linked immunosorbent assay (ELISA) kits were tested to determine the optimal analytical procedure, trying to minimize the shortcomings of ELISA kits. The fine-tune protocol was validated in a pilot study using both upon awakening (n = 150) and prior to sleeping (n = 106) urine samples from the same Spanish adolescent males in a well-characterized study population (the Spanish INMA-Granada cohort). Results: The best results were obtained in 0.6 ml of urine after the acidification and extraction (pre-concentration) of samples. The highest reproducibility was obtained with the ELISA kit from Raybiotech. Urinary BDNF concentrations of adolescent males were within the previously reported range (morning = 0.047– 6.801 ng/ml and night = 0.047–7.404 ng/ml). Urinary BDNF levels in the awakening and pre-sleep samples did not follow a normal distribution and were not correlated. Conclusion: The developed methodology offers good sensitivity and reproducibility. Having reliable markers in urine may facilitate both diagnosis and monitoring possible diseases (and treatment). Further studies are needed to implement urinary BDNF in biomonitoring studies to further elucidate its usefulness and biological significance for neurological impairments., European Commission 733032, Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP) of the Institute of Health Carlos III, Institute of Health Carlos III (SCIII) - European Regional Development Fund/FEDER FIS-PI17/01526 FIS-PI20/01656, Instituto de Salud Carlos III FI21/00236, Miguel Servet Type II Program CP1121/00014, Spanish Government FPU17/01848, Junta de Andalucia-PAIDI (Spain)
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Brain-derived neurotrophic factor (BDNF): an effect biomarker of neurodevelopment in human biomonitoring programs

  • Rodríguez Carrillo, Andrea
  • Verheyen, Veerle J.
  • Van Nuijs, Alexander L. N.
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Remy, Sylvie
The present narrative review summarizes recent findings focusing on the role of brain-derived neurotrophic factor (BDNF) as a biomarker of effect for neurodevelopmental alterations during adolescence, based on health effects of exposure to environmental chemical pollutants. To this end, information was gathered from the PubMed database and the results obtained in the European project Human Biomonitoring for Europe (HBM4EU), in which BDNF was measured at two levels of biological organization: total BDNF protein (serum) and BDNF gene DNA methylation (whole blood) levels. The obtained information is organized as follows. First, human biomonitoring, biomarkers of effect and the current state of the art on neurodevelopmental alterations in the population are presented. Second, BDNF secretion and mechanisms of action are briefly explained. Third, previous studies using BDNF as an effect biomarker were consulted in PubMed database and summarized. Finally, the impact of bisphenol A (BPA), metals, and nonpersistent pesticide metabolites on BDNF secretion patterns and its mediation role with behavioral outcomes are addressed and discussed. These findingswere obtained from three pilot studies conducted in HBM4EU project. Published findings suggested that exposure to some chemical pollutants such as fine particle matter (PM), PFAS, heavy metals, bisphenols, and non-persistent pesticides may alter circulating BDNF levels in healthy population. Therefore, BDNF could be used as a valuable effect biomarker to investigate developmental neurotoxicity of some chemical pollutants., European Human Biomonitoring Initiative (HMB4EU) project supported financially by the European Union’s Horizon 2020 research and innovation program under grant agreements No’s 733032, Partnership for the Assessment of Risks from Chemicals (PARC), supported financially by the European Union’s Horizon 2020 research and innovation program under grant agreements No’s 101057014, Postdoctoral fellowship granted by the Fundación Ramón Areces (BEVP34P01A6845), Spain
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

The Mixture of Bisphenol-A and Its Substitutes Bisphenol-S and Bisphenol-F Exerts Obesogenic Activity on Human Adipose-Derived Stem Cells

  • Reina Pérez, Iris
  • Olivas Martínez, Alicia
  • Mustieles Miralles, Vicente
  • Salamanca Fernández, Elena|||0000-0002-1795-2206
  • Molina Molina, José Manuel
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
Bisphenol A (BPA) and its substitutes, bisphenol F (BPF) and S (BPS), have previously shown in vitro obesogenic activity. This study was designed to investigate their combined effect on the adipogenic differentiation of human adipose-derived stem cells (hASCs). Cells were exposed for 14 days to an equimolar mixture of bisphenols (MIX) (range 10 nM-10 mu M). Oil Red staining was used to measure intracellular lipid accumulation, quantitative real-time polymerase chain reaction (qRT-PCR) to study gene expression of adipogenic markers (PPAR gamma, C/EBP alpha, LPL, and FABP4), and Western Blot to determine their corresponding proteins. The MIX promoted intracellular lipid accumulation in a dose-dependent manner with a maximal response at 10 mu M. Co-incubation with pure antiestrogen (ICI 182,780) inhibited lipid accumulation, suggesting that the effect was mediated by the estrogen receptor. The MIX also significantly altered the expression of PPAR gamma, C/EBP alpha, LPL, and FABP4 markers, observing a non-monotonic (U-shaped) dose-response, with maximal gene expression at 10 nM and 10 mu M and lesser expression at 1 mu M. This pattern was not observed when bisphenols were tested individually. Exposure to MIX (1-10 mu M) also increased all encoded proteins except for FABP4, which showed no changes. Evaluation of the combined effect of relevant chemical mixtures is needed rather than single chemical testing., European Commission 733032, Biomedical Research Networking CenterCIBER de Epidemiologia y Salud Publica (CIBERESP) of the Institute of Health Carlos III European Commission FIS-PI16/01820 FIS-PI16/01812 FIS-PI16/01858, Spanish Government FPU 17/01848
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Metabolic Syndrome and Endocrine Disrupting Chemicals: An Overview of Exposure and Health Effects

  • Haverinen, Elsi
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Mustieles Miralles, Vicente
The HBM4EU project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 733032., Increasing prevalence of metabolic syndrome (MetS) is causing a significant health burden among the European population. Current knowledge supports the notion that endocrine-disrupting chemicals (EDCs) interfere with human metabolism and hormonal balance, contributing to the conventionally recognized lifestyle-related MetS risk factors. This review aims to identify epidemiological studies focusing on the association between MetS or its individual components (e.g., obesity, insulin resistance, diabetes, dyslipidemia and hypertension) and eight HBM4EU priority substances (bisphenol A (BPA), per- and polyfluoroalkyl substances (PFASs), phthalates, polycyclic aromatic hydrocarbons (PAHs), pesticides and heavy metals (cadmium, arsenic and mercury)). Thus far, human biomonitoring (HBM) studies have presented evidence supporting the role of EDC exposures on the development of individual MetS components. The strength of the association varies between the components and EDCs. Current evidence on metabolic disturbances and EDCs is still limited and heterogeneous, and mainly represent studies from North America and Asia, highlighting the need for well-conducted and harmonized HBM programmes among the European population. Rigorous and ongoing HBM in combination with health monitoring can help to identify the most concerning EDC exposures, to guide future risk assessment and policy actions., European Commission 733032
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Characterization of Potential Adverse Outcome Pathways Related to Metabolic Outcomes and Exposure to Per- and Polyfluoroalkyl Substances Using Artificial Intelligence

  • Kaiser, Andreas Marius
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
Human exposure to per- and polyfluoroalkyl substances (PFAS) has been associated with numerous adverse health effects, depending on various factors such as the conditions of exposure (dose/concentration, duration, route of exposure, etc.) and characteristics associated with the exposed target (e.g., age, sex, ethnicity, health status, and genetic predisposition). The biological mechanisms by which PFAS might affect systems are largely unknown. To support the risk assessment process, AOP-helpFinder, a new artificial intelligence tool, was used to rapidly and systematically explore all available published information in the PubMed database. The aim was to identify existing associations between PFAS and metabolic health outcomes that may be relevant to support building adverse outcome pathways (AOPs). The collected information was manually organized to investigate linkages between PFAS exposures and metabolic health outcomes, including dyslipidemia, hypertension, insulin resistance, and obesity. Links between PFAS exposure and events from the existing metabolicrelated AOPs were also retrieved. In conclusion, by analyzing dispersed information from the literature, we could identify some associations between PFAS exposure and components of existing AOPs. Additionally, we identified some linkages between PFAS exposure and metabolic outcomes for which only sparse information is available or which are not yet present in the AOP-wiki database that could be addressed in future research., HBM4EU project 733032 European Commission 825712 Horizon 2020, Austrian Federal Ministry for Climate Action, Environment, Energy Mobility, Innovation, and Technology
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Kisspeptin as potential biomarker of environmental chemical mixture effect on reproductive hormone profile: A pilot study in adolescent males

  • Rodríguez Carrillo, Andrea
  • Remy, Sylvie
  • Salamanca Fernández, Elena|||0000-0002-1795-2206
  • Gil Hernández, Fernando|||0000-0001-9816-8618
  • Olmedo Palma, Pablo
  • Mustieles Miralles, Vicente
  • Vela Soria, Fernando
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Freire, Carmen
Background: Kisspeptin has been proposed as an effect biomarker to understand the mechanisms by which some environmental chemicals adversely affect the human reproductive system. Objective: To ascertain whether kisspeptin serum protein and DNA methylation levels are associated with exposure to several environmental chemicals (individually and as a mixture) and serum reproductive hormone levels in adolescent males. Methods: Three phenols (bisphenol A [BPA], methyl-paraben [MPB], and benzophenone-3 [BP3]); two toxic metals (arsenic and cadmium); and four metabolites of non-persistent pesticides, including insecticides (2-isopropyl-6- methyl-4-pyrimidinol [IMPy], malathion diacid [MDA], and dimethylcyclopropane carboxylic acid [DCCA]) and fungicides (ethylene thiourea [ETU]) were measured in first-morning urine samples of 133 adolescent males aged 15–17 years from the INMA-Granada cohort. In blood samples collected on the same day, KISS1 gene DNA methylation was measured at four CpGs from the Exon IV, as well as serumlevels of kiss54 protein, total testosterone (T), estradiol (E2), sex hormone binding-globulin, dehydroepiandrosterone sulfate, luteinizing hormone (LH), and follicle-stimulating hormone (FSH). Multiple linear regression and mixture (quantile g-computation) models were fit. Results: UrinaryMDA and DCCA concentrations were associatedwith higher kiss54 levels [%change (95%CI) for each log-unit increase in concentration = 2.90 (0.32;5.56), and 1.93 (0.45,3.43), respectively]; IMPy with lower DNA methylation percentage at CpG1 and total CpGs [% change (95%CI) = −1.15 (−1.96;-0.33): −0.89 (−1.73;- 0.01), respectively]; and BP3 and DCCA with lower total CpGs methylation [−0.53 (−1.04;-0.01) and − 0.69 (−1.37;-0.01), respectively]. The pesticide mixture and the whole chemical mixture were associated with higher kiss54 [% change (95%CI) = 9.09 (3.29;15.21) and 11.61 (3.96;19.82), respectively] and lower methylation levels at several CpGs. Additionally, serum kiss54 in the third tertile was associated with higher LH levels [% change (95%CI) = 28.69 (3.75–59.63)], and third-tertile CpG1, CpG2, and total CpG methylation percentages were associated with lower FSH and E2. Conclusion: The findings of the present study and the negative correlation between serumkiss54 levels and KISS1 DNA methylation percentages suggested that kisspeptin may be a promising effect biomarker., European Union's Horizon 2020 research and innovation program 733032 CP16/00085, Instituto de Salud Carlos III PI 17/01526 PT17/0019, Human Genotyping Laboratory at the Spanish National Cancer Research Centre UCE-PP2017-06, Instituto de Salud Carlos III European Commission European Commission, Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP), University of Granada CPII21/00014, Ramon Areces Foundation, Miguel Servet Type II program of the ISCIII, European Commission, Spanish Government
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Tesis doctoral (DoctoralThesis)

Carga obesogénica total efectiva: nuevo biomarcador de efecto combinado a obesógenos como factor de riesgo en obesidad

  • Reina Pérez, Iris
Cada vez es mayor la prevalencia de sobrepeso y obesidad, además de otras enfermedades metabólicas como el síndrome metabólico (MetS), en el mundo. Este incremento continuo no puede ser debido a única causa, sino que todo apunta a que serían múltiples los factores de riesgo implicados. La hipótesis de los obesógenos ambientales sugiere que la exposición humana a compuestos químicos-disruptores endocrinos (EDCs)- "obesogénicos" puede interferir inadecuadamente en la homeostasis lipídica y el metabolismo y promover la adipogénesis, modificando las vías de señalización hormonal y neuronal, predisponiendo así a las personas expuestas a un aumento de la masa grasa y sobrepeso. Los obesógenos se definen como sustancias químicas capaces de aumentar la cantidad de adipocitos (hiperplasia), promover el almacenamiento de grasa en las células (hipertrofia), afectar a la diferenciación o función de los preadipocitos e iniciar y/o desregular el metabolismo basal y el aumento de peso. Los obesógenos también pueden actuar indirectamente alterando el equilibrio energético alterando las señales de apetito y saciedad, así como los mecanismos centrales que mantienen la respuesta del organismo a los cambios nutricionales diarios. Los EDCs que no solo aumentan la masa de tejido adiposo, sino que también provocan otras disfunciones metabólicas, son conocidos como sustancias químicas disruptoras del metabolismo. La lista de sustancias químicas con potencial obesogénico no ha dejado de crecer en los últimos años, y los seres humanos están expuestos a esta multitud de compuestos desde diversas fuentes. Los desarrollos actuales en epidemiología ambiental y evaluación de riesgos toxicológicos son inadecuados e insatisfactorios para evaluar la exposición a múltiples EDCs obesogénicos, y para conocer su impacto en el desarrollo y la salud humana. Aunque ha habido algunos intentos de considerar el efecto combinado de varias sustancias químicas pertenecientes a la misma familia química, los métodos disponibles hasta ahora para cuantificar el efecto combinado de la exposición a múltiples residuos siguen siendo escasos, no están totalmente validados ni son concluyentes. Teniendo en cuenta todo lo anterior, la hipótesis de partida de esta Tesis Doctoral Internacional fue que la exposición a mezclas de EDCs constituye un factor de riesgo para la obesidad, y que el desarrollo de metodologías basadas en la medición del efecto combinado de múltiples EDCs obesogénicos almacenados en el tejido adiposo humano, mediante ensayos in vitro, serviría como biomarcador del efecto combinado en enfermedades metabólicas. Así pues, el objetivo principal de esta Tesis Doctoral Internacional es investigar la exposición humana a varios EDCs, con actividad obesogénica, analizando tanto la presencia de estos contaminantes en el tejido adiposo humano, como el efecto individual y combinado de estos contaminantes, mediante el desarrollo de biomarcadores in vitro, que pudieran ser utilizados como marcadores de riesgo de obesidad y otras enfermedades metabólicas. Los objetivos específicos definidos para este fin fueron los siguientes 1. Desarrollar y validar un modelo in vitro de células madre mesenquimales humanas para evaluar el efecto de EDC obesogénicos. Esta herramienta podría servir para comparar la potencia de diferentes obesógenos, así como para identificar nuevos compuestos con actividad obesogénica. 2. Estudiar mezclas ad hoc de sustancias químicas ambientales sobre el proceso de adipogénesis, investigando la posibilidad de efectos sinérgicos, aditivos o incluso antagónicos de los componentes individuales. 3. Profundizar en el conocimiento de los mecanismos y vías de señalización a través de los cuales los obesógenos-EDCs contribuyen a un fenotipo obesogénico, analizando la expresión génica y proteica de marcadores adipogénicos específicos (PPARγ, C/EBPα, LPL y FABP4). 4. Evaluar la exposición a obesógenos en muestras de tejido adiposo de pacientes adultos hospitalizados en el sur de España, con peso normal y obesidad e investigar la relación entre las concentraciones acumuladas en tejido adiposo y el riesgo de diagnóstico clínico de MetS. 5. Evaluar el biomarcador de carga total desarrollado ("O-Screen") en muestras de tejido adiposo de pacientes adultos con peso normal y obesidad e investigar su posible asociación con la obesidad y otros trastornos metabólicos. Para dar respuesta a los tres primeros objetivos se utilizaron células hASCs (células madre derivadas del tejido adiposo humano) in vitro que se expusieron a diferentes concentraciones de bisfenol-F (BPF) y bisfenol-S (BPS) y bisfenol-A (BPA) (0,01-25 μM), de manera individual y combinada (mezcla equimolar de los tres bisfenoles), durante 7 y 14 días de diferenciación adipocitaria. Se investigó el efecto de la exposición sobre la acumulación lipídica y la adipogénesis (tinción Oil Red O, ORO), además de la expresión génica (mRNA) y proteica (western blot, WB) de los marcadores lipogénicos PPARγ, C/EBPα, LPL y FABP4. En el estudio epidemiológico se investigó la exposición real de la población a EDCs persistentes empleando para ello la matriz biológica por la que tienen más apetencia, el tejido adiposo; de forma particular se seleccionó el tejido adiposo visceral, por ser éste el tejido asociado con un mayor riesgo de enfermedades metabólicas. Se evaluó también las posibles asociaciones entre los contaminantes y el diagnóstico clínico de MetS, utilizando tanto la información de biomarcadores de exposición como de los biomarcadores de efecto clínicos disponibles para la población de estudio. Los principales resultados de esta tesis doctoral son los siguientes: Artículo #1 (Reina-Pérez et al., 2021): La exposición de células hASCs a BPF y BPS promueve la adipogénesis como se comprueba al alterar la programación del desarrollo de los adipocitos y aumentar la acumulación de lípidos intracelulares. De forma particular, la exposición celular con BPF, a concentraciones de 10 o 25M durante 7 o 14 días, potencia la diferenciación de las células madre en adipocitos de manera dosis-dependiente, lo que se confirma al comprobar un incremento de la expresión de los genes adipogénicos seleccionados (PPARγ, C/EBPα, LPL y FABP4), así como de sus proteínas correspondientes. Se muestra por primera vez el potencial obesogénico de BPF sobre la diferenciación de adipocitos humanos, corroborando datos previos obtenidos en preadipocitos murinos. Artículo #2 (Reina-Pérez et al., 2022): La mezcla ternaria equimolar de los tres bisfenoles (BPF, BPS y BPA), interfiere en la programación de las células hASCs, aumentando su capacidad para diferenciarse en adipocitos. No obstante, el efecto obesogénico de la mezcla difirió del de los compuestos individuales, mostrando niveles de expresión génica mayores que los obtenidos para los componentes individuales de la misma. La exposición de las células resultó en un efecto dosisdependiente en la acumulación lipídica, mientras que la expresión de los genes mostró una respuesta no monotónica, adoptando forma de U. Este trabajo es uno de pocos estudios in vitro que han investigado la actividad obesogénica combinada de mezclas de EDCs-obesógenos sobre la diferenciación adipogénica, la acumulación de lípidos, la expresión génica y la síntesis proteica, en un intento de emular situaciones de exposición real en población humana. Artículo #3 (Reina-Pérez et al., 2023): La población adulta española sigue expuesta a contaminantes ambientales persistentes (POPs), con niveles de plaguicidas organoclorados (OCPs) y bifenilos policlorados (PCBs) significativamente mayores en el grupo de pacientes estudiados con MetS (MetS+) respecto a los individuos sin este síndrome (MetS-). Se encontraron asociaciones positivas entre ciertos POPs y el diagnóstico clínico de MetS o de algunos de sus componentes. Concretamente, niveles más altos de HCB y γ-HCH se relacionan con niveles más altos de glucosa en ayunas, con una presión arterial más elevada y con un mayor riesgo de MetS, tanto en los modelos de regresión lineal como en los modelos logísticos ajustados por edad y sexo. La exposición de la mezcla de los 7 POPs encontrada en el tejido adiposo se asocia también de manera positiva y significativa con el riesgo de MetS. La creciente prevalencia del MetS en el mundo, hace necesaria la identificación de factores de riesgo prevenibles, así como el establecimiento de medidas de intervención para detener y revertir la progresión de este síndrome. Dentro de este contexto se enmarca la exposición a contaminantes ambientales-obesogénicos, que una vez identificados y entendido su papel en la génesis de la enfermedad, deberían ser regulados en sus usos y aplicaciones de forma más estricta. La participación de los profesionales clínicos en esta área de investigación será fundamental para acometer los desafíos de salud ambiental a los que hacemos y haremos frente con medidas preventivas., Tesis Univ. Granada., Contrato predoctoral con cargo al programa de “Ayudas para la Formación de Profesorado Universitario (FPU)” (ref. FPU17/01848), Programa de investigación e innovación Horizonte 2020 de la Unión Europea, proyecto HBM4EU (#733032), CIBER de Epidemiología y Salud Pública (CIBERESP) del Instituto de Salud Carlos III, Los proyectos de investigación del Instituto de Salud Carlos III: FIS-PI13/02406 y FIS-PI16/01812, co-financiados por el Fondo Europeo de Desarrollo Regional/FEDER., Ayudas de movilidad para estancias breves en un centro extranjero” del programa de becas de Formación del Profesorado Universitario (FPU) (ref. EST21/00015), del Ministerio de Educación y Formación Profesional de España, Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, Institut régional du Cancer de Montpellier (ICM) (Francia)
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Implementation of effect biomarkers in human biomonitoring studies: A systematic approach synergizing toxicological and epidemiological knowledge

  • Rodríguez Carrillo, Andrea
  • Mustieles Miralles, Vicente
  • Salamanca Fernández, Elena|||0000-0002-1795-2206
  • Olivas Martínez, Alicia
  • Suárez González, Beatriz
  • Hernández Jérez, Antonio Francisco|||0000-0003-2983-5418
  • Lacasaña Navarro, Marina
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
Human biomonitoring (HBM) studies have highlighted widespread daily exposure to environmental chemicals. Some of these are suspected to contribute to adverse health outcomes such as reproductive, neurological, and metabolic disorders, among other developmental and chronic impairments. One of the objectives of the H2020 European Human Biomonitoring Initiative (HBM4EU) was the development of informative effect biomarkers for application in a more systematic and harmonized way in large-scale European HBM studies. The inclusion of effect biomarkers would complement exposure data with mechanistically-based information on early and late adverse effects. For this purpose, a stepwise strategy was developed to identify and implement a panel of vali- dated effect biomarkers in European HBM studies. This work offers an overview of the complete procedure followed, from comprehensive literature search strategies, selection of criteria for effect biomarkers and their classification and prioritization, based on toxi- cological data and adverse outcomes, to pilot studies for their analytical, physiological, and epidemiological validation. We present the example of one study that demonstrated the mediating role of the effect biomarker status of brain-derived neurotrophic factor BDNF in the longitudinal association between infant bisphenol A (BPA) exposure and behavioral function in adolescence. A panel of effect biomarkers has been implemented in the HBM4EU Aligned Studies as main outcomes, including traditional oxidative stress, reproductive, and thyroid hormone biomarkers. Novel biomarkers of effect, such as DNA methylation status of BDNF and kisspeptin (KISS) genes were also evaluated as molecular markers of neurological and reproductive health, respectively. A panel of effect biomarkers has also been applied in HBM4EU occupational studies, such as micronucleus analysis in lymphocytes and reticulocytes, whole blood comet assay, and malondialdehyde, 8-oxo-2′ -deoxyguanosine and untargeted metabolomic profile in urine, to investigate, for example, biological changes in response to hexavalent chromium Cr(VI) exposure. The use of effect biomarkers in HBM4EU has demonstrated their ability to detect early biological effects of chemical exposure and to identify subgroups that are at higher risk. The roadmap developed in HBM4EU con- firms the utility of effect biomarkers, and support one of the main objectives of HBM research, which is to link exposure biomarkers to mechanistically validated effect and susceptibility biomarkers in order to better un- derstand the public health implications of human exposure to environmental chemicals., European Union’s Horizon 2020 research and innovation program projects HBM4EU 733032
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies

  • Mustieles Miralles, Vicente
  • Peinado, F.M.
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
Background: Benzophenone-3 (BP-3) and its major metabolite benzophenone-1 (BP-1) are widely used as UV filters in sunscreens and cosmetics to prevent sunburn and skin damage, or as stabilizers to prevent photodegradation in many commercial products. As a result, their presence is ubiquitous in the environment, wildlife and humans. Based on endocrine disruption concerns, international regulatory agencies are performing a closer evaluation. Objective and methods: This work aimed to comprehensively review the available human relevant evidence for safety issues in MEDLINE/PubMed in order to create a structured database of studies, as well as to conduct an integrative analysis as part of the Human Biomonitoring for Europe (HBM4EU) Initiative. Results: A total of 1,635 titles and abstracts were screened and 254 references were evaluated and tabulated in detail, and classified in different categories: i) exposure sources and predictors; ii) human biomonitoring (HBM) exposure levels to perform a meta-analysis; iii) toxicokinetic data in both experimental animals and humans; iv) in vitro and in vivo rodent toxicity studies; and v) human data on effect biomarkers and health outcomes. Our integrative analysis showed that internal peak BP-3 concentrations achieved after a single whole-body application of a commercially available sunscreen (4% w/w) may overlap with concentrations eliciting endocrine disrupting effects in vitro, and with internal concentrations causing in vivo adverse female reproductive effects in rodents that were supported by still limited human data. The adverse effects in rodents included prolonged estrous cycle, altered uterine estrogen receptor gene expression, endometrium hyperplasia and altered proliferation and histology of the mammary gland, while human data indicated menstrual cycle hormonal alterations and increased risk of uterine fibroids and endometriosis. Among the modes of action reported (estrogenic, antiandrogenic, thyroid, etc.), BP-3 and especially BP-1 showed estrogenic activity at human-relevant concentrations, in agreement with the observed alterations in female reproductive endpoints. The meta-analysis of HBM studies identified a higher concern for North Americans, showing urinary BP-3 concentrations on average 10 and 20 times higher than European and Asian populations, respectively., European Commission 733032
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

The Use of Human Biomonitoring to Assess Occupational Exposure to PAHs in Europe: A Comprehensive Review

  • Louro, Henriqueta
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
Polycyclic aromatic hydrocarbons (PAHs) are among the chemicals with proven impact on workers’ health. The use of human biomonitoring (HBM) to assess occupational exposure to PAHs has becomemore common in recent years, but the data generated need an overall viewtomake themmore usable by regulators and policymakers. This comprehensive review, developed under theHuman Biomonitoring for Europe (HBM4EU) Initiative,was based on the literature available from2008–2022, aiming to present and discuss the information on occupational exposure to PAHs, in order to identify the strengths and limitations of exposure and effect biomarkers and the knowledge needs for regulation in the workplace. The most frequently used exposure biomarker is urinary 1-hydroxypyrene (1-OH-PYR), ametabolite of pyrene. As effect biomarkers, those based on the measurement of oxidative stress (urinary 8-oxo-dG adducts) and genotoxicity (blood DNA strand-breaks) are themost common. Overall, a need to advance newharmonized approaches both in data and sample collection and in the use of appropriate biomarkers in occupational studies to obtain reliable and comparable data on PAHexposure in different industrial sectors,was noted. Moreover, the use of effect biomarkers can assist to identify work environments or activities of high risk, thus enabling preventive riskmitigation andmanagementmeasures., European Unions' Horizon 2020 research and innovation Programme 733032 HBM4EU
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Concentrations of perfluoroalkyl substances in donor breast milk in Southern Spain and their potential determinants

  • Serrano, Laura
  • Iribarne Durán, Luz María
  • Suárez, Beatriz
  • Artacho Cordón, Francisco|||0000-0003-3850-6173
  • Vela Soria, Fernando
  • Peña Caballero, Manuela
  • Hurtado, José A.
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Freire, Carmen
This research would not have been achieved without the selfless collaboration of the donors who took part in the study. The authors gratefully acknowledge editorial assistance from Richard Davies and the support of the "UNETE research unit" of the Centro de Investigacion Biomedica (University of Granada). This research was funded in part by grants from the European Union Commission (The European Human Biomonitoring Initiative H2020-EJP-HBM4EU), Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP), and the Carlos III Institute of Health (ISCIII) (PI16/01820, PI16/01812, PI16/01858, PI17/01743, and PI17/01526). The authors are also grateful to the ISCIII and the "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) for the predoctoral research contract granted to L.M. Iribarne-Duran (FI17/00316), the Sara Borrell postdoctoral research contract granted to F. Vela-Soria (grant no. CD17/00212), the Jose Maria Segovia de Arana contract granted to N. Olea (INT18/00060) and the Miguel Servet Type I Program granted to C. Freire (grant no. MS16/00085). This paper is part of the PhD thesis developed by Laura Serrano in the context of the "Clinical Medicine and Public Health Program" of the University of Granada. The funders had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. Funding for open access charge: University of Granada/CBUA., Background: Breast milk is considered to offer the best nutrition to infants; however, it may be a source of exposure to environmental chemicals such as perfluoroalkyl compounds (PFAS) for breastfeeding infants. PFAS are a complex group of synthetic chemicals whose high stability has led to their ubiquitous contamination of the environment. Objective: To assess the concentrations and profiles of PFAS in breast milk from donors to a human milk bank and explore factors potentially related to this exposure. Methods: Pooled milk samples were collected from 82 donors to the Human Milk Bank of the Virgen de las Nieves University Hospital (Granada, Spain). Ultra-high performance liquid chromatography coupled with tandem mass spectrometry (UHPLC-MS/MS) was applied to determine milk concentrations of 11 PFAS, including long-chain and short-chain compounds. A questionnaire was used to collect information on donors’ socio-demographic characteristics, lifestyle, diet, and use of personal care products (PCPs). Factors related to individual and total PFAS concentrations were evaluated by multivariate regression analysis. Results: PFAS were detected in 24–100% of breast milk samples. PFHpA was detected in 100% of samples, followed by PFOA (84%), PFNA (71%), PFHxA (66%), and PFTrDA (62%). Perfluorooctane sulfonate (PFOS) was detected in only 34% of donors. The median concentrations ranged from <0.66 ng/dL (perfluorohexane sulfonic acid [PFHxS]) to 19.39 ng/L (PFHpA). The median of the sum of PFAS concentrations was 87.67 ng/L and was higher for short-chain than long-chain PFAS. Factors most frequently associated with increased PFAS concentrations included intake of creatin animal food items and use of PCPs such as skin care and makeup products. Conclusions: Several PFAS, including short-chain compounds, are detected in pooled donor milk samples. Breast milk may be an important pathway for the PFAS exposure of breastfed infants, including preterm infants in NICUs. Despite the reduced sample size, these data suggest that various lifestyle factors influence PFAS concentrations, highlighting the use of PCPs., "UNETE research unit" of the Centro de Investigacion Biomedica (University of Granada), European Union Commission (The European Human Biomonitoring Initiative H2020-EJP-HBM4EU), Biomedical Research Networking Center-CIBER de Epidemiologia y Salud Publica (CIBERESP), Instituto de Salud Carlos III PI16/01820 PI16/01812 PI16/01858 PI17/01743 PI17/01526 FI17/00316 CD17/00212 INT18/00060 MS16/00085, "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) FI17/00316 CD17/00212 INT18/00060 MS16/00085, University of Granada/CBUA
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Changes in molecular biomarkers of neurotoxicity in newborns following prenatal exposure to organophosphate compounds

  • Hernández Jérez, Antonio Francisco|||0000-0003-2983-5418
This study was supported by the Instituto de Salud Carlos III (Spain) under grants PI18/01156, PI17/00638, and PI13/01559, with funding from the European Regional Development Fund (FEDER). It is also part of the Human Biomonitoring for Europe (HBM4EU) project, which received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733032., The rising incidence of neurodevelopmental disorders has been associated with early-life exposure to environmental factors, particularly neurotoxicants like organophosphate compounds (OPCs), which can impact brain development and function. This study examined the relationship between prenatal exposure to OPCs and molecular biomarkers of neurotoxicity in cord blood from 398 mother-child pairs in the GENEIDA birth cohort (Southeastern Spain). Urine samples were collected in the first and third trimesters and analysed for metabolites of organophosphate pesticides (dialkylphosphates, DAPs) and flame retardants (OPFRs) using LC-MS/MS. Six neurotoxicity biomarkers-brain-derived neurotrophic factor (BDNF), neurogranin (Ng), ubiquitin C-terminal hydrolase L1 (UCHL1), neurofilament heavy chain (NFH), glial fibrillary acidic protein (GFAP), and S100 calcium-binding protein B (S100B)-were measured in cord blood via multiplex analysis using Luminex xMAP technology. The results showed that higher levels of DAP metabolites in maternal urine, particularly those with dimethyl groups, were associated with increased GFAP levels in cord blood. OPFR metabolites correlated with elevated GFAP and UCHL1 levels. Sex-specific effects were observed: OPFR levels were linked to higher GFAP in boys, while higher DAP metabolites, particularly those with diethyl groups, were associated with elevated BDNF in girls. Additionally, higher levels of diphenyl phosphate, an OPFR metabolite, were linked to increased S100B in boys. These findings suggest sexually dimorphic effects of prenatal OPC exposure. These findings provide preliminary evidence of developmental neurotoxicity and suggest potential biomarkers in cord blood for early detection of neurodevelopmental deficits. Further studies, including neurobehavioral evaluations and brain imaging, are needed to better understand these molecular effects., Instituto de Salud Carlos III (Spain) PI18/01156, PI17/00638, PI13/01559, European Regional Development Fund (FEDER), European Union’s Horizon 2020 No. 733032
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Assessment of chemical mixtures using biomarkers of combined biological activity: A screening study in human placentas

  • Rodríguez Carrillo, Andrea
  • Mustieles Miralles, Vicente
  • Vela Soria, Fernando
  • Molina Molina, José Manuel
  • Olea Serrano, Nicolás|||0000-0002-8938-3743
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
The authors thank the European Union’s Horizon 2020 research and innovation programme HBM4EU under Grant Agreement No. 733032 for its financial support. Vicente Mustieles and Stephan Couderq are under contract within the HBM4EU project. Additionally, we acknowledge the Biomedical Research Networking Center-CIBER de Epidemiología y Salud Pública (CIBERESP), and the Instituto de Salud Carlos III (ISCIII) (FIS-PI16/01820 and FIS-PI16/01858). The authors also thank the ISCIII and “Fondo Europeo de Desarrollo Regional” (ISCIII/FEDER) for the Sara Borrell postdoctoral research contract granted to F. Vela-Soria (grant no. CD17/00212), and the Spanish Ministry of Education for the predoctoral fellowship (FPU) granted to A. Rodríguez-Carrillo (FPU 16/03011). This article will be part of the doctoral thesis developed by Andrea Rodríguez-Carrillo in the context of the “Clinical Medicine and Public Health Program” of the University of Granada (Spain). The authors gratefully acknowledge the technical assistance of Birgitte Møller Plesning., Humans are simultaneously exposed to complex mixtures of chemicals with limited knowledge on potential health effects, therefore improved tools for assessing these mixtures are needed. As part of the Human Bio-monitoring for Europe (HBM4EU) Project, we aimed to examine the combined biological activity of chemical mixtures extracted from human placentas using one in vivo and four in vitro bioassays, also known as biomarkers of combined effect. Relevant endocrine activities (proliferative and/or reporter gene assays) and four endpoints were tested: the estrogen receptor (ER), androgen receptor (AR), and aryl hydrocarbon receptor (AhR) activities, as well as thyroid hormone (TH) signaling. Correlations among bioassays and their functional shapes were evaluated. Results showed that all placental extracts agonized or antagonized at least three of the above-mentioned endpoints. Most placentas induced ER-mediated transactivation and ER-dependent cell proliferation, together with a strong inhibition of TH signaling and the AR transactivity; while the induction of the AhR was found in only one placental extract. The effects in the two estrogenic bioassays were positively and significantly correlated and the AR-antagonism activity showed a positive borderline-significant correlation with both es-trogenic bioassay activities. However, the in vivo anti-thyroid activities of placental extracts were not correlated with any of the tested in vitro assays. Findings highlight the importance of comprehensively mapping the bio-logical effects of ?real-world? chemical mixtures present in human samples, through a battery of in vitro and in vivo bioassays. This approach should be a complementary tool for epidemiological studies to further elucidate the combined biological fingerprint triggered by chemical mixtures., European Commission 733032, "Fondo Europeo de Desarrollo Regional" (ISCIII/FEDER) CD17/00212, Spanish Government FPU 16/03011, Instituto de Salud Carlos III CD17/00212
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Pyrethroids and developmental neurotoxicity - A critical review of epidemiological studies and supporting mechanistic evidence

  • Raun Andersen, Helle
  • Freire, Carmen
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Reina Pérez, Iris
Background: Pyrethroid metabolites are widely detectable in urine from the general population, including pregnant women and children. Pyrethroids are neurotoxic and suggested endocrine disruptors. Exposure during vulnerable developmental time windows may have long-term impacts on neurodevelopment. Objective: To evaluate the epidemiological evidence for neurodevelopmental effects related to prenatal and childhood pyrethroid exposure in a systematic review and to assess biological plausibility by evaluating mechanistic evidence. Methods: We searched PubMed and Web of Science up to September 1, 2021 and included original studies published in English in which pyrethroid exposure was measured or estimated during pregnancy or childhood and associations with neurodevelopmental outcomes in the children were investigated. The Navigation Guide Systematic Review Methodology was used to evaluate the epidemiological evidence. For mechanistic evidence, we focused on relevant key events (KEs) suggested in Adverse Outcome Pathways (AOPs) using the OECDsupported AOP-wiki platform. A systematic search combining the KEs with pyrethroids, including 26 individual compounds, was performed in the ToxCast database. Results: Twenty-five epidemiological studies met the inclusion criteria, 17 presented findings on prenatal exposure, 10 on childhood exposure and two on both exposure windows. The overall body of evidence was rated as “moderate quality” with “sufficient evidence” for an association between prenatal pyrethroid exposure and adverse neurodevelopment. For childhood exposure, the overall rating was “low quality” with “limited evidence” because of cross-sectional study design. Regarding mechanistic evidence, we found that pyrethroids are able to interfere with neurodevelopmental KEs included in established AOPs for adverse neurodevelopmental. The evidence was strongest for interference with thyroid hormone (TH) function. Conclusion: Pyrethroids are probably human developmental neurotoxicants and adverse impacts of pyrethroid exposure on neurodevelopment are likely at exposure levels occurring in the general population. Preventive measures to reduce exposure among pregnant women and children are warranted., European Commission 733032 CZ.02.1.01/0.0/0.0/17_043/0009632, Ministry of Education, Youth and Sports, and Operational Programme Research, Development and Innovation - project CETOCOEN EXCELLENCE LM2018121, 857560
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Human risk associated with exposure to mixtures of antiandrogenic chemicals evaluated using in vitro hazard and human biomonitoring data

  • Ma, Yanying
  • Rodríguez Carrillo, Andrea
  • Mustieles Miralles, Vicente
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
The authors thank the European Union’s Horizon 2020 research and innovation programme HBM4EU under Grant Agreement No. 733032 and the Green Deal project PANORAMIX Grant Agreement No. 101036631 for its financial support., Supplementary data to this article can be found online at https://doi.org/10.1016/j.envint.2023.107815, Background Scientific evidence for underestimated toxicity from unintentional exposure to chemical mixtures is mounting. Yet, harmonized approaches on how to assess the actual risk of mixtures is lacking. As part of the European Joint programme ‘Human Biomonitoring for Europe’ we explored a novel methodology for mixture risk assessment of chemicals affecting male reproductive function. Methodology We explored a methodology for chemical mixture risk assessment based on human in vitro data combined with human exposure data, thereby circumventing the drawbacks of using hazard data from rodents and estimated exposure intake levels. Human androgen receptor (hAR) antagonism was selected as the most important molecular initiating event linked to adverse outcomes on male reproductive health. Results Our work identified 231 chemicals able to interfere with hAR activity. Among these were 61 finally identified as having both reliable hAR antagonist and human biomonitoring data. Calculation of risk quotients indicated that PCBs (118, 138, 157), phthalates (BBP, DBP, DIBP), benzophenone-3, PFOS, methylparaben, triclosan, some pesticides (i.e cypermethrin, β-endosulfan, methylparathion, p,p-DDE), and a PAH metabolite (1-hydroxypyrene) contributed to the mixture effect. The major chemical mixture drivers were PCB 118, BBP, PFOS, DBP, and the UV filter benzophenone-3, together contributing with 75% of the total mixture effect that was primarily driven by high exposure values. Conclusions This viable way forward for mixture risk assessment of chemicals has the advantages of (1) being a more comprehensive mixture risk assessment also covering data-poor chemicals, and (2) including human data only. However, the approach is subjected to uncertainties in terms of in vitro to in vivo extrapolation, it is not ready for decision making, and needs further development. Still, the results indicate a concern for adverse effects on reproductive function in highly exposed boys, especially when considering additional exposure to data-poor chemicals and chemicals acting by other mechanisms of action., European Union’s Horizon 2020 research and innovation programme HBM4EU No. 733032, Green Deal project PANORAMIX No. 101036631
Helvia. Repositorio Institucional de la Universidad de Córdoba
Publicación Artículo científico (JournalArticle)

Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring

  • Caballero-Casero, Noelia
  • Belova, Lidia
  • Vervliet, Philippe
  • Antignac, Jean-Philippe
  • Castaño, Argelia
  • Debrauwer, Laurent
  • Esteban López, Marta
  • Huber, Carolin
  • Klanova, Jana
  • Krauss, Martin
  • Lommen, Arjen
  • Mol, Hans G.J.
  • Oberacher, Herbert
  • Pardo, Olga
  • Price, Elliott J.
  • Reinstadler, Vera
  • Vitale, Chiara Maria
  • Van Nuijs, Alexander L.N.
  • Covaci, A.
Although the exposure assessment of chemicals of emerging concern (CECs) has taken a decisive step forward through advances in (bio)informatics, statistics, and the development of highly sophisticated analytical instruments, the lack of standardisation and harmonisation of analytical workflows and method performance assessment for suspect and non-target screening hampers the interpretation of results, their comparability and thus, its transmission to policymakers. To date, unlike in other research fields such as forensics or food analysis, there is a lack of guidelines for non-target analysis in human risk assessment and quality assurance and quality control (QA/QC) protocols. Moreover, the majority of efforts have been focused on the development and implementation of QA/QC actions for data acquisition, data analysis and mining, largely neglecting the sample preparation necessary for determination of CECs by suspect and non-target screening methods. In this article, we propose a set of QA/QC measures that covers sampling, sample preparation and data acquisition, as an aspect of work conducted within the European Biomonitoring for Europe initiative (HBM4EU). These measures include the use of standardised terminology and the implementation of dedicated QA/QC actions in each stage of the analytical process. Moreover, a framework for the analytical performance assessment has been developed for the first time for the identification of CECs in human samples by suspect and non-target approaches. Adoption of the actions proposed here for the identification of CECs in human matrices can significantly improve the comparability of reported results and contribute to the (challenging) Exposome research field.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Critical review of analytical methods for the determination of flame retardants in human matrices

  • Hajeb, Parvaneh
  • Castaño, Argelia
  • Cequier Manciñeiras, Enrique
  • Covaci, Adrian
  • Esteban López, Marta
  • Gonzalez Antuña, Ana
  • Småstuen Haug, Line
  • Henríquez-Hernández, Luis Alberto
  • Melymuk, Lisa
  • Pérez Luzardo, Octavio Luis
  • Thomsen, Cathrine
  • Vorkamp, Katrin
Human biomonitoring is a powerful approach in assessing exposure to environmental pollutants. Flame retardants (FRs) are of particular concern due to their wide distribution in the environment and adverse health effects. This article reviews studies published in 2009e2020 on the chemical analysis of FRs in a variety of human samples and discusses the characteristics of the analytical methods applied to different FR biomarkers of exposure, including polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane (HBCD), novel halogenated flame retardants (NHFRs), bromophenols, incl. tetrabromobisphenol A (TBBPA), and organophosphorous flame retardants (PFRs). Among the extraction techniques, liquid-liquid extraction (LLE) and solid phase extraction (SPE) were used most frequently due to the good efficiencies in the isolation of the majority of the FR biomarkers, but with challenges for highly lipophilic FRs. Gas chromatography-mass spectrometry (GC-MS) is mainly applied in the instrumental analysis of PBDEs and most NHFRs, with recent inclusions of GC-MS/MS and high resolution MS techniques. Liquid chromatography-MS/MS is mainly applied to HBCD, bromophenols, incl. TBBPA, and PFRs (including metabolites), however, GC-based analysis following derivatization has also been used for phenolic compounds and PFR metabolites. Developments are noticed towards more universal analytical methods, which enable widening method scopes in the human biomonitoring of FRs. Challenges exist with regard to sensitivity required for the low concentrations of FRs in the general population and limited sample material for some human matrices. A strong focus on quality assurance/quality control (QA/QC) measures is required in the analysis of FR biomarkers in human samples, related to their variety of physical-chemical properties, low levels in most human samples and the risk of contamination., This study was part of the HBM4EU project receiving funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 733032. The authors acknowledge Berith E. Knudsen for her help with the literature search.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiative

  • Vorkamp, Katrin
  • Castaño, Argelia
  • Antignac, Jean-Philippe
  • Boada, Luis D.
  • Cequier Manciñeiras, Enrique
  • Covaci, Adrian
  • Esteban López, Marta
  • Haug, Line S.
  • Kasper-Sonnenberg, Monika
  • Koch, Holger M.
  • Pérez Luzardo, Octavio Luis
  • Osīte, Agnese
  • Rambaud, Loïc
  • Pinorini, Maria-Teresa
  • Sabbioni, Gabriele
  • Thomsen, Cathrine
The major purpose of human biomonitoring is the mapping and assessment of human exposure to chemicals. The European initiative HBM4EU has prioritized seven substance groups and two metals relevant for human exposure: Phthalates and substitutes (1,2-cyclohexane dicarboxylic acid diisononyl ester, DINCH), bisphenols, per- and polyfluoroalkyl substances (PFASs), halogenated and organophosphorous flame retardants (HFRs and OPFRs), polycyclic aromatic hydrocarbons (PAHs), arylamines, cadmium and chromium. As a first step towards comparable European-wide data, the most suitable biomarkers, human matrices and analytical methods for each substance group or metal were selected from the scientific literature, based on a set of selection criteria. The biomarkers included parent compounds of PFASs and HFRs in serum, of bisphenols and arylamines in urine, metabolites of phthalates, DINCH, OPFRs and PAHs in urine as well as metals in blood and urine, with a preference to measure Cr in erythrocytes representing Cr (VI) exposure. High performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) was the method of choice for bisphenols, PFASs, the HFR hexabromocyclododecane (HBCDD), phenolic HFRs as well as the metabolites of phthalates, DINCH, OPFRs and PAHs in urine. Gas chromatographic (GC) methods were selected for the remaining compounds, e.g. GC-low resolution MS with electron capture negative ionization (ECNI) for HFRs. Both GC–MS and LC-MS/MS were suitable for arylamines. New developments towards increased applications of GC–MS/MS may offer alternatives to GC–MS or LC-MS/MS approaches, e.g. for bisphenols. The metals were best determined by inductively coupled plasma (ICP)-MS, with the particular challenge of avoiding interferences in the Cd determination in urine. The evaluation process revealed research needs towards higher sensitivity and non-invasive sampling as well as a need for more stringent quality assurance/quality control applications and assessments., This study was part of the HBM4EU project receiving funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733032.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Low doses of Bisphenol S affect post-translational modifications of sperm proteins in male mice

  • Řimnáčová, Hedvika
  • Štiavnická, Miriam
  • Moravec, Jiří
  • Chemek, Marouane
  • Kolinko, Yaroslav
  • García-Álvarez, Olga
  • Mouton, Peter R.
  • Carranza Trejo, Azalia Mariel
  • Fenclová, Tereza
  • Eretová, Nikola
  • Hošek, Petr
  • Klein, Pavel
  • Králíčková, Milena
  • Petr, Jaroslav
  • Nevoral, Jan
[Background]: Bisphenol S (BPS) is increasingly used as a replacement for bisphenol A in the manufacture of products containing polycarbonates and epoxy resins. However, further studies of BPS exposure are needed for the assessment of health risks to humans. In this study we assessed the potential harmfulness of low-dose BPS on reproduction in male mice., [Methods]: To simulate human exposure under experimental conditions, 8-week-old outbred ICR male mice received 8 weeks of drinking water containing a broad range of BPS doses [0.001, 1.0, or 100 μg/kg body weight (bw)/day, BPS1–3] or vehicle control. Mice were sacrificed and testicular tissue taken for histological analysis and protein identification by nano-liquid chromatography/mass spectrometry (MS) and sperm collected for immunodetection of acetylated lysine and phosphorylated tyrosine followed by protein characterisation using matrix-assisted laser desorption ionisation time-of-flight MS (MALDI-TOF MS)., [Results]: The results indicate that compared to vehicle, 100 μg/kg/day exposure (BPS3) leads to 1) significant histopathology in testicular tissue; and, 2) higher levels of the histone protein γH2AX, a reliable marker of DNA damage. There were fewer mature spermatozoa in the germ layer in the experimental group treated with 1 μg/kg bw (BPS2). Finally, western blot and MALDI-TOF MS studies showed significant alterations in the sperm acetylome and phosphorylome in mice treated with the lowest exposure (0.001 μg/kg/day; BPS1), although the dose is several times lower than what has been published so far., [Conclusions]: In summary, this range of qualitative and quantitative findings in young male mice raise the possibility that very low doses of BPS may impair mammalian reproduction through epigenetic modifications of sperm proteins., This study was supported by the Czech Health Research Council (grant no. NV18–01-00544); the Charles University Research Fund (Progres Q39); the National Sustainability Programme I (NPU I) Nr. LO1503 provided by the Ministry of Education, Youth and Sports of the Czech Republic (MEYS CR); project no. SVV 02690 awarded by MEYS CR; and project no. CZ.02.1.01/0.0/0.0/16_019/0000787 “Fighting Infectious Diseases“, awarded by MEYS CR and financed by The European Regional Development Fund, European Human Biomonitoring Initiative HBM4EU provided by H2020, and the United States Fulbright Commission (P001496 grant to P.R.M.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The NORMAN Suspect List Exchange (NORMAN-SLE): facilitating European and worldwide collaboration on suspect screening in high resolution mass spectrometry

  • Mohammed Taha, Hiba
  • Aalizadeh, Reza
  • Alygizakis, Nikiforos
  • Antignac, Jean-Philippe
  • Arp, Hans Peter H.
  • Bade, Richard
  • Baker, Nancy
  • Belova, Lidia
  • Bijlsma, Lubertus
  • Bolton, Evan E.
  • Brack, Werner
  • Celma, Alberto
  • Chen, Wen-Ling
  • Cheng, Tiejun
  • Chirsir, Parviel
  • Čirka, Ľuboš
  • D'Agostino, Lisa A.
  • Djoumbou Feunang, Yannick
  • Dulio, Valeria
  • Fischer, Stellan
  • Gago-Ferrero, Pablo
  • Galani, Aikaterini
  • Geueke, Birgit
  • Głowacka, Natalia
  • Glüge, Juliane
  • Groh, Ksenia
  • Grosse, Sylvia
  • Haglund, Peter
  • Hakkinen, Pertti J.
  • Hale, Sarah E.
  • Hernandez, Felix
  • Janssen, Elisabeth M.-L.
  • Jonkers, Tim
  • Kiefer, Karin
  • Kirchner, Michal
  • Koschorreck, Jan
  • Krauss, Martin
  • Krier, Jessy
  • Lamoree, Marja H.
  • Letzel, Marion
  • Letzel, Thomas
  • Li, Qingliang
  • Little, James
  • Liu, Yanna
  • Lunderberg, David M.
  • Martin, Jonathan W.
  • McEachran, Andrew D.
  • McLean, John A.
  • Meier, Christiane
  • Meijer, Jeroen
  • Menger, Frank
  • Merino, Carla
  • Muncke, Jane
  • Muschket, Matthias
  • Neumann, Michael
  • Neveu, Vanessa
  • Ng, Kelsey
  • Oberacher, Herbert
  • O'Brien, Jake
  • Oswald, Peter
  • Oswaldova, Martina
  • Picache, Jaqueline A.
  • Postigo, Cristina
  • Ramírez, Noelia
  • Reemtsma, Thorsten
  • Renaud, Justin
  • Rostkowski, Pawel
  • Rüdel, Heinz
  • Salek, Reza M.
  • Samanipour, Saer
  • Scheringer, Martin
  • Schliebner, Ivo
  • Schulz, Wolfgang
  • Schulze, Tobias
  • Sengl, Manfred
  • Shoemaker, Benjamin A.
  • Sims, Kerry
  • Singer, Heinz
  • Singh, Randolph R.
  • Sumarah, Mark
  • Thiessen, Paul A.
  • Thomas, Kevin V.
  • Torres, Sonia
  • Trier, Xenia
  • van Wezel, Annemarie P.
  • Vermeulen, Roel C. H.
  • Vlaanderen, Jelle J.
  • von der Ohe, Peter C.
  • Wang, Zhanyun
  • Williams, Antony J.
  • Willighagen, Egon L.
  • Wishart, David S.
  • Zhang, Jian
  • Thomaidis, Nikolaos S.
  • Hollender, Juliane
  • Slobodnik, Jaroslav
  • Schymanski, Emma L.
The NORMAN Association (https://www.norman-network.com/) initiated the NORMAN Suspect List Exchange (NORMAN-SLE; https://www.norman-network.com/nds/SLE/) in 2015, following the NORMAN collaborative trial on non-target screening of environmental water samples by mass spectrometry. Since then, this exchange of information on chemicals that are expected to occur in the environment, along with the accompanying expert knowledge and references, has become a valuable knowledge base for "suspect screening" lists. The NORMAN-SLE now serves as a FAIR (Findable, Accessible, Interoperable, Reusable) chemical information resource worldwide., The NORMAN-SLE project has received funding from the NORMAN Association via its joint proposal of activities. HMT and ELS are supported by the Luxembourg National Research Fund (FNR) for project A18/BM/12341006. ELS, PC, SEH, HPHA, ZW acknowledge funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101036756, project ZeroPM: Zero pollution of persistent, mobile substances. The work of EEB, TC, QL, BAS, PAT, and JZ was supported by the National Center for Biotechnology Information of the National Library of Medicine (NLM), National Institutes of Health (NIH). JOB is the recipient of an NHMRC Emerging Leadership Fellowship (EL1 2009209). KVT and JOB acknowledge the support of the Australian Research Council (DP190102476). The Queensland Alliance for Environmental Health Sciences, The University of Queensland, gratefully acknowledges the financial support of the Queensland Department of Health. NR is supported by a Miguel Servet contract (CP19/00060) from the Instituto de Salud Carlos III, co-financed by the European Union through Fondo Europeo de Desarrollo Regional (FEDER). MM and TR gratefully acknowledge financial support by the German Ministry for Education and Research (BMBF, Bonn) through the project “Persistente mobile organische Chemikalien in der aquatischen Umwelt (PROTECT)” (FKz: 02WRS1495 A/B/E). LiB acknowledges funding through a Research Foundation Flanders (FWO) fellowship (11G1821N). JAP and JMcL acknowledge financial support from the NIH for CCSCompendium (S50 CCSCOMPEND) via grants NIH NIGMS R01GM092218 and NIH NCI 1R03CA222452-01, as well as the Vanderbilt Chemical Biology Interface training program (5T32GM065086-16), plus use of resources of the Center for Innovative Technology (CIT) at Vanderbilt University. TJ was (partly) supported by the Dutch Research Council (NWO), project number 15747. UFZ (TS, MaK, WB) received funding from SOLUTIONS project (European Union’s Seventh Framework Programme for research, technological development and demonstration under Grant Agreement No. 603437). TS, MaK, WB, JPA, RCHV, JJV, JeM and MHL acknowledge HBM4EU (European Union’s Horizon 2020 research and innovation programme under the grant agreement no. 733032). TS acknowledges funding from NFDI4Chem—Chemistry Consortium in the NFDI (supported by the DFG under project number 441958208). TS, MaK, WB and EMLJ acknowledge NaToxAq (European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 722493). S36 and S63 (HPHA, SEH, MN, IS) were funded by the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) Project No. (FKZ) 3716 67 416 0, updates to S36 (HPHA, SEH, MN, IS) by the German Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection (BMUV) Project No. (FKZ) 3719 65 408 0. MiK acknowledges financial support from the EU Cohesion Funds within the project Monitoring and assessment of water body status (No. 310011A366 Phase III). The work related to S60 and S82 was funded by the Swiss Federal Office for the Environment (FOEN), KK and JH acknowledge the input of Kathrin Fenner’s group (Eawag) in compiling transformation products from European pesticides registration dossiers. DSW and YDF were supported by the Canadian Institutes of Health Research and Genome Canada. The work related to S49, S48 and S77 was funded by the MAVA foundation; for S77 also the Valery Foundation (KG, JaM, BG). DML acknowledges National Science Foundation Grant RUI-1306074. YL acknowledges the National Natural Science Foundation of China (Grant No. 22193051 and 21906177), and the Chinese Postdoctoral Science Foundation (Grant No. 2019M650863). WLC acknowledges research project 108C002871 supported by the Environmental Protection Administration, Executive Yuan, R.O.C. Taiwan (Taiwan EPA). JG acknowledges funding from the Swiss Federal Office for the Environment. AJW was funded by the U.S. Environmental Protection Agency. LuB, AC and FH acknowledge the financial support of the Generalitat Valenciana (Research Group of Excellence, Prometeo 2019/040). KN (S89) acknowledges the PhD fellowship through Marie Skłodowska-Curie grant agreement No. 859891 (MSCA-ETN). Exposome-Explorer (S34) was funded by the European Commission projects EXPOsOMICS FP7-KBBE-2012 [308610]; NutriTech FP7-KBBE-2011-5 [289511]; Joint Programming Initiative FOODBALL 2014–17. CP acknowledges grant RYC2020-028901-I funded by MCIN/AEI/1.0.13039/501100011033 and “ESF investing in your future”, and August T Larsson Guest Researcher Programme from the Swedish University of Agricultural Sciences. The work of ML, MaSe, SG, TL and WS creating and filling the STOFF-IDENT database (S2) mostly sponsored by the German Federal Ministry of Education and Research within the RiSKWa program (funding codes 02WRS1273 and 02WRS1354). XT acknowledges The National Food Institute, Technical University of Denmark. MaSch acknowledges funding by the RECETOX research infrastructure (the Czech Ministry of Education, Youth and Sports, LM2018121), the CETOCOEN PLUS project (CZ.02.1.01/0.0/0.0/15_003/0000469), and the CETOCOEN EXCELLENCE Teaming 2 project supported by the Czech ministry of Education, Youth and Sports (No CZ.02.1.01/0.0/0.0/17_043/0009632)., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

HBM4EU Chromates Study Genotoxicity and Oxidative Stress Biomarkers in workers exposed to Hexavalent Chromium

  • Tavares, Ana
  • Aimonen, Kukka
  • Ndaw, Sophie
  • Fucic, Aleksandra
  • Catalan, Julia
  • Duca, Radu Corneliu
  • Godderis, Lode
  • Gomes, Bruno C.
  • Janasik, Beata
  • Ladeira, Carina
  • Louro, Henriqueta
  • Namorado, Sonia
  • Nieuwenhuyse, An Van
  • Norppa, Hannu
  • Scheepers, Paul T. J.
  • Ventura, Celia
  • Verdonck, Jelle
  • Viegas, Susana
  • Wasowicz, Wojciech
  • Santonen, Tiina
  • Silva, Maria Joao
  • HBM4EU Chromates Study Team
A study was conducted within the European Human Biomonitoring Initiative (HBM4EU) to characterize occupational exposure to Cr(VI). Herein we present the results of biomarkers of genotoxicity and oxidative stress, including micronucleus analysis in lymphocytes and reticulocytes, the comet assay in whole blood, and malondialdehyde and 8-oxo-2''-deoxyguanosine in urine. Workers from several Cr(VI)-related industrial activities and controls from industrial (within company) and nonindustrial (outwith company) environments were included. The significantly increased genotoxicity (p = 0.03 for MN in lymphocytes and reticulocytes; p < 0.001 for comet assay data) and oxidative stress levels (p = 0.007 and p < 0.001 for MDA and 8-OHdG levels in pre-shift urine samples, respectively) that were detected in the exposed workers over the outwith company controls suggest that Cr(VI) exposure might still represent a health risk, particularly, for chrome painters and electrolytic bath platers, despite the low Cr exposure. The within-company controls displayed DNA and chromosomal damage levels that were comparable to those of the exposed group, highlighting the relevance of considering all industry workers as potentially exposed. The use of effect biomarkers proved their capacity to detect the early biological effects from low Cr(VI) exposure, and to contribute to identifying subgroups that are at higher risk. Overall, this study reinforces the need for further re-evaluation of the occupational exposure limit and better application of protection measures. However, it also raised some additional questions and unexplained inconsistencies that need follow-up studies to be clarified.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Childhood exposure to non-persistent endocrine disrupting chemicals and multi-omic profiles: a panel study

  • Fabbri, Lorenzo
  • Garlantézec, Ronan
  • Audouze, Karine
  • Bustamante Pineda, Mariona
  • Carracedo, Ángel
  • Chatzi, Leda
  • González, Juan Ramón
  • Gražulevičienė, Regina
  • Keun, Hector C.
  • Lau, Chung-Ho E.
  • Sabidó Aguadé, Eduard, 1981-
  • Siskos, Alexandros P.
  • Slama, Rémy
  • Thomsen, Cathrine
  • Wright, John
  • Yuan, Wen Lun
  • Casas, Maribel
  • Vrijheid, Martine
  • Maitre, Léa
Individuals are exposed to environmental pollutants with endocrine disrupting activity (endocrine disruptors, EDCs) and the early stages of life are particularly susceptible to these exposures. Previous studies have focused on identifying molecular signatures associated with EDCs, but none have used repeated sampling strategy and integrated multiple omics. We aimed to identify multi-omic signatures associated with childhood exposure to non-persistent EDCs. We used data from the HELIX Child Panel Study, which included 156 children aged 6 to 11. Children were followed for one week, in two time periods. Twenty-two non-persistent EDCs (10 phthalate, 7 phenol, and 5 organophosphate pesticide metabolites) were measured in two weekly pools of 15 urine samples each. Multi-omic profiles (methylome, serum and urinary metabolome, proteome) were measured in blood and in a pool urine samples. We developed visit-specific Gaussian Graphical Models based on pairwise partial correlations. The visit-specific networks were then merged to identify reproducible associations. Independent biological evidence was systematically sought to confirm some of these associations and assess their potential health implications. 950 reproducible associations were found among which 23 were direct associations between EDCs and omics. For 9 of them, we were able to find corroborating evidence from previous literature: DEP - serotonin, OXBE - cg27466129, OXBE - dimethylamine, triclosan - leptin, triclosan - serotonin, MBzP - Neu5AC, MEHP - cg20080548, oh-MiNP - kynurenine, oxo-MiNP − 5-oxoproline. We used these associations to explore possible mechanisms between EDCs and health outcomes, and found links to health outcomes for 3 analytes: serotonin and kynurenine in relation to neuro-behavioural development, and leptin in relation to obesity and insulin resistance. This multi-omics network analysis at two time points identified biologically relevant molecular signatures related to non-persistent EDC exposure in childhood, suggesting pathways related to neurological and metabolic outcomes., The research leading to these results was supported by the European Community’s Seventh Framework Programme [FP7/2007–2013] under grant agreement no. 308333 [the HELIX project], and by the European Union’s Horizon 2020 research and innovation programme under grant agreements no. 874583 [ATHLETE], and no. 733032 [HBM4EU]. We acknowledge the input of the entire HELIX consortium. We are grateful to all the participating families in the five cohorts (BiB, EDEN, INMA, MoBa, KANC, and RHEA cohorts) that took part in this study. We are equally grateful to all the fieldworkers for their dedication and efficiency in this study. LM is funded by a Juan de la Cierva-Incorporación fellowship (IJC2018-035394-I) awarded by the Spanish Ministerio de Economía, Industria y Competitividad. ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019-2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Exposure to bisphenol A in European women from 2007 to 2014 using human biomonitoring data - The European Joint Programme HBM4EU

  • Tagne-Fotso, Romuald
  • Montazeri, Parisa, 1988-
  • Urquiza, José M.
  • Vrijheid, Martine
  • Rambaud, Loïc
Background: Bisphenol A (BPA; or 4,4'-isopropylidenediphenol) is an endocrine disrupting chemical. It was widely used in a variety of plastic-based manufactured products for several years. The European Food Safety Authority (EFSA) recently reduced the Tolerable Daily Intake (TDI) for BPA by 20,000 times due to concerns about immune-toxicity. Objective: We used human biomonitoring (HBM) data to investigate the general level of BPA exposure from 2007 to 2014 of European women aged 18-73 years (n = 4,226) and its determinants. Methods: Fifteen studies from 12 countries (Austria, Belgium, Denmark, France, Germany, Greece, Israel, Luxembourg, Slovenia, Spain, Sweden, and the United Kingdom) were included in the BPA Study protocol developed within the European Joint Programme HBM4EU. Seventy variables related to the BPA exposure were collected through a rigorous post-harmonization process. Linear mixed regression models were used to investigate the determinants of total urine BPA in the combined population. Results: Total BPA was quantified in 85-100 % of women in 14 out of 15 contributing studies. Only the Austrian PBAT study (Western Europe), which had a limit of quantification 2.5 to 25-fold higher than the other studies (LOQ=2.5 µg/L), found total BPA in less than 5 % of the urine samples analyzed. The geometric mean (GM) of total urine BPA ranged from 0.77 to 2.47 µg/L among the contributing studies. The lowest GM of total BPA was observed in France (Western Europe) from the ELFE subset (GM=0.77 µg/L (0.98 µg/g creatinine), n = 1741), and the highest levels were found in Belgium (Western Europe) and Greece (Southern Europe), from DEMOCOPHES (GM=2.47 µg/L (2.26 µg/g creatinine), n = 129) and HELIX-RHEA (GM=2.47 µg/L (2.44 µg/g creatinine), n = 194) subsets, respectively. One hundred percent of women in 14 out of 15 data collections in this study exceeded the health-based human biomonitoring guidance value for the general population (HBM-GVGenPop) of 0.0115 µg total BPA/L urine derived from the updated EFSA's BPA TDI. Variables related to the measurement of total urine BPA and those related to the main socio-demographic characteristics (age, height, weight, education, smoking status) were collected in almost all studies, while several variables related to BPA exposure factors were not gathered in most of the original studies (consumption of beverages contained in plastic bottles, consumption of canned food or beverages, consumption of food in contact with plastic packaging, use of plastic film or plastic containers for food, having a plastic floor covering in the house, use of thermal paper…). No clear determinants of total urine BPA concentrations among European women were found. A broader range of data planned for collection in the original questionnaires of the contributing studies would have resulted in a more thorough investigation of the determinants of BPA exposure in European women. Conclusion: This study highlights the urgent need for action to further reduce exposure to BPA to protect the population, as is already the case in the European Union. The study also underscores the importance of pre-harmonizing HBM design and data for producing comparable data and interpretable results at a European-wide level, and to increase HBM uptake by regulatory agencies., This study was a part of the HBM4EU project receiving funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 733032. Born in Bradford is funded from a variety of sources including A Wellcome Trust infrastructure grant (WT101597MA), a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC): MR/N024391/1; The British Heart Foundation (BHF) (CS/16/4/32482); The National Institute for Health and Care Research under its Applied Research Collaboration for Yorkshire and Humber NIHR200166; the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement 308333–the HELIX project. The views expressed in this publication are those of the author(s) and not necessarily those of the National Institute for Health and Care Research or the Department of Health and Social Care. DEMOCOPHES running in 2011–2012 was funded by the 7th European Union program (DG Research – No. 244237-COPHES), with a LIFE+2009 'Policy and governance' (DG Environment – LIFE09/ENV/BE/000410-DEMOCOPHES), with additional co-funding from DEMOCOPHES partners. The Belgian DEMOCOPHES study was co-financed by the Ministers of Environment and Health. It was coordinated by the Federal public service for health, food chain safety and environment (FOD) and followed up by the Belgian Cell Environment and Health including all federal, Flemish, Walloon and Brussels governmental entities working on Health and Environment. The Danish DEMOCOPHES study from 2011 to 2012 was co-financed by the Danish ministries of health, environment and food safety. The contribution of Luxembourg to DEMOCOPHES from 2011 to 2012 was co-financed by Luxembourg Institute of Science and Technology (LIST). The Slovenian DEMOCOPHES study was co-funded by the Slovenian Research Agency program P-0143. DEMOCOPHES in Spain was co-funded by the Spanish Ministry of Agricultures, Food and Environmental and the Instituto de Salud Carlos III (SEG 1251/07 and SEG 1112/10). The German ESB is funded by the Federal Ministry for the Environment, Nature Conservation, Nuclear Safety and Consumer Protection. The Israeli IBS study was supported by Research Grant Award No. RGA 902 from the Environment and Health Fund, Jerusalem, Israel. The Austrian PBAT study was partially financed by the former Austrian Federal Ministry of Agriculture, Forestry, Environment and Water Management and by the Environment Agency Austria. Samples were provided from the Austrian Study of Nutritional Status 2012, which was funded by the former Austrian Federal Ministry of Health. The French human biomonitoring program, of which the ELFE cohort was a component, was funded by the French Ministries of Health and the Environment. ELFE benefited from additional funding from the Ministry of Research, Committee on SHS data (CCDSHS) and Ministry of Culture and Communication (Deps), and as part of the RECONAI platform, from National Research Agency funding (ANR-11-EQPX-0038).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Position paper on management of personal data in environment and health research in Europe

  • Govarts, Eva
  • Gilles, Liese
  • Bopp, Stephanie
  • Holub, Petr
  • Matalonga, Leslie
  • Vermeulen, Roel
  • Vrijheid, Martine
  • Beltran, Sergi
  • Hartlev, Mette
  • Jones, Sarah
  • Rodriguez Martin, Laura
  • Standaert, Arnout
  • Swertz, Morris A.
  • Theunis, Jan
  • Trier, Xenia
  • Vogel, Nina
  • Van Espen, Koert
  • Remy, Sylvie
  • Schoeters, Greet
Management of datasets that include health information and other sensitive personal information of European study participants has to be compliant with the General Data Protection Regulation (GDPR, Regulation (EU) 2016/679). Within scientific research, the widely subscribed'FAIR' data principles should apply, meaning that research data should be findable, accessible, interoperable and re-usable. Balancing the aim of open science driven FAIR data management with GDPR compliant personal data protection safeguards is now a common challenge for many research projects dealing with (sensitive) personal data. In December 2020 a workshop was held with representatives of several large EU research consortia and of the European Commission to reflect on how to apply the FAIR data principles for environment and health research (E&H). Several recent data intensive EU funded E&H research projects face this challenge and work intensively towards developing solutions to access, exchange, store, handle, share, process and use such sensitive personal data, with the aim to support European and transnational collaborations. As a result, several recommendations, opportunities and current limitations were formulated. New technical developments such as federated data management and analysis systems, machine learning together with advanced search software, harmonized ontologies and data quality standards should in principle facilitate the FAIRification of data. To address ethical, legal, political and financial obstacles to the wider re-use of data for research purposes, both specific expertise and underpinning infrastructure are needed. There is a need for the E&H research data to find their place in the European Open Science Cloud. Communities using health and population data, environmental data and other publicly available data have to interconnect and synergize. To maximize the use and re-use of environment and health data, a dedicated supporting European infrastructure effort, such as the EIRENE research infrastructure within the ESFRI roadmap 2021, is needed that would interact with existing infrastructures., HBM4EU is co-financed under Horizon 2020 (grant agreement No 733032). EUCAN-Connect is funded by the European Commission within the call topic SC1-BHC-05-2018: “International flagship collaboration with Canada for human data storage, integration and sharing to enable personalized medicine approaches” (Grant Agreement No 824989). The Canadian project partners have been funded by the Canadian Institutes of Health Research (CIHR) and the Fonds de recherche du Québec – Santé. The LifeCycle project received funding from the European Union’s Horizon 2020 research and innovation programme (Grant Agreement No. 733206 LifeCycle). The HELIX project received funding from the European Community’s Seventh Framework Programme (grant agreement no 308333 HELIX). ISGlobal acknowledges support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019-2023” Program (CEX2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. Roel Vermeulen is supported by EXPOSOME-NL and EXPANSE. EXPOSOME-NL is funded through the Gravitation program of the Dutch Ministry of Education, Culture, and Science and the Netherlands Organization for Scientific Research (NWO grant number 024.004.017). EXPANSE has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 874627. EOSC-Life project supported by EU Horizon 2020, grant agreement no. 824087. EJP-RD and Solve-RD projects have been financed under Horizon 2000 (grant numbers H2020 779257 and H2020 825575).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Harmonized human biomonitoring in European children, teenagers and adults: EU-wide exposure data of 11 chemical substance groups from the HBM4EU Aligned Studies (2014-2021)

  • Govarts, Eva
  • Montazeri, Parisa, 1988-
  • Schoeters, Greet
As one of the core elements of the European Human Biomonitoring Initiative (HBM4EU) a human biomonitoring (HBM) survey was conducted in 23 countries to generate EU-wide comparable HBM data. This survey has built on existing HBM capacity in Europe by aligning national or regional HBM studies, referred to as the HBM4EU Aligned Studies. The HBM4EU Aligned Studies included a total of 10,795 participants of three age groups: (i) 3,576 children aged 6-12 years, (ii) 3,117 teenagers aged 12-18 years and (iii) 4,102 young adults aged 20-39 years. The participants were recruited between 2014 and 2021 in 11-12 countries per age group, geographically distributed across Europe. Depending on the age group, internal exposure to phthalates and the substitute DINCH, halogenated and organophosphorus flame retardants, per- and polyfluoroalkyl substances (PFASs), cadmium, bisphenols, polycyclic aromatic hydrocarbons (PAHs), arsenic species, acrylamide, mycotoxins (deoxynivalenol (total DON)), benzophenones and selected pesticides was assessed by measuring substance specific biomarkers subjected to stringent quality control programs for chemical analysis. For substance groups analyzed in different age groups higher average exposure levels were observed in the youngest age group, i.e., phthalates/DINCH in children versus teenagers, acrylamide and pesticides in children versus adults, benzophenones in teenagers versus adults. Many biomarkers in teenagers and adults varied significantly according to educational attainment, with higher exposure levels of bisphenols, phthalates, benzophenones, PAHs and acrylamide in participants (from households) with lower educational attainment, while teenagers from households with higher educational attainment have higher exposure levels for PFASs and arsenic. In children, a social gradient was only observed for the non-specific pyrethroid metabolite 3-PBA and di-isodecyl phthalate (DiDP), with higher levels in children from households with higher educational attainment. Geographical variations were seen for all exposure biomarkers. For 15 biomarkers, the available health-based HBM guidance values were exceeded with highest exceedance rates for toxicologically relevant arsenic in teenagers (40%), 3-PBA in children (36%), and between 11 and 14% for total DON, Σ (PFOA + PFNA + PFHxS + PFOS), bisphenol S and cadmium. The infrastructure and harmonized approach succeeded in obtaining comparable European wide internal exposure data for a prioritized set of 11 chemical groups. These data serve as a reference for comparison at the global level, provide a baseline to compare the efficacy of the European Commission's chemical strategy for sustainability and will give leverage to national policy makers for the implementation of targeted measures., We would like to acknowledge Sun Kyoung Jung from the National Institute of Environmental Research of South-Korea for providing the KoNEHS Cycle III results (crt adjusted). HBM4EU is co-financed under Horizon 2020 (grant agreement No 733032). The authors thank all principal investigators of the contributing studies for their participation and contribution to the HBM4EU Aligned Studies and the national program owners for their financial support. Further details on funding for all the participating studies can be found in the Supplemental Material, Table S12.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies

  • Mustieles, Vicente
  • Balogh, Ria K.
  • Axelstad, Marta
  • Montazeri, Parisa, 1988-
  • Márquez, Sandra
  • Vrijheid, Martine
  • Draskau, Monica K.
  • Taxvig, Camilla
  • Peinado, Francisco M.
  • Berman, Tamar
  • Frederiksen, Hanne
  • Fernández, Mariana F.
  • Vinggaard, Anne Marie
  • Andersson, Anna-Maria
Background: Benzophenone-3 (BP-3) and its major metabolite benzophenone-1 (BP-1) are widely used as UV filters in sunscreens and cosmetics to prevent sunburn and skin damage, or as stabilizers to prevent photodegradation in many commercial products. As a result, their presence is ubiquitous in the environment, wildlife and humans. Based on endocrine disruption concerns, international regulatory agencies are performing a closer evaluation. Objective and methods: This work aimed to comprehensively review the available human relevant evidence for safety issues in MEDLINE/PubMed in order to create a structured database of studies, as well as to conduct an integrative analysis as part of the Human Biomonitoring for Europe (HBM4EU) Initiative. Results: A total of 1,635 titles and abstracts were screened and 254 references were evaluated and tabulated in detail, and classified in different categories: i) exposure sources and predictors; ii) human biomonitoring (HBM) exposure levels to perform a meta-analysis; iii) toxicokinetic data in both experimental animals and humans; iv) in vitro and in vivo rodent toxicity studies; and v) human data on effect biomarkers and health outcomes. Our integrative analysis showed that internal peak BP-3 concentrations achieved after a single whole-body application of a commercially available sunscreen (4% w/w) may overlap with concentrations eliciting endocrine disrupting effects in vitro, and with internal concentrations causing in vivo adverse female reproductive effects in rodents that were supported by still limited human data. The adverse effects in rodents included prolonged estrous cycle, altered uterine estrogen receptor gene expression, endometrium hyperplasia and altered proliferation and histology of the mammary gland, while human data indicated menstrual cycle hormonal alterations and increased risk of uterine fibroids and endometriosis. Among the modes of action reported (estrogenic, anti-androgenic, thyroid, etc.), BP-3 and especially BP-1 showed estrogenic activity at human-relevant concentrations, in agreement with the observed alterations in female reproductive endpoints. The meta-analysis of HBM studies identified a higher concern for North Americans, showing urinary BP-3 concentrations on average 10 and 20 times higher than European and Asian populations, respectively. Discussion and conclusions: Our work supports that these benzophenones present endocrine disrupting properties, endorsing recent European regulatory efforts to limit human exposure. The reproducible and comprehensive database generated may constitute a point of departure in future risk assessments to support regulatory initiatives. Meanwhile, individuals should not refrain from sunscreen use. Commercially available formulations using inorganic UV filters that are practically not absorbed into systemic circulation may be recommended to susceptible populations., This work is a direct product of the Human Biomonitoring for Europe Project (European Union Commission H2020-EJP-HBM4EU Grant agreement No 733032). The funder had no role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. V. Mustieles and P. Montazeri were under contract within the HBM4EU Initiative.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Unravelling sex-specific BPA toxicokinetics in children using a pediatric PBPK model

  • Deepika, Deepika
  • Sharma, Raju Prasad
  • Schuhmacher, Marta
  • Sakhi, Amrit Kaur
  • Thomsen, Cathrine
  • Chatzi, Leda
  • Vafeiadi, Marina, 1983-
  • Quentin, Joane
  • Slama, Rémy
  • Gražulevičienė, Regina
  • Andrušaitytė, Sandra
  • Waiblinger, Dagmar
  • Wright, John
  • Yang, Tiffany C.
  • Urquiza, José M.
  • Vrijheid, Martine
  • Casas Sanahuja, Maribel
  • Domingo, José L.
  • Kumar, Vikas
Bisphenol A (BPA) is a widely known endocrine disruptor (ED) found in many children's products such as toys, feeding utensils, and teething rings. Recent epidemiology association studies have shown postnatal BPA exposure resulted in developing various diseases such as diabetes, obesity, and neurodegeneration, etc., later in their lives. However, little is known about its sex-specific metabolism and consequently internal exposure. The aim of this study was to develop a sex-specific pediatric physiologically based pharmacokinetic model (PBPK) for BPA to compare their toxicokinetic differences. First, the published adult PBPK model was re-validated, and then this model was extended by interpolation to incorporate pediatric sex specific physiological and biochemical parameters. We used both the classical body weight and ontogeny-based scaling approach to interpolate the metabolic process. Then, the pharmacokinetic attributes of the models using the two-scaling approach mentioned above were compared with adult model. Further, a sex-specific PBPK model with an ontogeny scaling approach was preferred to evaluate the pharmacokinetic differences. Moreover, this model was used to reconstruct the BPA exposure from two cohorts (Helix and PBAT Cohort) from 7 EU countries. The half-life of BPA was found to be almost the same in boys and girls at the same exposure levels. Our model estimated BPA children's exposure to be about 1500 times higher than the tolerable daily intake (TDI) recently set by European Food Safety Authority (EFSA) i.e., 0.04 ng/kg BW/day. The model demonstrated feasibility of extending the adult PBPK to sex-specific pediatric, thus investigate a gender-specific health risk assessment., This study was financially supported by Marie Skłodowska-Curie “Neurosome Project” under the grant agreement No. 766251, the European Community funded H2020 HBM4EU project under Grant Agreements no. 733032, and the Instituto de Salud Carlos III (PI17/01194), and the European Community's Seventh Framework Programme (FP7/2007–206) under grant agreement no 308333 (HELIX project). Maribel Casas holds a Miguel Servet fellowship (CP16/00128) funded by Instituto de Salud Carlos III and co-funded by European Social Fund “Investing in your future”. We acknowledge support from the Spanish Ministry of Science and Innovation through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (2018-000806-S), and support from the Generalitat de Catalunya through the CERCA Program. This publication reflects only the authors' views. The Community and other funding organizations are not liable for any use made of the information contained therein. Born in Bradford is only possible because of the enthusiasm and commitment of the children and parents in Born in Bradford. We are grateful to all participants, health professionals and researchers who have made Born in Bradford happen. BiB receives core infrastructure funding from the Wellcome Trust (WT101597MA) and a joint grant from the UK Medical Research Council (MRC) and Economic and Social Science Research Council (ESRC) (MR/N024397/1). This study has received support from European Research Council under the European Union's Seventh Framework Programme (FP7/2007–2013)/ERC grant agreement no 669545 and National Institute for Health Research Applied Research Collaboration Yorkshire and Humber (NIHR200166).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Association of exposure to mixture of chemicals during pregnancy with cognitive abilities and fine motor function of children

  • Brennan Kearns, Pavla
  • van den Dries, Michiel
  • Júlvez Calvo, Jordi
  • Kampouri, Mariza
  • López Vicente, Mònica, 1988-
  • Maitre, Léa
  • Philippat, Claire
  • Haug, Line Småstuen
  • Vafeiadi, Marina, 1983-
  • Thomsen, Cathrine
  • Yang, Tiffany C.
  • Vrijheid, Martine
  • Tiemeier, Henning
  • Guxens Junyent, Mònica
Chemical exposures often occur in mixtures and exposures during pregnancy may lead to adverse effects on the fetal brain, potentially reducing lower cognitive abilities and fine motor function of the child. We investigated the association of motheŕs exposure to a mixture of chemicals during pregnancy (i.e., organochlorine compounds, per- and polyfluoroalkyl substances, phenols, phthalates, organophosphate pesticides) with cognitive abilties and fine motor function in their children. We studied 1097 mother-child pairs from five European cohorts participating in the Human Early Life Exposome study (HELIX). Measurement of 26 biomarkers of exposure to chemicals was performed on urine or blood samples of pregnant women (mean age 31 years). Cognitive abilities and fine motor function were assessed in their children (mean age 8 years) with a battery of computerized tests administered in person (Raveńs Coloured Progressive Matrices, Attention Network Test, N-back Test, Trail Making Test, Finger Tapping Test). We estimated the joint effect of prenatal exposure to chemicals on cognitive abilities and fine motor function using the quantile-based g-computation method, adjusting for sociodemographic characteristics. A quartile increase in all the chemicals in the overall mixture was associated with worse fine motor function, specifically lower scores in the Finger Tapping Test [-8.5 points, 95 % confidence interval (CI) -13.6 to -3.4; -14.5 points, 95 % CI -22.4 to -6.6, and -18.0 points, 95 % CI -28.6 to -7.4) for the second, third and fourth quartile of the overal mixture, respectively, when compared to the first quartile]. Organochlorine compounds, phthalates, and per- and polyfluoroalkyl substances contributed most to this association. We did not find a relationship with cognitive abilities. We conclude that exposure to chemical mixtures during pregnancy may influence neurodevelopment, impacting fine motor function of the offspring., The study was supported by the European Community’s Seventh Framework Programme [FP7/2007–2013] under grant agreement no. 308333 [the HELIX project], and by the European Union’s Horizon 2020 research and innovation programme under grant agreements no. 874583 [ATHLETE], and no. 733032 [HBM4EU]. We further acknowledge funding from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. FEDER funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds, CPII18/00018), CIBERESP, Generalitat de Catalunya-CIRIT 1999SGR 00241, Generalitat de Catalunya-AGAUR (2009 SGR 501, 2014 SGR 822), Fundació La marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds, Juan de la Cierva-Incorporación fellowship IJC2018-035394-I), Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010), EU Commission (261357, 603794 and 634453), project IJC2020-045355-I, funded by MCIN/AEI/10.13039/501100011033 and by the European Union NextGenerationEU/PRTR. We also acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/ 10.13039/501100011033, the European Union NextGenerationEU/PRTR and support from the Generalitat de Catalunya through the CERCA Program. BiB receives funding from by a joint grant from the UK Medical Research Council (MRC) and UK Economic and Social Science Research Council (ESRC) [MR/N024391/1]; the British Heart Foundation [CS/16/4/32482]; a Wellcome Infrastructure Grant [WT101597MA]; The National Institute for Health Research under its Applied Research Collaboration for Yorkshire and Humber [NIHR200166]. The views expressed are those of the author(s), and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. The authors acknowledge that BiB is only possible because of the enthusiasm and commitment of the children and parents in BiB. We are grateful to all participants, health professionals and researchers who have made BiB happen. MoBa is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. EDEN was supported by Foundation for medical research (FRM), National Agency for Research (ANR), National Institute for Research in Public health (IRESP: TGIR cohorte santé 2008 program), French Ministry of Health (DGS), French Ministry of Research, INSERM Bone and Joint Diseases National Research (PRO-A), and Human Nutrition National Research Programs, Paris-Sud University, Nestlé, French National Institute for Population Health Surveillance (InVS), French National Institute for Health Education (INPES), Diabetes National Research Program (through a collaboration with the French Association of Diabetic Patients (AFD)), French Agency for Environmental Health Safety (now ANSES), Mutuelle Générale de l’Education Nationale a complementary health insurance (MGEN), French national agency for food security, French-speaking association for the study of diabetes and metabolism (ALFEDIAM). RHEA was supported by the General Secretariat for Research and Technology in Greece and the Research Committee of the University of Crete, Greece. We acknowledge the input of the entire HELIX consortium. We are grateful to all the participating families in the cohorts that took part in this study and all fieldworkers. The funding sources had no role in the conceptualization of this manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

PFAS levels and exposure determinants in sensitive population groups

  • Fábelová, Lucia
  • Casas Sanahuja, Maribel
  • Vrijheid, Martine
  • Palkovičová Murínová, Lubica
Background: Per- and polyfluoroalkyl substances (PFAS) are persistent organic pollutants. The first exposure to PFAS occurs in utero, after birth it continues via breast milk, food intake, environment, and consumer products that contain these chemicals. Our aim was to identify determinants of PFAS concentrations in sensitive population subgroups- pregnant women and newborns. Methods: Nine European birth cohorts provided exposure data on PFAS in pregnant women (INMA-Gipuzkoa, Sabadell, Valencia, ELFE and MoBa; total N = 5897) or newborns (3xG study, FLEHS 2, FLEHS 3 and PRENATAL; total N = 940). PFOS, PFOA, PFHxS and PFNA concentrations were measured in maternal or cord blood, depending on the cohort (FLEHS 2 measured only PFOS and PFOA). PFAS concentrations were analysed according to maternal characteristics (age, BMI, parity, previous breastfeeding, smoking, and food consumption during pregnancy) and parental educational level. The association between potential determinants and PFAS concentrations was evaluated using multiple linear regression models. Results: We observed significant variations in PFAS concentrations among cohorts. Higher PFAS concentrations were associated with higher maternal age, primipara birth, and educational level, both for maternal blood and cord blood. Higher PFAS concentrations in maternal blood were associated with higher consumption of fish and seafood, meat, offal and eggs. In cord blood, higher PFHxS concentrations were associated with daily meat consumption and higher PFNA with offal consumption. Daily milk and dairy consumption were associated with lower concentrations of PFAS in both, pregnant women and newborns. Conclusion: High detection rates of the four most abundant PFAS demonstrate ubiquitous exposure of sensitive populations, which is of concern. This study identified several determinants of PFAS exposure in pregnant women and newborns, including dietary factors, and these findings can be used for proposing measures to reduce PFAS exposure, particularly from dietary sources., This work was supported by the European Union’s Horizon 2020 research and innovation programme under Grant agreement No 733032 HBM4EU (http://www.hbm4eu.eu), and received co-funding from the authors' organizations: 3xG: The 3xG study was financed and steered by NIRAS and the local partnerships MONA and STORA. ELFE: The Elfe survey is a joint project between the French Institute for Demographic Studies (INED) and the National Institute of Health and Medical Research (INSERM), in partnership with the French blood transfusion service (Etablissement français du sang, EFS), Santé publique France, the National Institute for Statistics and Economic Studies (INSEE), the Direction générale de la santé (DGS, part of the Ministry of Health and Social Affairs), the Direction générale de la prévention des risques (DGPR, Ministry for the Environment), the Direction de la recherche, des études, de l’évaluation et des statistiques (DREES, Ministry of Health and Social Affairs), the Département des études, de la prospective et des statistiques (DEPS, Ministry of Culture), and the Caisse nationale des allocations familiales (CNAF), with the support of the Ministry of Higher Education and Research and the Institut national de la jeunesse et de l’éducation populaire (INJEP). Via the RECONAI platform, it receives a government grant managed by the National Research Agency under the “Investissements d'avenir” programme (ANR-11-EQPX-0038 and ANR-19-COHO-0001). FLEHS: The Flemish Environment and Health studie (FLEHS) were commissioned, financed and steered by the Flemish Government (Department of Economy, Science and Innovations, Agency for Care and Health and Department of Environment). INMA Valencia: This study was funded by Grants from UE (FP7-ENV-2011 cod 282,957 and HEALTH.2010.2.4.5–1), Spain: ISCIII (Red INMA G03/176, CB06/02/0041; FIS-FEDER: PI03/1615, PI04/1509, PI04/1112, PI04/1931, PI05/1079, PI05/1052, PI06/1213, PI07/0314, PI09/02647, PI11/01007, PI11/02591, PI11/02038, PI13/1944, PI13/2032, PI14/00891, PI14/01687, PI16/1288, and PI17/00663; Miguel Servet-FEDER CP11/00178, CP15/00025, and CPII16/00051), Generalitat Valenciana: FISABIO (UGP 15–230, UGP-15-244, and UGP-15-249), and Alicia Koplowitz Foundation 2017.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Critical review of analytical methods for the determination of flame retardants in human matrices

  • Hajeb, Parvaneh
  • Castaño, Argelia
  • Cequier Manciñeiras, Enrique
  • Covaci, Adrian
  • Esteban López, Marta
  • Gonzalez Antuña, Ana
  • Småstuen Haug, Line
  • Henríquez-Hernández, Luis Alberto
  • Melymuk, Lisa
  • Pérez Luzardo, Octavio Luis
  • Thomsen, Cathrine
  • Vorkamp, Katrin
Human biomonitoring is a powerful approach in assessing exposure to environmental pollutants. Flame retardants (FRs) are of particular concern due to their wide distribution in the environment and adverse health effects. This article reviews studies published in 2009e2020 on the chemical analysis of FRs in a variety of human samples and discusses the characteristics of the analytical methods applied to different FR biomarkers of exposure, including polybrominated diphenyl ethers (PBDEs), hexabromocyclododecane (HBCD), novel halogenated flame retardants (NHFRs), bromophenols, incl. tetrabromobisphenol A (TBBPA), and organophosphorous flame retardants (PFRs). Among the extraction techniques, liquid-liquid extraction (LLE) and solid phase extraction (SPE) were used most frequently due to the good efficiencies in the isolation of the majority of the FR biomarkers, but with challenges for highly lipophilic FRs. Gas chromatography-mass spectrometry (GC-MS) is mainly applied in the instrumental analysis of PBDEs and most NHFRs, with recent inclusions of GC-MS/MS and high resolution MS techniques. Liquid chromatography-MS/MS is mainly applied to HBCD, bromophenols, incl. TBBPA, and PFRs (including metabolites), however, GC-based analysis following derivatization has also been used for phenolic compounds and PFR metabolites. Developments are noticed towards more universal analytical methods, which enable widening method scopes in the human biomonitoring of FRs. Challenges exist with regard to sensitivity required for the low concentrations of FRs in the general population and limited sample material for some human matrices. A strong focus on quality assurance/quality control (QA/QC) measures is required in the analysis of FR biomarkers in human samples, related to their variety of physical-chemical properties, low levels in most human samples and the risk of contamination., This study was part of the HBM4EU project receiving funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 733032. The authors acknowledge Berith E. Knudsen for her help with the literature search.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Biomarkers, matrices and analytical methods targeting human exposure to chemicals selected for a European human biomonitoring initiative

  • Vorkamp, Katrin
  • Castaño, Argelia
  • Antignac, Jean-Philippe
  • Boada, Luis D.
  • Cequier Manciñeiras, Enrique
  • Covaci, Adrian
  • Esteban López, Marta
  • Haug, Line S.
  • Kasper-Sonnenberg, Monika
  • Koch, Holger M.
  • Pérez Luzardo, Octavio Luis
  • Osīte, Agnese
  • Rambaud, Loïc
  • Pinorini, Maria-Teresa
  • Sabbioni, Gabriele
  • Thomsen, Cathrine
The major purpose of human biomonitoring is the mapping and assessment of human exposure to chemicals. The European initiative HBM4EU has prioritized seven substance groups and two metals relevant for human exposure: Phthalates and substitutes (1,2-cyclohexane dicarboxylic acid diisononyl ester, DINCH), bisphenols, per- and polyfluoroalkyl substances (PFASs), halogenated and organophosphorous flame retardants (HFRs and OPFRs), polycyclic aromatic hydrocarbons (PAHs), arylamines, cadmium and chromium. As a first step towards comparable European-wide data, the most suitable biomarkers, human matrices and analytical methods for each substance group or metal were selected from the scientific literature, based on a set of selection criteria. The biomarkers included parent compounds of PFASs and HFRs in serum, of bisphenols and arylamines in urine, metabolites of phthalates, DINCH, OPFRs and PAHs in urine as well as metals in blood and urine, with a preference to measure Cr in erythrocytes representing Cr (VI) exposure. High performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) was the method of choice for bisphenols, PFASs, the HFR hexabromocyclododecane (HBCDD), phenolic HFRs as well as the metabolites of phthalates, DINCH, OPFRs and PAHs in urine. Gas chromatographic (GC) methods were selected for the remaining compounds, e.g. GC-low resolution MS with electron capture negative ionization (ECNI) for HFRs. Both GC–MS and LC-MS/MS were suitable for arylamines. New developments towards increased applications of GC–MS/MS may offer alternatives to GC–MS or LC-MS/MS approaches, e.g. for bisphenols. The metals were best determined by inductively coupled plasma (ICP)-MS, with the particular challenge of avoiding interferences in the Cd determination in urine. The evaluation process revealed research needs towards higher sensitivity and non-invasive sampling as well as a need for more stringent quality assurance/quality control applications and assessments., This study was part of the HBM4EU project receiving funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 733032.